{"meta":{"query_hash":"dc5f51d17aeb","filters":{"venue":"American Society of Clinical Oncology Educational Book"},"cohort_total":109,"direct_labels_cover":1,"predictions_cover":109,"exported":109,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/dc5f51d17aeb","api":"https://metacan.xera.ac/api/v1/cohort?venue=American+Society+of+Clinical+Oncology+Educational+Book"},"results":[{"id":"W1143070445","doi":"10.14694/edbook_am.2015.35.e458","title":"Cell-of-Origin in Diffuse Large B-Cell Lymphoma: Are the Assays Ready for the Clinic?","year":2015,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Foundation","keywords":"Lymphoma; Diffuse large B-cell lymphoma; Gene expression profiling; Immunophenotyping; Immunohistochemistry; Tissue microarray; Malignancy; Computational biology; Pathology; Cancer research; Gene expression; Biology; Gene; Medicine; Immunology; Genetics; Flow cytometry","score_opus":0.2117505345741191,"score_gpt":0.5167497764654623,"score_spread":0.3049992418913432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1143070445","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00051863777,0.97503555,0.000009411331,0.015608172,0.0007579519,0.0025751612,0.00032037054,0.000011168848,0.005163604],"genre_scores_gemma":[0.0005678128,0.9783442,0.001796267,0.006485008,0.001013778,0.0013830322,0.00034305203,0.00005027831,0.010016567],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99528915,0.00065808604,0.002638377,0.00057883706,0.00044528887,0.00039026415],"domain_scores_gemma":[0.95523417,0.03961119,0.0036326756,0.00082282664,0.00048108018,0.00021805527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034531364,0.00040552585,0.0039747413,0.000043488577,0.00010339097,0.0000069799084,0.00052556995,0.00052028155,0.00011858966],"category_scores_gemma":[0.0012666583,0.00021209878,0.0025848527,0.000313926,0.001636308,0.000034818833,0.00012718396,0.00048778605,0.00008663982],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011260305,0.032416437,0.008531258,0.0015277535,0.0007611256,0.000001826178,0.0003402586,1.4575086e-7,2.2617584e-8,0.0002920932,0.44351685,0.51249963],"study_design_scores_gemma":[0.009291499,0.0013492623,0.0051058116,0.00076519063,0.0028901147,0.000009738283,0.0019419016,0.0000087202725,2.7276818e-7,0.000088466964,0.97837144,0.0001775934],"about_ca_topic_score_codex":0.00018071347,"about_ca_topic_score_gemma":0.000015431227,"teacher_disagreement_score":0.5348546,"about_ca_system_score_codex":0.0007707034,"about_ca_system_score_gemma":0.013504606,"threshold_uncertainty_score":0.9920879},"labels":[],"label_agreement":null},{"id":"W1239254370","doi":"10.14694/edbook_am.2015.35.e299","title":"Nonsurgical Management of Cervical Cancer: Locally Advanced, Recurrent, and Metastatic Disease, Survivorship, and Beyond","year":2015,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Survivorship curve; Psychological intervention; Disease; Cervical cancer; Intensive care medicine; Quality of life (healthcare); Incidence (geometry); Cancer; Internal medicine; Nursing","score_opus":0.096030730672649,"score_gpt":0.46097176720035227,"score_spread":0.36494103652770327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1239254370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8857648,0.020016363,0.00013570761,0.08272244,0.0006222683,0.0010006826,0.00013206105,0.000023849652,0.009581851],"genre_scores_gemma":[0.93860036,0.019138852,0.031186296,0.0076310374,0.00027141185,0.00018041796,0.000075213065,0.000022598697,0.0028938144],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99798495,0.00018943074,0.00084975566,0.0003829335,0.00039480036,0.0001981528],"domain_scores_gemma":[0.9963518,0.0019552116,0.00047208605,0.00018012062,0.00029347386,0.000747329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006453567,0.00015946334,0.0009714663,0.00003387324,0.000033295182,0.0000033025344,0.00008879701,0.000056910696,0.00023524057],"category_scores_gemma":[0.0002458754,0.00012719404,0.00025172738,0.00027936016,0.0016751414,0.00006293184,0.000102367056,0.00021965109,0.00000394389],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049797255,0.0037822037,0.37250295,0.0004895614,0.0013471332,0.000012404403,0.0003029435,0.0000072023895,0.0000042777333,0.004330814,0.0054170853,0.6068237],"study_design_scores_gemma":[0.01076219,0.0044642896,0.88835186,0.00019376757,0.0013302366,0.000014197001,0.0019941747,0.000121144156,0.000008780949,0.0036371006,0.08890338,0.00021887007],"about_ca_topic_score_codex":0.00019931841,"about_ca_topic_score_gemma":0.000018579945,"teacher_disagreement_score":0.6066048,"about_ca_system_score_codex":0.000121438396,"about_ca_system_score_gemma":0.0011838402,"threshold_uncertainty_score":0.61721283},"labels":[],"label_agreement":null},{"id":"W1458558311","doi":"10.14694/edbook_am.2015.35.e420","title":"Expectations in the Care of Lung Cancer","year":2015,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Metric (unit); Lung cancer; Clinical Practice; Medicine; Value (mathematics); Face (sociological concept); Population; Intensive care medicine; Actuarial science; Family medicine; Computer science; Operations management; Oncology; Sociology; Economics; Machine learning","score_opus":0.1420664096474788,"score_gpt":0.6069059533660344,"score_spread":0.46483954371855557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1458558311","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009400004,0.98090357,0.0000033240565,0.008685678,0.00026857137,0.0009989928,0.0001181612,0.0000047891513,0.008922938],"genre_scores_gemma":[0.0002807664,0.9910408,0.0024623128,0.0020536396,0.00050802005,0.0008562332,0.00039505283,0.00001953379,0.0023835874],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99766845,0.00031399954,0.0013146922,0.0002694231,0.00029194803,0.00014149943],"domain_scores_gemma":[0.99473506,0.0030440683,0.0013222203,0.00030049344,0.0004977764,0.000100408724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037081877,0.00017552507,0.0020390956,0.00005121593,0.000036471305,0.000002235073,0.00019528494,0.00019660722,0.00021321206],"category_scores_gemma":[0.00023161803,0.00011148924,0.0010192131,0.00038342457,0.0009666306,0.00003309144,0.000025646938,0.00043398846,0.000006377421],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014165399,0.00090089155,0.0032693688,0.001824776,0.0008550142,7.9956965e-7,0.0071336813,0.0000014168322,1.9652372e-8,0.00031275,0.08136887,0.9043183],"study_design_scores_gemma":[0.00060000987,0.00043186083,0.003278195,0.0013089175,0.0029980121,0.000006285169,0.008332916,0.0000023450777,3.3739155e-8,0.000029206978,0.9829264,0.00008578399],"about_ca_topic_score_codex":0.00042678564,"about_ca_topic_score_gemma":0.000039209233,"teacher_disagreement_score":0.90423244,"about_ca_system_score_codex":0.00067174056,"about_ca_system_score_gemma":0.020813528,"threshold_uncertainty_score":0.9847376},"labels":[],"label_agreement":null},{"id":"W1507518844","doi":"10.14694/edbook_am.2015.35.e504","title":"Multiple Myeloma: From Front-Line to Relapsed Therapies","year":2015,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Pomalidomide; Ixazomib; Lenalidomide; Thalidomide; Medicine; Carfilzomib; Multiple myeloma; Bortezomib; Oncology; Internal medicine; Proteasome inhibitor; Refractory (planetary science); Pharmacology; Biology","score_opus":0.21686139164684204,"score_gpt":0.531727034602765,"score_spread":0.314865642955923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1507518844","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00044136262,0.9774246,0.000047265872,0.016325435,0.0005500164,0.0019432615,0.00044073022,0.0000434137,0.0027838743],"genre_scores_gemma":[0.000098777804,0.9186809,0.05058153,0.0053319805,0.001967635,0.0005151622,0.0017868843,0.00007590589,0.020961234],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99501324,0.000721348,0.0021685748,0.00087035785,0.0007450163,0.00048146065],"domain_scores_gemma":[0.9855405,0.010441291,0.0014225519,0.0007793101,0.00070913293,0.0011072011],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0011526837,0.0004940454,0.0051784874,0.0000965995,0.00008346426,0.0000098668925,0.0004250356,0.00058317,0.0015074646],"category_scores_gemma":[0.0028365508,0.0003669244,0.002186495,0.0003013179,0.001460818,0.00006258921,0.00018464116,0.0010704235,0.0009926802],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032680618,0.0020283586,0.00286484,0.00043632078,0.0024225528,0.0000065246372,0.00033176536,2.4722138e-7,6.5170957e-7,0.000013418197,0.15823601,0.83333254],"study_design_scores_gemma":[0.0025782962,0.0027045684,0.0085535925,0.0011685072,0.0011464804,0.000010680279,0.00033770647,0.000013743617,4.8732556e-7,0.00009802567,0.9831205,0.00026739234],"about_ca_topic_score_codex":0.0007466792,"about_ca_topic_score_gemma":0.000037847087,"teacher_disagreement_score":0.8330651,"about_ca_system_score_codex":0.0007921086,"about_ca_system_score_gemma":0.013189516,"threshold_uncertainty_score":0.9998783},"labels":[],"label_agreement":null},{"id":"W1589268924","doi":"10.14694/edbook_am.2015.35.e662","title":"Clonal Evolution Models of Tumor Heterogeneity","year":2015,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Somatic evolution in cancer; Epigenetics; Biology; Multicellular organism; Somatic cell; Clonal selection; Population; Cancer; Epigenesis; Evolutionary biology; Genetics; Cell; Immunology; Gene; DNA methylation; Medicine","score_opus":0.1239913541255759,"score_gpt":0.47544590697740857,"score_spread":0.3514545528518327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1589268924","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007978592,0.9954626,0.00045584393,0.0004502127,0.0005014191,0.0003743631,0.0003561149,0.0000034747798,0.0015980905],"genre_scores_gemma":[0.00046893215,0.9879356,0.0075794053,0.0012264504,0.0012858509,0.00008473191,0.00063421455,0.000033948603,0.00075089047],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99718297,0.00027836795,0.001592946,0.0005055999,0.0002300904,0.00021003738],"domain_scores_gemma":[0.9957648,0.0008323597,0.0021961245,0.00045158877,0.000546271,0.00020883862],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00092332636,0.000260534,0.0019746874,0.000028409799,0.000033516455,0.000003292739,0.00038710612,0.0003986759,0.000035637],"category_scores_gemma":[0.00044704688,0.00024662405,0.001601997,0.00012358691,0.0014664135,0.0000044867074,0.00020510578,0.00030164345,0.000008934752],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000104191284,0.0014381505,0.00042326484,0.0013259125,0.0010845403,4.2832434e-7,0.000041718184,0.00013430872,0.000021061203,0.0016699797,0.17542018,0.81833625],"study_design_scores_gemma":[0.00029552347,0.001027506,0.00014991297,0.00018803634,0.00040894674,0.00001157455,0.00004498528,0.000030923995,0.000006933619,0.00058867567,0.99703264,0.00021431634],"about_ca_topic_score_codex":0.00009511816,"about_ca_topic_score_gemma":0.000013452057,"teacher_disagreement_score":0.8216125,"about_ca_system_score_codex":0.00020442398,"about_ca_system_score_gemma":0.013147829,"threshold_uncertainty_score":0.9999986},"labels":[],"label_agreement":null},{"id":"W1921068618","doi":"10.14694/edbook_am.2015.35.e634","title":"Adjuvant Radiation for Soft Tissue Sarcomas","year":2015,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Adjuvant radiotherapy; Sarcoma; Soft tissue sarcoma; Medicine; Radiation therapy; Soft tissue; Context (archaeology); Adjuvant; Radiology; Adjuvant therapy; Surgery; Oncology; Pathology; Chemotherapy; Biology","score_opus":0.21267640580622243,"score_gpt":0.5576231839542395,"score_spread":0.34494677814801705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1921068618","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013178353,0.97979003,0.00006396269,0.015769657,0.0006087059,0.0019608892,0.0001290397,0.000022885592,0.0016416713],"genre_scores_gemma":[0.000014184751,0.96411365,0.019346101,0.0056006373,0.0020539986,0.001112237,0.0013036325,0.000056390567,0.00639915],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965274,0.0002817606,0.001974948,0.0005793726,0.0003473136,0.0002892095],"domain_scores_gemma":[0.98734397,0.009190132,0.0021214841,0.00043086187,0.00051287847,0.0004006691],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011590071,0.00035269573,0.0044535324,0.00005831258,0.00006288202,0.0000056349672,0.00019426599,0.00048242314,0.00032341827],"category_scores_gemma":[0.0010399059,0.00027457954,0.0022270202,0.00020591506,0.00096783077,0.000046154775,0.0000521907,0.00043528795,0.00011820395],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003374521,0.0019795506,0.0006770683,0.0010290302,0.0007846607,0.0000011193617,0.00006155559,1.414561e-7,3.665113e-8,0.00022234305,0.24855769,0.7466531],"study_design_scores_gemma":[0.0014100847,0.0023728341,0.0018987719,0.0008533457,0.0034197285,0.000036591584,0.00009548509,0.000006183788,3.9081127e-7,0.00021768287,0.9894784,0.00021050125],"about_ca_topic_score_codex":0.00005224414,"about_ca_topic_score_gemma":0.0000019737304,"teacher_disagreement_score":0.74644256,"about_ca_system_score_codex":0.00072040875,"about_ca_system_score_gemma":0.012016645,"threshold_uncertainty_score":0.9999706},"labels":[],"label_agreement":null},{"id":"W1966738941","doi":"10.14694/edbook_am.2014.34.e44","title":"Predisposition to Pediatric and Hematologic Cancers: A Moving Target","year":2014,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Cancer; Genetic predisposition; Leukemia; Li–Fraumeni syndrome; Population; Oncology; Internal medicine; Disease; Germline mutation; Mutation; Genetics; Biology","score_opus":0.10135375601084165,"score_gpt":0.5218871085534017,"score_spread":0.4205333525425601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966738941","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017241127,0.98563087,0.00007155374,0.008975856,0.00026645602,0.0015586618,0.0000596077,0.000029849478,0.0016830285],"genre_scores_gemma":[0.00024446636,0.9761909,0.014903234,0.004596117,0.001040306,0.00034776484,0.00013397388,0.00003161803,0.0025115795],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972164,0.0003779842,0.0011987082,0.0005813491,0.00031647537,0.00030908152],"domain_scores_gemma":[0.99341613,0.004557138,0.0009793323,0.0002765829,0.00020289604,0.0005678966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005744941,0.0002705939,0.0028724638,0.00009296463,0.00007037182,0.0000067574992,0.00014659014,0.00027187518,0.00021174752],"category_scores_gemma":[0.0009364339,0.00021028118,0.0008831947,0.00031513025,0.00069783686,0.000043171185,0.00011312256,0.00059917994,0.000079263365],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000120873636,0.0011040561,0.005318665,0.006517326,0.00069914263,0.000008714866,0.00009386753,5.7080143e-7,3.9867717e-7,0.00010049314,0.079743065,0.90629286],"study_design_scores_gemma":[0.0005620106,0.0034373547,0.0055229086,0.00089118123,0.0010592863,0.00008797084,0.00004218474,0.000007957138,2.932303e-7,0.000069772526,0.9881616,0.00015745986],"about_ca_topic_score_codex":0.000057279995,"about_ca_topic_score_gemma":0.0000020567277,"teacher_disagreement_score":0.90841854,"about_ca_system_score_codex":0.00042812913,"about_ca_system_score_gemma":0.0066133705,"threshold_uncertainty_score":0.9990182},"labels":[],"label_agreement":null},{"id":"W1971335911","doi":"10.1200/edbook_am.2013.33.e20","title":"Treatment Algorithms for Hormone Receptor-Positive Advanced Breast Cancer: Applying the Results from Recent Clinical Trials into Daily Practice—Insights, Limitations, and Moving Forward","year":2013,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Exemestane; Fulvestrant; Breast cancer; Medicine; Oncology; Tamoxifen; Everolimus; Aromatase inhibitor; Internal medicine; Estrogen receptor; Clinical trial; Metastatic breast cancer; Aromatase; Letrozole; Cancer","score_opus":0.07697496632451407,"score_gpt":0.4536372477676764,"score_spread":0.37666228144316233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971335911","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.62178195,0.033794247,0.0021754343,0.33168644,0.0016574907,0.0069901277,0.0007425777,0.000033227345,0.0011384864],"genre_scores_gemma":[0.1919189,0.5249741,0.24536364,0.020775635,0.005400482,0.0063231904,0.0026487408,0.00008941919,0.0025058754],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960376,0.0013263241,0.0016356697,0.00061291194,0.00016231553,0.00022520217],"domain_scores_gemma":[0.97799456,0.019141424,0.001717076,0.0002965524,0.0006288287,0.00022154195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020446738,0.00021837265,0.0008493311,0.000014658914,0.00024199694,0.000021478332,0.00017673193,0.0003472289,0.000015723883],"category_scores_gemma":[0.0051042154,0.00014781891,0.0005717474,0.00009561999,0.001148258,0.000030458901,0.0000777019,0.00029668323,0.000008006688],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019247801,0.00082650624,0.00053993333,0.0000036843287,0.0013988802,1.5121967e-7,0.0006250778,0.000025213136,0.009487822,0.0000647095,0.041846693,0.94325656],"study_design_scores_gemma":[0.008421088,0.007203318,0.027641308,0.00004053623,0.0007851985,0.000009980698,0.008589819,0.0007483619,0.0017619946,0.0005739961,0.943827,0.00039743193],"about_ca_topic_score_codex":0.00057202455,"about_ca_topic_score_gemma":0.0000115162275,"teacher_disagreement_score":0.9428591,"about_ca_system_score_codex":0.00012284172,"about_ca_system_score_gemma":0.0014872651,"threshold_uncertainty_score":0.6110591},"labels":[],"label_agreement":null},{"id":"W1982570340","doi":"10.1200/edbook_am.2013.33.e205","title":"Revisiting the Role of Radiation Treatment for Non-serous Subtypes of Epithelial Ovarian Cancer","year":2013,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Serous fluid; Medicine; Ovarian cancer; Radiation therapy; Oncology; Chemotherapy; Cancer; Disease; Internal medicine; Serous ovarian cancer; Clear cell; Stage (stratigraphy); Carcinoma; Biology","score_opus":0.042238208908425265,"score_gpt":0.4209099409121961,"score_spread":0.3786717320037708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982570340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83205384,0.0027243933,0.000116482945,0.16001591,0.00034206736,0.001870633,0.00011700159,0.000008261272,0.0027514328],"genre_scores_gemma":[0.9816313,0.0033733246,0.009467932,0.0026444655,0.0012358953,0.00066302647,0.000041757787,0.000013601473,0.0009287431],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986082,0.000079529695,0.0008235036,0.0002057004,0.00014615738,0.00013696418],"domain_scores_gemma":[0.9951519,0.0031365175,0.0010498753,0.00021081649,0.00036678696,0.0000841308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035138335,0.000107033906,0.00073043373,0.000016261447,0.000049209557,0.000002304144,0.000080730824,0.000082378094,0.00045901493],"category_scores_gemma":[0.00017608644,0.00007044187,0.000530055,0.00009810391,0.00060636975,0.000041180894,0.000013923877,0.00008183676,0.0000052973955],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014864557,0.000888088,0.24574947,0.000033012933,0.0006740729,4.2689358e-8,0.0007389522,0.000011059497,0.00048536024,0.0007154612,0.0030446404,0.7475112],"study_design_scores_gemma":[0.0025758606,0.0024362272,0.89048564,0.000071479735,0.00052960764,0.0000014912962,0.0011784245,0.00023684061,0.003756683,0.00059067004,0.098067455,0.00006959342],"about_ca_topic_score_codex":0.0029013557,"about_ca_topic_score_gemma":0.000010608859,"teacher_disagreement_score":0.7474416,"about_ca_system_score_codex":0.0002262095,"about_ca_system_score_gemma":0.002117132,"threshold_uncertainty_score":0.50258917},"labels":[],"label_agreement":null},{"id":"W2023408434","doi":"10.14694/edbook_am.2014.34.e69","title":"Hype versus Hope: Metformin and Vitamin D as Anticancer Agents","year":2014,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Medicine; Observational study; Metformin; Cancer; Confounding; Population; Intensive care medicine; Clinical trial; Oncology; Internal medicine; Insulin; Environmental health","score_opus":0.09381474747362305,"score_gpt":0.49451229983836625,"score_spread":0.4006975523647432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023408434","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008732332,0.99406064,0.000017683236,0.000372983,0.0011392233,0.00035566775,0.00005262467,0.0000055960268,0.003122341],"genre_scores_gemma":[0.000038077425,0.98433524,0.0027966518,0.005594837,0.0022244456,0.00015919466,0.0003346801,0.000046296766,0.0044705835],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99702436,0.00043566717,0.001255009,0.00071902195,0.00024216418,0.00032380887],"domain_scores_gemma":[0.99624,0.0013738327,0.0014430981,0.00047249743,0.0002022961,0.00026826074],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010061887,0.0003579491,0.0023569216,0.00003040145,0.000071512266,0.000010249666,0.00038492086,0.00057892915,0.0004025306],"category_scores_gemma":[0.00083196844,0.00031151358,0.001153029,0.00013668563,0.0018828864,0.000006876266,0.00018408045,0.00040968484,0.000055944147],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051216964,0.00019474227,0.00004491602,0.00052091246,0.00065290125,1.7756439e-7,0.000021388043,1.6013563e-7,0.0000017325523,0.00015939602,0.08583783,0.9125146],"study_design_scores_gemma":[0.000765031,0.0010265942,0.0001519736,0.00020915232,0.0008277613,0.0000053991675,0.000067354464,0.0000015866041,0.0000068352356,0.000047869213,0.99658,0.0003104151],"about_ca_topic_score_codex":0.00004523583,"about_ca_topic_score_gemma":0.0000061980845,"teacher_disagreement_score":0.9122042,"about_ca_system_score_codex":0.000072259354,"about_ca_system_score_gemma":0.0040485384,"threshold_uncertainty_score":0.9999337},"labels":[],"label_agreement":null},{"id":"W2036318798","doi":"10.1200/edbook_am.2013.33.81","title":"Connecting Molecular Pathways to Hereditary Cancer Risk Syndromes","year":2013,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"SDHB; SDHD; BAP1; SDHA; Cancer research; Cancer; Fumarase; Paraganglioma; Germline mutation; Biology; Cowden syndrome; Cancer syndrome; Melanoma; Pathology; Medicine; Mutation; Genetics; Succinate dehydrogenase; Gene; Mitochondrion","score_opus":0.124149141516906,"score_gpt":0.48115377788551644,"score_spread":0.35700463636861046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036318798","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017579634,0.9847681,0.00021537351,0.007345991,0.0016253423,0.002131607,0.00024574465,0.000068667665,0.0018412225],"genre_scores_gemma":[0.000072542825,0.96337867,0.023456661,0.008666517,0.0016139454,0.0009423934,0.00026998713,0.0001464269,0.0014528297],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99436176,0.00073152874,0.0026970154,0.0010780036,0.00058310485,0.00054860144],"domain_scores_gemma":[0.9898629,0.0048763063,0.0030458148,0.0008167911,0.00061681954,0.0007813751],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010910083,0.0006013471,0.005220882,0.00012405965,0.0001190667,0.000011072794,0.00044549108,0.0008826523,0.0020135976],"category_scores_gemma":[0.002166473,0.000535827,0.0033556751,0.00062073796,0.0009620972,0.000063167114,0.00022676065,0.0021015995,0.00037708116],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026147412,0.0006172797,0.00008266767,0.0019809252,0.0022330643,0.000016358174,0.00023476714,0.000014846238,0.0000072838675,0.00008186934,0.0865108,0.908194],"study_design_scores_gemma":[0.0006153495,0.0015672157,0.00026347017,0.0038405457,0.0033013986,0.00017941034,0.00046332108,0.000015829113,0.0000048906218,0.000080642756,0.9892114,0.00045651838],"about_ca_topic_score_codex":0.00082015566,"about_ca_topic_score_gemma":0.00001588753,"teacher_disagreement_score":0.9077375,"about_ca_system_score_codex":0.0010560942,"about_ca_system_score_gemma":0.015139931,"threshold_uncertainty_score":0.9997093},"labels":[],"label_agreement":null},{"id":"W2051442794","doi":"10.14694/edbook_am.2013.33.469","title":"Selecting the Best Drugs for Phase I Clinical Development and Beyond","year":2013,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Phase (matter); Drug development; Computer science; Psychology; Medicine; Drug; Pharmacology; Chemistry","score_opus":0.6706187306284069,"score_gpt":0.6420796561741821,"score_spread":0.028539074454224878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051442794","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039995072,0.91817164,0.0006402778,0.073657945,0.0013212147,0.002746225,0.00019679383,0.000016838927,0.0028491106],"genre_scores_gemma":[0.000012741492,0.87716806,0.07241605,0.039652307,0.0023601893,0.0013938261,0.0001859383,0.00005745525,0.006753411],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9831921,0.0012233129,0.01404407,0.00097322406,0.00012305712,0.00044422905],"domain_scores_gemma":[0.92195296,0.06185367,0.015070039,0.0005035326,0.00027242678,0.00034735914],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.036733832,0.00037861004,0.0058299447,0.000086102315,0.00037652574,0.0000394794,0.00056123716,0.0005929552,0.00033580375],"category_scores_gemma":[0.010543784,0.0003417968,0.001467938,0.00020420674,0.0017406099,0.00017907518,0.00013235916,0.0008810379,0.00057500275],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000073136944,0.0007702569,0.00056539744,0.0017740999,0.0006845406,2.4486987e-8,0.0010296559,2.5351125e-7,1.8570877e-9,0.0087739015,0.18407585,0.8023187],"study_design_scores_gemma":[0.0008335346,0.00056833355,0.00017411474,0.00037383556,0.00017281264,0.0000040756404,0.0022174441,0.000085385494,1.6895077e-8,0.0018035183,0.9934392,0.00032775642],"about_ca_topic_score_codex":0.0001244534,"about_ca_topic_score_gemma":0.000008543509,"teacher_disagreement_score":0.8093633,"about_ca_system_score_codex":0.0006095821,"about_ca_system_score_gemma":0.007989599,"threshold_uncertainty_score":0.9999034},"labels":[],"label_agreement":null},{"id":"W2069491777","doi":"10.14694/edbook_am.2013.33.237","title":"Locally Advanced Head and Neck Cancer","year":2013,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Head and neck cancer; Chemoradiotherapy; Radiation therapy; Head and neck; Multidisciplinary approach; Modalities; Head and neck squamous-cell carcinoma; Treatment modality; Medical physics; Surgery","score_opus":0.1525429383812818,"score_gpt":0.5485583139625851,"score_spread":0.39601537558130334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069491777","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033968702,0.9690153,0.000004328114,0.023311423,0.0005063902,0.00091033464,0.000031188825,0.000019208373,0.005862147],"genre_scores_gemma":[0.000008586648,0.9554234,0.01085266,0.014102953,0.0011260377,0.00065636187,0.00005008386,0.000039663824,0.017740222],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99697363,0.0001859938,0.0016813232,0.00058915245,0.00026013548,0.00030975716],"domain_scores_gemma":[0.99404514,0.0035466384,0.0013605589,0.0003040874,0.00037665537,0.0003669002],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040013148,0.00034714656,0.0048645604,0.000035487268,0.00008073802,0.0000043706927,0.00015185135,0.0003801999,0.0008357547],"category_scores_gemma":[0.0004311975,0.00026138136,0.0011865429,0.0002136525,0.0024931827,0.000058439877,0.00010857174,0.0008405459,0.00006070425],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003362412,0.00042541252,0.00085806695,0.002590606,0.0007172577,5.939e-7,0.00010958506,8.154377e-8,2.2172941e-7,0.00007226569,0.12204998,0.8731423],"study_design_scores_gemma":[0.000883728,0.0017644241,0.0053408486,0.0046268073,0.0009647405,0.000016877279,0.0001547985,0.0000025773363,1.06724606e-7,0.000034527788,0.9859933,0.00021724819],"about_ca_topic_score_codex":0.00024571086,"about_ca_topic_score_gemma":0.000017404502,"teacher_disagreement_score":0.87292504,"about_ca_system_score_codex":0.00032144127,"about_ca_system_score_gemma":0.010600026,"threshold_uncertainty_score":0.99998385},"labels":[],"label_agreement":null},{"id":"W2129508275","doi":"10.14694/edbook_am.2015.35.e41","title":"Neoadjuvant and Adjuvant Therapy for HER2 Positive Disease","year":2015,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Trastuzumab; Medicine; Oncology; Internal medicine; Breast cancer; Clinical trial; Disease; Chemotherapy; Adjuvant; Metastatic breast cancer; Pertuzumab; Adjuvant therapy; Cancer; Targeted therapy","score_opus":0.30777071585932586,"score_gpt":0.6224921145437846,"score_spread":0.31472139868445875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129508275","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000047499467,0.962302,0.00002898282,0.03262757,0.00039677732,0.0027811076,0.00030341325,0.000018168012,0.0014944227],"genre_scores_gemma":[0.000013542823,0.9686348,0.0075295307,0.0104577895,0.0019417626,0.0009578268,0.0005664943,0.000076209195,0.009822065],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99596745,0.0005707418,0.0016982568,0.0007855772,0.0005605419,0.0004174464],"domain_scores_gemma":[0.98730594,0.008845156,0.0013176951,0.00049682014,0.0009708525,0.0010635346],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0022187275,0.00038291307,0.0041681537,0.00006306208,0.00008095549,0.000009742988,0.00028348563,0.0004026704,0.000315116],"category_scores_gemma":[0.0014794206,0.0002929014,0.0017797033,0.00023327992,0.003337992,0.00005030027,0.00011343156,0.00094596547,0.000033120148],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033173422,0.0010077199,0.00046727125,0.0016375533,0.00063224585,0.0000025669578,0.00013716544,6.617326e-8,9.676116e-8,0.00017117157,0.18898045,0.806632],"study_design_scores_gemma":[0.0014882465,0.0038959887,0.003350817,0.002091225,0.0009157907,0.000021746275,0.00019174097,0.000011632816,1.250891e-7,0.00034765896,0.98743755,0.0002474778],"about_ca_topic_score_codex":0.000086155436,"about_ca_topic_score_gemma":0.0000021127805,"teacher_disagreement_score":0.8063845,"about_ca_system_score_codex":0.0006473897,"about_ca_system_score_gemma":0.033754546,"threshold_uncertainty_score":0.9999523},"labels":[],"label_agreement":null},{"id":"W2396574717","doi":"10.14694/edbook_am.2012.32.2","title":"Initial Management of Low-Risk Pediatric Fever and Neutropenia: Efficacy and Safety, Costs, Quality-of-Life Considerations, and Preferences","year":2012,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Hospital for Sick Children","funders":"","keywords":"Medicine; Quality of life (healthcare); Discontinuation; Adverse effect; Intensive care medicine; Ambulatory; Ambulatory care; Regimen; Emergency medicine; Health care; Psychiatry; Internal medicine; Nursing","score_opus":0.09853419242739564,"score_gpt":0.47128790491288225,"score_spread":0.3727537124854866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2396574717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986727,0.0022988562,0.000032217962,0.007405699,0.00017152233,0.00039611265,0.000030573545,0.0000063634106,0.0029316319],"genre_scores_gemma":[0.9736502,0.01757179,0.0057104486,0.0024346015,0.00033139854,0.000029380468,0.000013422441,0.000007696877,0.00025105404],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822176,0.00028050283,0.00097453187,0.0002126227,0.00017228046,0.0001383201],"domain_scores_gemma":[0.9947051,0.0039391187,0.00080021686,0.00013758984,0.00018625101,0.00023173443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008073071,0.000108545624,0.0007191273,0.00003246078,0.00009130218,0.0000038740795,0.000038798848,0.000089936824,0.00022276254],"category_scores_gemma":[0.00033305422,0.0000951826,0.000114819435,0.00010962388,0.0016372893,0.000103701066,0.00008007863,0.00024024387,0.000001964149],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003486257,0.0011487117,0.96109813,0.00023314817,0.00038266217,1.4979777e-7,0.00051493046,0.0000010956122,0.00003174115,0.006283874,0.007118285,0.022838648],"study_design_scores_gemma":[0.0025155568,0.0006890776,0.9879783,0.000031559237,0.00043763858,0.000007630131,0.0011616582,0.0000018573124,0.00001695627,0.00024783632,0.006827578,0.000084386935],"about_ca_topic_score_codex":0.00020708023,"about_ca_topic_score_gemma":0.000010284828,"teacher_disagreement_score":0.026880136,"about_ca_system_score_codex":0.000037680573,"about_ca_system_score_gemma":0.00078180776,"threshold_uncertainty_score":0.60326606},"labels":[],"label_agreement":null},{"id":"W2405213138","doi":"10.14694/edbook_am.2012.32.171","title":"Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma","year":2012,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Hepatocellular carcinoma; Medicine; Radiation therapy; Carcinoma; Oncology; Radiology; Internal medicine","score_opus":0.14856231441226558,"score_gpt":0.42083168924894526,"score_spread":0.2722693748366797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2405213138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9667271,0.0033690564,0.000114607115,0.02651828,0.00042188817,0.0010446747,0.000014077416,0.00002184399,0.0017684879],"genre_scores_gemma":[0.97579485,0.0011335711,0.0076115443,0.009773461,0.0016304732,0.00030918824,0.00021226748,0.000028258017,0.003506374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816275,0.00018720455,0.000818862,0.00027280254,0.00022441706,0.000333987],"domain_scores_gemma":[0.9958447,0.0026684958,0.00062043493,0.00026094468,0.00026213456,0.0003432569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009577056,0.00017218404,0.0007795914,0.00003666732,0.000087522625,0.0000045154943,0.000092234935,0.0001807225,0.0005180253],"category_scores_gemma":[0.00027427336,0.00014845523,0.00089011027,0.00014663282,0.00055847043,0.00013822458,0.000018268236,0.00021326047,0.000040318926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036303428,0.0022440287,0.91132843,0.000028543935,0.00040623156,4.6676948e-7,0.0005308032,2.6459517e-8,0.00022776426,0.00037173444,0.021792408,0.062706545],"study_design_scores_gemma":[0.002065739,0.0021394389,0.6515061,0.000006351789,0.00022457646,0.000008998193,0.00014760556,0.00035496865,0.0005561292,0.00006983712,0.3428149,0.00010533183],"about_ca_topic_score_codex":0.00007288465,"about_ca_topic_score_gemma":2.704441e-7,"teacher_disagreement_score":0.3210225,"about_ca_system_score_codex":0.00018364462,"about_ca_system_score_gemma":0.0014690085,"threshold_uncertainty_score":0.60538286},"labels":[],"label_agreement":null},{"id":"W2407614483","doi":"10.14694/edbk_159161","title":"A Value-Based Approach to Treatment of HER2-Positive Breast Cancer: Examining the Evidence","year":2016,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Breast cancer; Medicine; Value (mathematics); Evidence-based practice; Family medicine; Cancer treatment; Alternative medicine; Cancer; Oncology; Intensive care medicine; Internal medicine; Pathology; Computer science","score_opus":0.14732628627133523,"score_gpt":0.40432017123961644,"score_spread":0.25699388496828124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407614483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6076577,0.0048552277,0.0128508415,0.33036217,0.0010925073,0.0012208283,0.0011347692,0.000025619129,0.04080038],"genre_scores_gemma":[0.97394824,0.0035846,0.008126227,0.01030094,0.0005943772,0.00020308816,0.0000041395015,0.000017913178,0.003220449],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99804765,0.00007509627,0.001168408,0.00041991676,0.00005269149,0.00023624544],"domain_scores_gemma":[0.9942793,0.0037066853,0.0013960693,0.00031732436,0.00014851842,0.00015210346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008776294,0.00014726323,0.0009033637,0.000036477548,0.00007065316,0.000006435285,0.00029173805,0.00010266636,0.00030658444],"category_scores_gemma":[0.00036272244,0.00010272259,0.0004112387,0.00016438334,0.0013179557,0.000144485,0.00003344458,0.00008628533,0.00005013338],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045044138,0.0023086115,0.46298492,0.000022699352,0.00049224077,1.3626249e-7,0.0023069966,0.00036911553,0.000054345666,0.0481258,0.019032676,0.46385202],"study_design_scores_gemma":[0.00084351376,0.0017016162,0.8712087,0.0000761816,0.000036531535,0.0000016310195,0.0003432227,0.00016444735,0.000052889387,0.0016372392,0.12375361,0.00018037904],"about_ca_topic_score_codex":0.0018001182,"about_ca_topic_score_gemma":0.000013381921,"teacher_disagreement_score":0.46367165,"about_ca_system_score_codex":0.0005664732,"about_ca_system_score_gemma":0.0014324052,"threshold_uncertainty_score":0.48560628},"labels":[],"label_agreement":null},{"id":"W2411478210","doi":"10.14694/edbook_am.2012.32.29","title":"Important Early Advances in Squamous Cell Carcinoma of the Head and Neck","year":2012,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Head and neck; Head and neck squamous-cell carcinoma; Basal cell; Medicine; Carcinoma; Oncology; Head and neck cancer; Internal medicine; Surgery; Cancer","score_opus":0.047354846333294134,"score_gpt":0.4300073429530166,"score_spread":0.3826524966197225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411478210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96222544,0.012074151,0.0000010409086,0.01850693,0.00023981261,0.00017975843,0.0000051025127,0.000002672789,0.0067651123],"genre_scores_gemma":[0.98878074,0.0020703946,0.0018490552,0.005799596,0.0002838995,0.000022245566,0.0000017372452,0.000006687558,0.0011856536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986742,0.00009013901,0.0007406686,0.00015007293,0.00015810394,0.00018682225],"domain_scores_gemma":[0.9975851,0.0015525823,0.00049101503,0.00015179759,0.00009771994,0.00012179082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004949972,0.000084417086,0.00064643944,0.0000130496055,0.00003630513,6.4341145e-7,0.000070948656,0.000071570954,0.00006240297],"category_scores_gemma":[0.0002795645,0.000057969122,0.00021984425,0.00013180503,0.001449893,0.00006820441,0.000049196842,0.00024784365,0.0000017544339],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009651182,0.000934776,0.9801326,0.000046064724,0.000015268266,1.4050073e-7,0.0019094124,1.954668e-7,0.00007800924,0.00017641173,0.004756773,0.011853844],"study_design_scores_gemma":[0.0010227415,0.0012146204,0.91868395,0.000022212223,0.00004087736,0.000003488359,0.0012428464,0.0000036823178,0.00009977464,0.000072694245,0.077543505,0.000049592287],"about_ca_topic_score_codex":0.00028281834,"about_ca_topic_score_gemma":0.000034505807,"teacher_disagreement_score":0.072786726,"about_ca_system_score_codex":0.00006442425,"about_ca_system_score_gemma":0.0010633544,"threshold_uncertainty_score":0.5342191},"labels":[],"label_agreement":null},{"id":"W2618094628","doi":"10.1200/edbk_173836","title":"Bench-to-Bedside Approaches for Personalized Exercise Therapy in Cancer","year":2017,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Cancer survivorship and care","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia, Okanagan Campus","funders":"","keywords":"Medicine; Bench to bedside; Exercise prescription; Personalization; Cancer therapy; Disease; Medical prescription; Cancer; Intensive care medicine; Physical therapy; Precision oncology; Precision medicine; Oncology; Internal medicine; Medical physics; Pharmacology; Pathology; Computer science","score_opus":0.46773737057415876,"score_gpt":0.5789959447128415,"score_spread":0.11125857413868279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2618094628","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000107007785,0.9740301,0.000022509588,0.020209165,0.00089726323,0.0024769697,0.00013757117,0.000012787167,0.0021066305],"genre_scores_gemma":[0.000032659584,0.9592159,0.0032575391,0.007788154,0.0015877421,0.0037327486,0.0002606426,0.000060311853,0.024064315],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99673826,0.00022397954,0.0016191478,0.00074182526,0.0003161292,0.00036064096],"domain_scores_gemma":[0.9933297,0.0037013819,0.0017462182,0.00058718806,0.00029827285,0.00033723144],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001292011,0.0003813247,0.004861397,0.00008821454,0.00008972469,0.000010344482,0.0004399695,0.0005222523,0.0005199775],"category_scores_gemma":[0.0004899004,0.00031182045,0.0028551447,0.00021734445,0.0015941535,0.00005111946,0.000066044784,0.00070833886,0.000014713768],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028142447,0.00081900484,0.0008821871,0.0021382722,0.00046697093,5.377832e-7,0.001028799,4.0042056e-7,5.881375e-8,0.00019672097,0.048525143,0.9456605],"study_design_scores_gemma":[0.0012541659,0.0010251444,0.0020037577,0.0032754347,0.000757767,0.000004268662,0.00067575194,0.000003970176,1.8724765e-7,0.0000950614,0.9906258,0.00027869272],"about_ca_topic_score_codex":0.0012063454,"about_ca_topic_score_gemma":0.00024197173,"teacher_disagreement_score":0.94538176,"about_ca_system_score_codex":0.0005626855,"about_ca_system_score_gemma":0.014583511,"threshold_uncertainty_score":0.99993336},"labels":[],"label_agreement":null},{"id":"W2619800458","doi":"10.1200/edbk_100008","title":"Global Health Initiatives of the International Oncology Community","year":2017,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Global health; Medicine; Radiation oncology; Oncology; Internal medicine; Political science; Nursing; Public health; Radiation therapy","score_opus":0.11629873718752741,"score_gpt":0.6016962184847499,"score_spread":0.48539748129722243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619800458","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2777035,0.0006043055,0.00048576045,0.5955075,0.0034135096,0.0004611678,0.00006755183,0.000015091937,0.1217416],"genre_scores_gemma":[0.8736144,0.0034385207,0.034001485,0.08479824,0.0011270622,0.000027146849,0.000021192647,0.00000995602,0.002962046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775857,0.0006744584,0.00097208703,0.00018599964,0.0002391465,0.0001697529],"domain_scores_gemma":[0.9920321,0.0040746597,0.002764709,0.00063880265,0.00035569078,0.00013400108],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.00171328,0.00011277661,0.00092396105,0.00001242993,0.00046261813,0.0000030415363,0.00078701496,0.00018880761,0.00036906757],"category_scores_gemma":[0.0022691367,0.00008111965,0.00053756445,0.00007213577,0.009303587,0.00011526869,0.00020280427,0.0007094193,0.000004536761],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004770522,0.0033955935,0.67592543,0.000025767971,0.0006227836,4.735438e-7,0.0013404163,0.000007094147,0.000024561137,0.0079064565,0.07602354,0.23425081],"study_design_scores_gemma":[0.0012343725,0.0018113694,0.6832786,0.000029648572,0.000033517263,0.00001968927,0.0012345545,0.00001986025,0.000012060798,0.002364176,0.3099184,0.00004373454],"about_ca_topic_score_codex":0.00038061256,"about_ca_topic_score_gemma":0.000109680135,"teacher_disagreement_score":0.59591085,"about_ca_system_score_codex":0.0006715646,"about_ca_system_score_gemma":0.008853814,"threshold_uncertainty_score":0.9967651},"labels":[],"label_agreement":null},{"id":"W2620264080","doi":"10.1200/edbk_175668","title":"Breast Cancer After Childhood, Adolescent, and Young Adult Cancer: It’s Not Just About Chest Radiation","year":2017,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Breast cancer; Cancer; Young adult; Childhood cancer; Radiation therapy; Oncology; Pediatrics; Epidemiology of cancer; Genetic predisposition; Internal medicine; Disease","score_opus":0.05691772192460063,"score_gpt":0.45050385259004555,"score_spread":0.3935861306654449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620264080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5094335,0.0013038686,0.00001581747,0.48581848,0.0012621372,0.00046876693,0.00024239793,0.000025322272,0.0014296928],"genre_scores_gemma":[0.85043263,0.01849533,0.0016454812,0.121207304,0.004217104,0.00024164672,0.000042236195,0.00003897853,0.0036792974],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99689955,0.00019489528,0.0013165727,0.0006800992,0.00052876666,0.00038014294],"domain_scores_gemma":[0.9954606,0.0008419699,0.0019284459,0.0006640604,0.0006069247,0.0004979733],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0008852109,0.00028449818,0.0012353976,0.00003607272,0.0003089765,0.00003332001,0.00031307613,0.00027395494,0.0008205399],"category_scores_gemma":[0.00066593173,0.0002764933,0.00054993527,0.00008841449,0.0030759547,0.00025838718,0.00013383049,0.00072259345,0.000022660492],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004950854,0.0011010123,0.7332947,0.00014207396,0.0003864762,9.833998e-7,0.0028698836,0.0000011546734,0.000015364698,0.00008669009,0.11348177,0.14812477],"study_design_scores_gemma":[0.0026189864,0.00030777877,0.93521905,0.00036643978,0.00036104186,0.000041631825,0.0012870923,0.000037761736,0.00002466652,0.000030246356,0.05945208,0.00025320618],"about_ca_topic_score_codex":0.010778802,"about_ca_topic_score_gemma":0.0014684189,"teacher_disagreement_score":0.36461115,"about_ca_system_score_codex":0.00039650363,"about_ca_system_score_gemma":0.0045370315,"threshold_uncertainty_score":0.9999687},"labels":[],"label_agreement":null},{"id":"W2803388295","doi":"10.1200/edbk_200841","title":"Global Approaches in Myeloma: Critical Trials That May Change Practice","year":2018,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Clinical trial; Multiple myeloma; Medicine; Intensive care medicine; Clinical Practice; Transplantation; Family medicine; Internal medicine","score_opus":0.6743432344979641,"score_gpt":0.6407470193452658,"score_spread":0.03359621515269828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803388295","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000027758717,0.931737,0.00001793137,0.051815234,0.00056139514,0.002412786,0.00018946963,0.000021250898,0.013217185],"genre_scores_gemma":[0.00022368101,0.9586209,0.028371437,0.0059509757,0.003173001,0.0011655808,0.00044358862,0.000040782037,0.0020100437],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9911537,0.0036002137,0.0029077304,0.0009262686,0.0008081845,0.00060390413],"domain_scores_gemma":[0.95018494,0.04580584,0.0022877562,0.00060075,0.00046178876,0.000658937],"candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.006844279,0.00047081997,0.0066331145,0.00009072816,0.00007596571,0.000014927815,0.00036273262,0.00080867554,0.0007444971],"category_scores_gemma":[0.030431066,0.0003482622,0.0027559763,0.0005498784,0.004232052,0.00018821633,0.00018553667,0.0009968145,0.00022867788],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040788596,0.0048477,0.0061418307,0.00243037,0.0015226073,0.000021753816,0.00012296747,9.8408774e-9,5.0706115e-9,0.00079265784,0.045080885,0.93863136],"study_design_scores_gemma":[0.0016763658,0.0020512794,0.014816415,0.0018899887,0.0021111937,0.00013832978,0.00051105564,0.0000056260874,6.6385326e-8,0.00013167746,0.9764372,0.0002307985],"about_ca_topic_score_codex":0.00033801346,"about_ca_topic_score_gemma":0.000018787492,"teacher_disagreement_score":0.9384005,"about_ca_system_score_codex":0.0011009531,"about_ca_system_score_gemma":0.011429418,"threshold_uncertainty_score":0.99989694},"labels":[],"label_agreement":null},{"id":"W2803691214","doi":"10.1200/edbk_201307","title":"Best Practices in Oncology Distress Management: Beyond the Screen","year":2018,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Cancer survivorship and care","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Distress; Psychosocial; Psychological intervention; Accreditation; Medicine; Triage; Psychology; Psychiatry; Clinical psychology; Medical education","score_opus":0.21171648675357807,"score_gpt":0.5573110537638986,"score_spread":0.3455945670103205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803691214","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004696555,0.8495216,0.000005863269,0.03513685,0.0011252494,0.0010816738,0.00008339074,0.000012223973,0.11298619],"genre_scores_gemma":[0.000030703955,0.95399976,0.0018599303,0.013352338,0.002349882,0.0003918719,0.00040071446,0.000039580988,0.027575236],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99549955,0.0010076853,0.002024623,0.0006977355,0.00041997363,0.0003504595],"domain_scores_gemma":[0.9835703,0.0108238645,0.0044072303,0.0006939914,0.0002877439,0.00021688284],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0022075067,0.0003416365,0.003126069,0.000072079056,0.00009320617,0.0000102519725,0.00060497754,0.00056154374,0.00079946365],"category_scores_gemma":[0.0007378544,0.00023564514,0.001585277,0.00054916565,0.00394387,0.000076089396,0.00023228413,0.0013630494,0.00015890162],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008885282,0.0013850611,0.00080292596,0.0018807374,0.0008487124,0.0000062750255,0.00038880567,5.3672096e-8,9.956243e-9,0.0005945687,0.11956375,0.87444025],"study_design_scores_gemma":[0.00055634277,0.0014811355,0.0015466198,0.0016034555,0.0022377034,0.000036327452,0.002764642,0.0000014321682,2.6394014e-8,0.00013675883,0.98943704,0.00019850886],"about_ca_topic_score_codex":0.0014865132,"about_ca_topic_score_gemma":0.0008720247,"teacher_disagreement_score":0.8742417,"about_ca_system_score_codex":0.0006529196,"about_ca_system_score_gemma":0.006065318,"threshold_uncertainty_score":0.99956936},"labels":[],"label_agreement":null},{"id":"W2804127993","doi":"10.1200/edbk_200981","title":"Incorporating Biology Into Breast Cancer Staging: American Joint Committee on Cancer, Eighth Edition, Revisions and Beyond","year":2018,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Breast cancer; Cancer; Joint (building); Medicine; Library science; Medical physics; Internal medicine; Engineering; Computer science","score_opus":0.07649113368365164,"score_gpt":0.4752532346450592,"score_spread":0.3987621009614076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804127993","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00067724416,0.95877403,0.00005666923,0.036386777,0.0010924077,0.00069189025,0.0013195919,0.000020777268,0.0009806141],"genre_scores_gemma":[0.00068435795,0.9768703,0.006154093,0.009653569,0.0045659225,0.0006854445,0.00084499666,0.00006497984,0.00047635115],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960165,0.0006642751,0.0016196446,0.0011149918,0.0002095272,0.00037503758],"domain_scores_gemma":[0.99399924,0.0013738989,0.0032564418,0.0005482547,0.0005528727,0.00026930723],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0006459584,0.0005640276,0.0028023403,0.00006799767,0.00032506618,0.000012150444,0.00036558032,0.00039184626,0.00018108776],"category_scores_gemma":[0.00029199297,0.00046181434,0.00092209986,0.0003059098,0.0074313283,0.00000999676,0.0003622235,0.00057527283,0.000012555727],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057335994,0.000531569,0.004684899,0.00048349434,0.0014651426,3.0367698e-7,0.00011830873,8.761107e-7,0.0000052502137,0.00024429726,0.16116619,0.8312423],"study_design_scores_gemma":[0.00045892823,0.0012317597,0.007455971,0.0010323039,0.0007676014,0.000013436807,0.0003215071,0.0000018807,0.0000036143977,0.00024316773,0.9880356,0.0004341803],"about_ca_topic_score_codex":0.0011843902,"about_ca_topic_score_gemma":0.00011121094,"teacher_disagreement_score":0.83080816,"about_ca_system_score_codex":0.00037152017,"about_ca_system_score_gemma":0.0049910783,"threshold_uncertainty_score":0.99978334},"labels":[],"label_agreement":null},{"id":"W2804165635","doi":"10.1200/edbk_208509","title":"Cardiac Toxicities in the Era of Precision Medicine: Underlying Risk Factors, Targeted Therapies, and Cardiac Biomarkers","year":2018,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Disease; Myocarditis; Internal medicine; Intensive care medicine; Hyperlipidemia; Cardiology; Cardiotoxicity; Cancer; Heart failure; Cardiomyopathy; Oncology; Chemotherapy; Diabetes mellitus","score_opus":0.12436894785379701,"score_gpt":0.46615215470918403,"score_spread":0.341783206855387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804165635","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030767947,0.9614855,0.000017815411,0.0045133405,0.0006664989,0.0014085507,0.00012452663,0.000013055702,0.0010027584],"genre_scores_gemma":[0.005319171,0.99012816,0.0018616744,0.0010147155,0.0009003991,0.000095215146,0.00032081731,0.00003653894,0.0003232821],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949746,0.0017851638,0.0019311181,0.0005239598,0.00053729984,0.0002478227],"domain_scores_gemma":[0.98168397,0.0152444905,0.0021712664,0.00048673365,0.00027599576,0.00013755007],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0036376975,0.000371438,0.003977434,0.00008886295,0.00010331683,0.000006093444,0.00025553006,0.000599322,0.00011180041],"category_scores_gemma":[0.0012789563,0.0002379545,0.0017697354,0.00048118908,0.0042933687,0.00007058134,0.00004896959,0.0011461929,0.0000021378642],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007868786,0.00033509196,0.0055698734,0.001319228,0.0028463136,2.7471825e-7,0.004879772,1.2326723e-7,0.000051007093,0.00010998797,0.027728816,0.95708084],"study_design_scores_gemma":[0.0006374077,0.0015856154,0.03996849,0.0028809349,0.0017964733,0.000004509441,0.008306092,0.0000021295457,0.000016031949,0.00028195602,0.9442942,0.00022615242],"about_ca_topic_score_codex":0.0006286409,"about_ca_topic_score_gemma":0.000004624418,"teacher_disagreement_score":0.9568547,"about_ca_system_score_codex":0.00027908752,"about_ca_system_score_gemma":0.0031010814,"threshold_uncertainty_score":0.99841636},"labels":[],"label_agreement":null},{"id":"W2804649716","doi":"10.1200/edbk_201215","title":"Personalized Management of Advanced Kidney Cancer","year":2018,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Kidney cancer; Medicine; Renal cell carcinoma; Context (archaeology); Cancer; Oncology; Translational research; Targeted therapy; Clear cell renal cell carcinoma; PI3K/AKT/mTOR pathway; Intensive care medicine; Internal medicine; Bioinformatics; Pathology; Biology; Signal transduction","score_opus":0.15324590002521474,"score_gpt":0.526550103224348,"score_spread":0.37330420319913327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804649716","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020487623,0.97648305,0.000008346744,0.0064301416,0.0005863135,0.0013801622,0.00010091505,0.000015517155,0.014790698],"genre_scores_gemma":[0.000013477972,0.92051685,0.029893719,0.004034713,0.00076438277,0.00053494214,0.00029217385,0.00005113871,0.04389863],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958167,0.00032884264,0.0023437187,0.0006896172,0.00052147446,0.00029963432],"domain_scores_gemma":[0.9932971,0.0020017803,0.003155316,0.0005835826,0.00049576216,0.0004664597],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00070396735,0.00040781073,0.0046887835,0.000060560695,0.000045063516,0.0000021863316,0.0003024601,0.00035209645,0.0023293258],"category_scores_gemma":[0.00019052361,0.00031599618,0.0032537137,0.00034674729,0.0034303966,0.000036814345,0.0001224206,0.0004969021,0.00007551583],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016536588,0.0015078088,0.00032844112,0.010711746,0.0041341987,0.0000040780205,0.00012917028,1.4041268e-7,5.395468e-7,0.00030206083,0.1266279,0.8560885],"study_design_scores_gemma":[0.0014210255,0.0017828933,0.0018393568,0.007193137,0.0055433866,0.000018889428,0.0002875396,0.0000010937345,0.0000018417239,0.000037846068,0.9816621,0.00021091868],"about_ca_topic_score_codex":0.00006987966,"about_ca_topic_score_gemma":8.357122e-7,"teacher_disagreement_score":0.85587764,"about_ca_system_score_codex":0.00077524607,"about_ca_system_score_gemma":0.009876778,"threshold_uncertainty_score":0.9999292},"labels":[],"label_agreement":null},{"id":"W2804803500","doi":"10.1200/edbk_200679","title":"New Treatment Algorithms in Hodgkin Lymphoma: Too Much or Too Little?","year":2018,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; Medicine; Pembrolizumab; Nivolumab; Hodgkin lymphoma; Clinical trial; Intensive care medicine; Disease; Oncology; Lymphoma; Internal medicine; Cancer; Immunotherapy","score_opus":0.2095668149700712,"score_gpt":0.5368109536088498,"score_spread":0.32724413863877855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804803500","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027195542,0.9724347,0.000012056891,0.017935753,0.00094732415,0.0018138292,0.00008739975,0.000033650183,0.006463339],"genre_scores_gemma":[0.0000127920675,0.9012047,0.032551996,0.0059352685,0.002654658,0.00061752705,0.000419803,0.00005846619,0.05654481],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947483,0.00046295405,0.0028120254,0.0010338771,0.00043574462,0.0005071166],"domain_scores_gemma":[0.98838973,0.008116794,0.0019045236,0.0007292786,0.00024583365,0.00061383453],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007009859,0.0006494217,0.00567651,0.00011161,0.00007101934,0.000012801946,0.00030725304,0.0007342048,0.00159778],"category_scores_gemma":[0.0005739263,0.00042845987,0.0028843132,0.0005425837,0.0014006045,0.00006908398,0.0001046686,0.00028481855,0.00037431598],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011745996,0.006109913,0.0015859008,0.00042943898,0.0013368415,0.000019188661,0.00021794731,4.609155e-8,1.3339417e-8,0.000105219144,0.22498406,0.765094],"study_design_scores_gemma":[0.0046039904,0.007499285,0.010332362,0.0015961288,0.0023268939,0.00012891633,0.00019196642,0.0000038350327,7.564957e-7,0.00007305706,0.9729078,0.00033499827],"about_ca_topic_score_codex":0.0013847008,"about_ca_topic_score_gemma":0.00005016199,"teacher_disagreement_score":0.76475894,"about_ca_system_score_codex":0.003431681,"about_ca_system_score_gemma":0.03778221,"threshold_uncertainty_score":0.9998167},"labels":[],"label_agreement":null},{"id":"W2805443984","doi":"10.1200/edbk_200989","title":"Integrating Genomics Into Neuro-Oncology Clinical Trials and Practice","year":2018,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Genomics; Clinical trial; Medicine; Personalized medicine; Disease; Bioinformatics; Clinical Practice; Oncology; Internal medicine; Biology; Genome; Gene; Genetics","score_opus":0.3566667920267713,"score_gpt":0.623973234451059,"score_spread":0.2673064424242877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805443984","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023311829,0.9347934,0.00003958567,0.05683183,0.0015740317,0.0018149555,0.000034378892,0.000025785126,0.0046528783],"genre_scores_gemma":[0.000016214799,0.8765524,0.094792776,0.023513747,0.0041182786,0.00031171337,0.00018398557,0.00005868658,0.0004521802],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9836965,0.00768627,0.006838105,0.001088208,0.00033669826,0.00035417321],"domain_scores_gemma":[0.77868694,0.20992565,0.009205474,0.0006409197,0.00084469886,0.00069633254],"candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.018408457,0.0005215336,0.009796015,0.00009006371,0.00013814127,0.000017893446,0.00028789352,0.0011780336,0.0003093069],"category_scores_gemma":[0.076766506,0.00037845498,0.0037331665,0.00029261305,0.004786079,0.00009859658,0.00024553266,0.0017104468,0.00012058104],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002143776,0.0036299326,0.0007028064,0.00073794305,0.002618995,0.000010816371,0.00026337375,2.8772192e-8,8.3706925e-7,0.00038933742,0.13066846,0.8607631],"study_design_scores_gemma":[0.001754888,0.0068553095,0.0005334273,0.0010350303,0.008279822,0.0003393392,0.00086279,0.000008643029,3.171393e-7,0.00016492045,0.97991496,0.00025055188],"about_ca_topic_score_codex":0.00013179057,"about_ca_topic_score_gemma":0.000010051791,"teacher_disagreement_score":0.86051255,"about_ca_system_score_codex":0.0006940577,"about_ca_system_score_gemma":0.017258191,"threshold_uncertainty_score":0.9998667},"labels":[],"label_agreement":null},{"id":"W2806074738","doi":"10.1200/edbk_199665","title":"Moving From Mutation to Actionability","year":2018,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Mutation; Genetics; Computer science; Psychology; Biology; Gene","score_opus":0.07876465480636548,"score_gpt":0.4844489251781276,"score_spread":0.40568427037176213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806074738","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022158667,0.9894517,0.0006518616,0.0036339487,0.0013743934,0.000668802,0.00041383583,0.000008310485,0.0015813027],"genre_scores_gemma":[0.00008470161,0.96822214,0.018777683,0.0058772583,0.003996172,0.0001521618,0.0011457425,0.0000331795,0.0017109824],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975365,0.00023571886,0.0012223185,0.00066808215,0.00015224534,0.00018517282],"domain_scores_gemma":[0.9955198,0.00229126,0.001169054,0.00047270238,0.00033828872,0.00020886786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057933974,0.00023190198,0.0012822171,0.000023470986,0.00006511731,0.000008910637,0.00032328395,0.00042616657,0.00024837014],"category_scores_gemma":[0.001686402,0.00022736199,0.0011052382,0.00013126472,0.0008409653,0.0000035085038,0.00018279941,0.0002571227,0.00007922603],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030041338,0.0003109213,0.00017372226,0.00017423645,0.00034384854,1.2953214e-7,0.000050232346,0.000003909222,0.000009141465,0.000036182984,0.15656807,0.8422996],"study_design_scores_gemma":[0.00014604704,0.0007620615,0.0011355246,0.0001714222,0.0002700671,0.00000245292,0.00008008289,0.000002684563,0.000008996868,0.00017474998,0.99703294,0.00021297757],"about_ca_topic_score_codex":0.00024028141,"about_ca_topic_score_gemma":0.000041730127,"teacher_disagreement_score":0.8420866,"about_ca_system_score_codex":0.00019586287,"about_ca_system_score_gemma":0.0058153737,"threshold_uncertainty_score":0.9998207},"labels":[],"label_agreement":null},{"id":"W2807528614","doi":"10.1200/edbk_200731","title":"Incorporating Genomics Into the Care of Patients With Advanced Breast Cancer","year":2018,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Breast cancer; Genomics; Metastatic breast cancer; Disease; Clinical trial; Cancer; Genomic sequencing; Medicine; Circulating tumor cell; Patient care; Computational biology; Bioinformatics; Oncology; Biology; Metastasis; Internal medicine; Genome; Genetics; Gene","score_opus":0.026786579917471735,"score_gpt":0.41111775154764935,"score_spread":0.3843311716301776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807528614","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0094536375,0.9873705,0.000030436946,0.0010670834,0.00044150985,0.00065833074,0.00059273664,0.0000026435112,0.00038313915],"genre_scores_gemma":[0.0011986754,0.9876849,0.007146829,0.001658964,0.0011490594,0.00015277578,0.0007689083,0.00004150183,0.00019839745],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979806,0.00015636151,0.0010972086,0.00043982422,0.00016087614,0.00016515303],"domain_scores_gemma":[0.9951917,0.00084272696,0.0025893261,0.00044622383,0.0008324023,0.0000976121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027469549,0.00024818032,0.00123825,0.000015821652,0.0000863601,0.0000049341566,0.00043554947,0.00027356533,0.000038811195],"category_scores_gemma":[0.00017794303,0.0001706435,0.00067262223,0.00013304105,0.002283392,0.0000036392437,0.00019583583,0.00026536593,0.0000027317406],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009587758,0.0002745421,0.0050945617,0.0006160615,0.0005145534,4.2228795e-8,0.00027020954,0.000014112762,0.0000026222078,0.000047530208,0.009157794,0.9839121],"study_design_scores_gemma":[0.00038071882,0.0010388201,0.004518278,0.00034462812,0.00041094862,0.0000010445808,0.00034741953,9.72374e-7,0.0000041214807,0.000021688382,0.9927348,0.00019656573],"about_ca_topic_score_codex":0.00014547257,"about_ca_topic_score_gemma":0.00009195589,"teacher_disagreement_score":0.98371553,"about_ca_system_score_codex":0.00018568269,"about_ca_system_score_gemma":0.008644821,"threshold_uncertainty_score":0.99697524},"labels":[],"label_agreement":null},{"id":"W2944907268","doi":"10.1200/edbk_237419","title":"Redrawing the Lines: The Next Generation of Treatment in Metastatic Breast Cancer","year":2019,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; PI3K/AKT/mTOR pathway; Metastatic breast cancer; Estrogen receptor; Breast cancer; Targeted therapy; Cancer research; Cancer; Systemic therapy; Protein kinase B; Bioinformatics; Signal transduction; Oncology; Internal medicine; Biology","score_opus":0.37035670190059716,"score_gpt":0.553309647800282,"score_spread":0.18295294589968486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944907268","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003623383,0.9644868,0.00002817384,0.03284567,0.0004901957,0.0014980286,0.0000894912,0.000006283245,0.00019305505],"genre_scores_gemma":[0.00027519677,0.98673594,0.0028419588,0.0046524806,0.0014892492,0.0006824333,0.00010479285,0.00003832074,0.0031796056],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965833,0.00063936866,0.0018905522,0.00040285688,0.00026536433,0.00021859666],"domain_scores_gemma":[0.99001366,0.0066788946,0.0023936317,0.0005500053,0.00028872854,0.00007508669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085987244,0.00030278147,0.0029373765,0.000042113934,0.00005918668,0.0000049490786,0.0002793223,0.00016262583,0.0003663422],"category_scores_gemma":[0.00017645692,0.00015306177,0.0014152366,0.00038364192,0.0019067604,0.00007150884,0.00004649173,0.00055424724,0.000013175654],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006288623,0.0005983697,0.00053948525,0.0008685529,0.0011696588,2.852381e-7,0.0006610903,0.00003836268,0.0000045378556,0.0001049228,0.0017577204,0.99419415],"study_design_scores_gemma":[0.0007456899,0.00066683395,0.002071961,0.0014489947,0.002008512,0.000047258825,0.0010011252,0.00007936334,7.3341647e-7,0.00004157383,0.99176145,0.00012651831],"about_ca_topic_score_codex":0.0007290078,"about_ca_topic_score_gemma":0.000055562916,"teacher_disagreement_score":0.9940676,"about_ca_system_score_codex":0.0010674378,"about_ca_system_score_gemma":0.014241697,"threshold_uncertainty_score":0.99134666},"labels":[],"label_agreement":null},{"id":"W2945036583","doi":"10.1200/edbk_238057","title":"The Impact of Big Data Research on Practice, Policy, and Cancer Care","year":2019,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Big data; Cancer; Psychology; Data science; Political science; Medicine; Computer science; Data mining","score_opus":0.5981172090700837,"score_gpt":0.6204913123710402,"score_spread":0.02237410330095646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945036583","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004391479,0.9450133,0.0000036532567,0.008151744,0.0006766665,0.0005631095,0.0019036744,0.0000032620753,0.04364067],"genre_scores_gemma":[0.00031856858,0.9907021,0.00031836404,0.0011403912,0.0020904471,0.00008301842,0.00013361592,0.000039651517,0.0051738434],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99619883,0.00029293622,0.0022703803,0.0007318447,0.00010291396,0.0004030722],"domain_scores_gemma":[0.974699,0.019189,0.0043623634,0.0011667906,0.00040602032,0.00017681923],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0039493553,0.00025988332,0.0029303157,0.00013870235,0.00015802617,0.000028823886,0.0010997468,0.00041025737,0.00011410256],"category_scores_gemma":[0.005003074,0.00019846798,0.0009730436,0.0004048827,0.0029445558,0.00018888523,0.00040752537,0.001079828,0.00011128322],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004773787,0.00021420051,0.0009138453,0.00049119355,0.00069011166,7.994214e-8,0.00020813142,0.0000028951256,3.2764518e-9,0.018763037,0.07772397,0.90094477],"study_design_scores_gemma":[0.00025306453,0.0009688201,0.0025266092,0.0003812048,0.000093931885,0.000001912561,0.00041725714,0.000009900374,1.2681129e-8,0.0010787379,0.9940892,0.00017936974],"about_ca_topic_score_codex":0.008606392,"about_ca_topic_score_gemma":0.00004980816,"teacher_disagreement_score":0.9163652,"about_ca_system_score_codex":0.0010497421,"about_ca_system_score_gemma":0.015456583,"threshold_uncertainty_score":0.99976885},"labels":[],"label_agreement":null},{"id":"W2945053476","doi":"10.1200/edbk_238831","title":"Value-Added Decisions in Oncology","year":2019,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Null hypothesis; Value (mathematics); Outcome (game theory); Statement (logic); Actuarial science; p-value; Medicine; Set (abstract data type); Agency (philosophy); Test (biology); Food and drug administration; Economics; Statistics; Econometrics; Mathematics; Computer science; Risk analysis (engineering); Political science; Microeconomics","score_opus":0.826436994075985,"score_gpt":0.7366554256937266,"score_spread":0.08978156838225848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945053476","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001575747,0.9434726,0.0031941684,0.0121263955,0.0051547526,0.0035891652,0.00033722047,0.00006966596,0.03204028],"genre_scores_gemma":[5.132872e-7,0.5503589,0.44135118,0.0030818488,0.0009430776,0.00024631276,0.000025806781,0.00006557585,0.003926795],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9788057,0.008875071,0.009498091,0.0013699374,0.00075981003,0.0006913946],"domain_scores_gemma":[0.51330245,0.47981054,0.0052989656,0.0009237414,0.00032151604,0.0003427808],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.015610208,0.00068522705,0.013247892,0.00017327965,0.00007246017,0.000011941824,0.0014100169,0.0020559358,0.0020589943],"category_scores_gemma":[0.23663856,0.00056656223,0.004540707,0.0008990051,0.0039815363,0.00007665923,0.00048186295,0.0031786265,0.0005069986],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057899535,0.0026476495,0.000051490068,0.0011758001,0.000572918,0.0000030110277,0.00008942306,5.90905e-7,5.5197965e-8,0.040891547,0.10286575,0.85164386],"study_design_scores_gemma":[0.00091908214,0.0012521219,0.00013642781,0.002210006,0.0013286133,0.000011658806,0.00013237458,0.00001251431,6.309482e-8,0.20347898,0.7901252,0.00039294135],"about_ca_topic_score_codex":0.000055164,"about_ca_topic_score_gemma":0.000008889376,"teacher_disagreement_score":0.85125095,"about_ca_system_score_codex":0.0011061501,"about_ca_system_score_gemma":0.019096065,"threshold_uncertainty_score":0.9996786},"labels":[],"label_agreement":null},{"id":"W2945139022","doi":"10.1200/edbk_242229","title":"Patient-Centered Cancer Drug Development: Clinical Trials, Regulatory Approval, and Value Assessment","year":2019,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Queen's University","funders":"","keywords":"Expediting; Medicine; Clinical trial; Drug development; Cancer drugs; Drug; Intensive care medicine; Cancer; Regulatory science; Pharmacology; Internal medicine; Pathology","score_opus":0.49918607865207054,"score_gpt":0.592009268955778,"score_spread":0.09282319030370745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945139022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8339276,0.0027193855,0.00036822408,0.15377593,0.0025720254,0.0012554221,0.00011457616,0.000025941135,0.0052409167],"genre_scores_gemma":[0.6158627,0.0050725206,0.15926026,0.20163643,0.0024793863,0.00061420567,0.00019044243,0.00009035897,0.014793689],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9839813,0.0026446867,0.011918322,0.00090172724,0.00019488399,0.00035909182],"domain_scores_gemma":[0.9687919,0.01959663,0.010540046,0.00049041945,0.00019652073,0.0003845071],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.053970743,0.0002307732,0.0031918143,0.000080058075,0.00014178966,0.000022370166,0.00027968912,0.00027326358,0.0015918403],"category_scores_gemma":[0.0055256155,0.00025854493,0.0006828307,0.0001377494,0.0009948176,0.0002727541,0.00012681715,0.0005521868,0.00033884423],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000635298,0.0011073432,0.7259912,0.0001500108,0.0006045842,7.743152e-8,0.0018215455,0.00003058513,0.0000015694269,0.026205052,0.21197501,0.03204951],"study_design_scores_gemma":[0.0012830613,0.00023850636,0.495888,0.0000483915,0.000021576558,8.570544e-7,0.0017202675,0.0007466514,0.000001022759,0.0017835482,0.49806312,0.0002050006],"about_ca_topic_score_codex":0.00044407864,"about_ca_topic_score_gemma":0.000020678344,"teacher_disagreement_score":0.2860881,"about_ca_system_score_codex":0.0007016889,"about_ca_system_score_gemma":0.0052575334,"threshold_uncertainty_score":0.99998665},"labels":[],"label_agreement":null},{"id":"W2945273075","doi":"10.1200/edbk_238755","title":"Wanna Get Away? Maintenance Treatments and Chemotherapy Holidays in Gynecologic Cancers","year":2019,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute","keywords":"Medicine; Bevacizumab; Oncology; Chemotherapy; Maintenance therapy; Internal medicine; Ovarian cancer; Disease; Clinical trial; Adjuvant therapy; Adjuvant; Intensive care medicine; Surgery; Cancer","score_opus":0.14584485210320305,"score_gpt":0.510635520712278,"score_spread":0.36479066860907494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945273075","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009445757,0.9674177,0.0000021263493,0.02401636,0.0005048911,0.0017813349,0.00008644893,0.000013662149,0.0052328794],"genre_scores_gemma":[0.00024767,0.97257644,0.003669598,0.013312766,0.00040860494,0.0006192179,0.00015877736,0.00004438227,0.00896252],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967903,0.0002566312,0.0015490886,0.00080282125,0.0002289205,0.00037226395],"domain_scores_gemma":[0.9936608,0.0039743194,0.0015612087,0.00042549073,0.00013256312,0.00024563842],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005709519,0.00041795455,0.0043500713,0.00006879993,0.000039651874,0.0000062479394,0.00016625682,0.00046486635,0.0006173109],"category_scores_gemma":[0.00020466949,0.00031036767,0.0012431334,0.00026498828,0.0013261441,0.000048570033,0.000053696254,0.0006087187,0.000052431173],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006709868,0.0017307771,0.020575041,0.0012795096,0.0014023375,0.0000058298574,0.00015890699,6.151963e-7,3.2766586e-8,0.00012713941,0.042699292,0.93195343],"study_design_scores_gemma":[0.0026505513,0.0023337011,0.07099272,0.001831125,0.0012742459,0.0000235807,0.00014946547,0.0000047159892,1.2269359e-7,0.00007033611,0.92045534,0.00021407205],"about_ca_topic_score_codex":0.00040717347,"about_ca_topic_score_gemma":0.000022665923,"teacher_disagreement_score":0.93173933,"about_ca_system_score_codex":0.0021525633,"about_ca_system_score_gemma":0.010795921,"threshold_uncertainty_score":0.99993485},"labels":[],"label_agreement":null},{"id":"W2945470322","doi":"10.1200/edbk_239397","title":"A Career in Lung Cancer: Pushing Beyond Chemotherapy","year":2019,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Immunotherapy; Lung cancer; Medicine; Targeted therapy; Disease; Acquired resistance; Immune checkpoint; Chemotherapy; Cancer; Oncology; Intensive care medicine; Internal medicine","score_opus":0.11820955466647794,"score_gpt":0.5606485425989242,"score_spread":0.44243898793244624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945470322","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012167289,0.9693302,0.0000068141117,0.020544978,0.00067850127,0.0013452574,0.000073483876,0.0000132181185,0.00788591],"genre_scores_gemma":[0.000031863565,0.965513,0.0037450686,0.012369566,0.00086267,0.00054277584,0.0003033373,0.000050856437,0.016580846],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99715436,0.00018876154,0.0015626256,0.00054029416,0.00027831094,0.00027565932],"domain_scores_gemma":[0.994972,0.0028226404,0.0014463672,0.0003616294,0.00021447601,0.00018291759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047721944,0.00029852128,0.0034370052,0.00007651331,0.0000392343,0.0000059247304,0.00019353301,0.00039358638,0.0008875778],"category_scores_gemma":[0.00014660899,0.00023873904,0.0015606644,0.00035615772,0.00066894677,0.00006519545,0.000040920902,0.0007735265,0.000027224629],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027456153,0.0008789539,0.008226103,0.0030121952,0.0016607661,0.0000013621418,0.0005658762,0.000001568696,1.08891676e-7,0.00011992916,0.07010594,0.91539973],"study_design_scores_gemma":[0.0013135966,0.00041707998,0.005892315,0.0026638908,0.0025501654,0.000009510887,0.00021510253,0.0000112293665,7.206952e-8,0.000027001079,0.9867151,0.00018494626],"about_ca_topic_score_codex":0.0007902903,"about_ca_topic_score_gemma":0.00003928013,"teacher_disagreement_score":0.91660917,"about_ca_system_score_codex":0.0014033194,"about_ca_system_score_gemma":0.019531533,"threshold_uncertainty_score":0.9860268},"labels":[],"label_agreement":null},{"id":"W2946123967","doi":"10.1200/edbk_237641","title":"A Practical Guide to Geriatric Syndromes in Older Adults With Cancer: A Focus on Falls, Cognition, Polypharmacy, and Depression","year":2019,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"National Cancer Institute; National Institute on Aging","keywords":"Polypharmacy; Geriatric oncology; Medicine; Geriatrics; Delirium; Depression (economics); Psychological intervention; Population; Cognition; Cancer; Gerontology; Psychiatry; Intensive care medicine; Internal medicine","score_opus":0.08603774570996878,"score_gpt":0.5208808547397794,"score_spread":0.4348431090298106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946123967","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022955667,0.94794965,0.000033841414,0.0409385,0.0005941791,0.0050347038,0.00014606447,0.000033217275,0.0029742932],"genre_scores_gemma":[0.0008533816,0.9798083,0.0040618246,0.010257683,0.0007395983,0.0012987979,0.00009548416,0.00005965842,0.0028252797],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99614406,0.00040651532,0.0016746497,0.0009175902,0.0004775177,0.0003796706],"domain_scores_gemma":[0.98929197,0.007970348,0.0015603092,0.00026992155,0.00054369215,0.00036378024],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000600389,0.0004488794,0.0034606408,0.00018137254,0.0000651288,0.000007147303,0.0001213294,0.00035438564,0.00039166134],"category_scores_gemma":[0.001285721,0.00033698586,0.00060343137,0.000603304,0.00095159916,0.000077847915,0.00013168312,0.0011635759,0.00006151932],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001143073,0.0021592753,0.0054430235,0.0026536512,0.0012277768,0.0000118030675,0.00036200174,4.2986105e-7,1.1140094e-7,0.0000119504975,0.14104871,0.8459382],"study_design_scores_gemma":[0.0050816312,0.003758158,0.037114695,0.019181496,0.0037693381,0.000182728,0.00094161875,0.000004521507,5.826772e-7,0.00000848058,0.9295466,0.00041015263],"about_ca_topic_score_codex":0.0004425901,"about_ca_topic_score_gemma":0.000038293547,"teacher_disagreement_score":0.845528,"about_ca_system_score_codex":0.0006653635,"about_ca_system_score_gemma":0.009171631,"threshold_uncertainty_score":0.9999082},"labels":[],"label_agreement":null},{"id":"W3012972211","doi":"10.1200/edbk_286019","title":"Optimizing Cardiovascular Health in Patients With Cancer: A Practical Review of Risk Assessment, Monitoring, and Prevention of Cancer Treatment–Related Cardiovascular Toxicity","year":2020,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System","funders":"","keywords":"Medicine; Cardiovascular health; Cancer; Risk assessment; Intensive care medicine; Oncology; Internal medicine; Disease; Computer science","score_opus":0.08491795244821411,"score_gpt":0.4997347504733523,"score_spread":0.4148167980251382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012972211","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028449728,0.9920173,0.00006755501,0.002346297,0.00014943931,0.0023280375,0.00013504634,0.000008924558,0.00010237463],"genre_scores_gemma":[0.00054694334,0.9850281,0.013188785,0.0003816415,0.00025288653,0.00032793154,0.00019415366,0.000038486847,0.000041107476],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99507934,0.0013431926,0.0021724314,0.00061334256,0.000576427,0.00021527064],"domain_scores_gemma":[0.99419177,0.0013375782,0.0033421784,0.0004403788,0.00046474513,0.00022333876],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016786093,0.00033901335,0.006830356,0.00006143188,0.0000432878,0.0000026173848,0.000093352435,0.0003252096,0.000049863218],"category_scores_gemma":[0.00042071828,0.00027335642,0.0034768574,0.0004974701,0.0007380866,0.000087655855,0.000039121624,0.0007815703,3.4635516e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007240014,0.001092889,0.013506777,0.015768597,0.014011022,6.654179e-7,0.00023811952,0.000012866217,4.1996606e-7,0.000007869518,0.00027523964,0.95501316],"study_design_scores_gemma":[0.0052389493,0.0042781453,0.057623465,0.06453634,0.018175386,0.0000126773975,0.00020390187,0.000007323563,0.000015207757,0.00001669573,0.84954023,0.00035169814],"about_ca_topic_score_codex":0.0011715178,"about_ca_topic_score_gemma":0.000008442201,"teacher_disagreement_score":0.9546614,"about_ca_system_score_codex":0.0012084788,"about_ca_system_score_gemma":0.013215083,"threshold_uncertainty_score":0.99997187},"labels":[],"label_agreement":null},{"id":"W3013640632","doi":"10.1200/edbk_280687","title":"Novel Strategies to Effectively De-escalate Curative-Intent Therapy for Patients With HPV-Associated Oropharyngeal Cancer: Current and Future Directions","year":2020,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Cetuximab; De-escalation; Radiation therapy; Chemoradiotherapy; Oncology; Internal medicine; Adjuvant; Chemotherapy; Cancer; Intensive care medicine","score_opus":0.06413475537158633,"score_gpt":0.4475230542294617,"score_spread":0.3833882988578754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013640632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74454373,0.0020718153,0.0005970389,0.25057706,0.00040607704,0.0012447994,0.0001551414,0.000027722395,0.0003766014],"genre_scores_gemma":[0.9114569,0.020497702,0.012875029,0.051506065,0.0020985103,0.0011331098,0.00009663231,0.000045516263,0.00029053152],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987671,0.00008346316,0.00043275167,0.00033694712,0.0001694709,0.00021030621],"domain_scores_gemma":[0.9972785,0.0013989809,0.00033480363,0.000067777604,0.000625002,0.00029490187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001970421,0.00015585769,0.0008438746,0.000014968263,0.00012566615,0.0000058796104,0.000059569666,0.00007367668,0.00005512101],"category_scores_gemma":[0.00023077986,0.0001151115,0.0002164527,0.00019404718,0.0005947687,0.00006783127,0.000025354557,0.00027842418,0.0000011537697],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025677548,0.0034092295,0.32043025,0.00007526926,0.0011484526,1.5099037e-7,0.00846149,0.000003930052,0.00018993209,0.00020108157,0.042783417,0.620729],"study_design_scores_gemma":[0.0030873355,0.0075134733,0.7893928,0.00003946241,0.00010724504,3.998326e-7,0.0014418565,0.00005306104,0.00001206512,0.000029189987,0.19822235,0.00010071823],"about_ca_topic_score_codex":0.00015374261,"about_ca_topic_score_gemma":0.000029354083,"teacher_disagreement_score":0.6206283,"about_ca_system_score_codex":0.00023346014,"about_ca_system_score_gemma":0.0023611477,"threshold_uncertainty_score":0.46941108},"labels":[],"label_agreement":null},{"id":"W3014556675","doi":"10.1200/edbk_280495","title":"Therapeutic Targets and Opportunities in Endometrial Cancer: Update on Endocrine Therapy and Nonimmunotherapy Targeted Options","year":2020,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Endometrial cancer; Medicine; Oncology; Disease; Cancer; Incidence (geometry); Internal medicine; Stage (stratigraphy); Targeted therapy; Gynecology; Biology","score_opus":0.25374383317710825,"score_gpt":0.5040458800593774,"score_spread":0.2503020468822692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014556675","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029798612,0.96645224,0.0000029186197,0.030905081,0.00040323808,0.0012026549,0.00016339087,0.000019459998,0.0005530588],"genre_scores_gemma":[0.00023601623,0.9787324,0.0013452414,0.016778512,0.0009820337,0.00054834905,0.00027038436,0.000050542127,0.0010565061],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99651986,0.0005889934,0.0016265676,0.0006344562,0.00032365156,0.00030646264],"domain_scores_gemma":[0.99206996,0.006064766,0.0011485618,0.00024441062,0.00013764715,0.000334631],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00053055026,0.00044021956,0.0039490345,0.00019269626,0.00007636186,0.000011820369,0.00016664265,0.00027995344,0.0011028926],"category_scores_gemma":[0.0002531835,0.00032730313,0.0008997608,0.00053695054,0.0014599083,0.00006153284,0.00005881264,0.00086443056,0.000009027263],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093678146,0.0013337602,0.0004189834,0.0004435199,0.001716664,0.0000069447356,0.00014078304,1.609188e-7,0.0000010945708,0.00065781036,0.001732007,0.99261147],"study_design_scores_gemma":[0.00599105,0.004736227,0.0023311588,0.0006294074,0.00060987304,0.000018603705,0.00013513406,0.0000031180173,0.0000010883329,0.00019354212,0.98511297,0.00023782333],"about_ca_topic_score_codex":0.00023458112,"about_ca_topic_score_gemma":0.000006408003,"teacher_disagreement_score":0.99237365,"about_ca_system_score_codex":0.0003390292,"about_ca_system_score_gemma":0.0040939623,"threshold_uncertainty_score":0.9999179},"labels":[],"label_agreement":null},{"id":"W3014871370","doi":"10.1200/edbk_281093","title":"How Do We Align Health Services Research and Quality Improvement?","year":2020,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Healthcare cost, quality, practices","field":"Health Professions","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Health Centre; University of Toronto","funders":"","keywords":"Health care; Multidisciplinary approach; Quality management; Leverage (statistics); Quality (philosophy); Pareto chart; Population; Medicine; Process management; Business; Knowledge management; Pareto principle; Computer science; Operations management; Marketing; Engineering; Service (business); Environmental health; Political science","score_opus":0.8583349122118643,"score_gpt":0.7506523640025407,"score_spread":0.10768254820932366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014871370","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000042989206,0.6484422,0.000010677667,0.34704852,0.0007625206,0.0023933428,0.00019755911,0.000037727135,0.0010644374],"genre_scores_gemma":[0.000034289755,0.92025447,0.0050348267,0.060689267,0.003225392,0.00094233867,0.00020424282,0.00008124976,0.009533912],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9626087,0.027556648,0.0058491076,0.0015426404,0.0012650749,0.0011778547],"domain_scores_gemma":[0.8976757,0.08841392,0.010010407,0.00095034664,0.0016018248,0.0013478177],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.03009006,0.00054772,0.0064554675,0.000121867204,0.0011312327,0.000038907026,0.0010098481,0.0012581648,0.00042371225],"category_scores_gemma":[0.0036907,0.00047074503,0.0010493329,0.0008872302,0.004000237,0.0003296096,0.00089037913,0.0067911195,0.00021864589],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050252813,0.0006594226,0.0013763233,0.040233318,0.00044760393,5.1898667e-7,0.0041475655,3.9038843e-9,1.3472005e-7,0.0044557266,0.056955166,0.891674],"study_design_scores_gemma":[0.0004509335,0.0021642027,0.0011557237,0.0058801426,0.00015063127,0.0000017776468,0.030970102,8.4155374e-7,2.7802642e-8,0.0012708766,0.9576498,0.00030488448],"about_ca_topic_score_codex":0.004094144,"about_ca_topic_score_gemma":0.00027618028,"teacher_disagreement_score":0.90069467,"about_ca_system_score_codex":0.0016204837,"about_ca_system_score_gemma":0.056339446,"threshold_uncertainty_score":0.9997744},"labels":[],"label_agreement":null},{"id":"W3019605854","doi":"10.1200/edbk_278171","title":"Cutting to the Front of the Line: Immunotherapy for Childhood Acute Lymphoblastic Leukemia","year":2020,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Blinatumomab; Medicine; Oncology; Chemotherapy; CD22; Immunotherapy; Internal medicine; Clinical trial; Mitoxantrone; Refractory (planetary science); Disease; Lymphoblastic Leukemia; Calicheamicin; Immunology; Leukemia; Immune system; Lymphoma; Myeloid leukemia; CD20","score_opus":0.06589324316166924,"score_gpt":0.4639014552021747,"score_spread":0.39800821204050546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3019605854","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013824496,0.8843596,0.0016114172,0.10475453,0.0012341696,0.0061458442,0.0003866703,0.000032174295,0.0013373396],"genre_scores_gemma":[0.00007477915,0.94446373,0.019671641,0.02565118,0.002852946,0.0008196038,0.000114726594,0.000106274216,0.0062451395],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947415,0.0005860723,0.0027557283,0.00070090685,0.000743731,0.0004720631],"domain_scores_gemma":[0.9746736,0.020680485,0.0027390157,0.0009362892,0.0006378946,0.00033268952],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015557276,0.00045001798,0.0040910156,0.00004939735,0.0001834835,0.000009424468,0.0012735939,0.00048257495,0.00022013979],"category_scores_gemma":[0.0043359688,0.0002478599,0.0038166244,0.0005718519,0.0022825422,0.000034897814,0.00036759162,0.0011522013,0.00007484705],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001998758,0.0004829605,0.000051086456,0.0011363368,0.0029660822,6.6336906e-7,0.0007182127,0.0000062919253,0.0000029063094,0.00012018259,0.15898596,0.8353294],"study_design_scores_gemma":[0.0016839115,0.0021790906,0.0010377743,0.0019594817,0.0022928782,0.000061691,0.00029122105,0.00013627787,0.0000032827818,0.000059476984,0.9900949,0.00020001813],"about_ca_topic_score_codex":0.00008687454,"about_ca_topic_score_gemma":0.0000025437025,"teacher_disagreement_score":0.83512944,"about_ca_system_score_codex":0.0024171518,"about_ca_system_score_gemma":0.059878875,"threshold_uncertainty_score":0.9999974},"labels":[],"label_agreement":null},{"id":"W3022356865","doi":"10.1200/edbk_288015","title":"PARP Inhibitors for Ovarian Cancer: Current Indications, Future Combinations, and Novel Assets in Development to Target DNA Damage Repair","year":2020,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"DNA Damage Repair; Ovarian cancer; Serous fluid; Cancer; PARP inhibitor; DNA damage; DNA repair; Medicine; Olaparib; Biology; Oncology; Poly ADP ribose polymerase; Cancer research; Internal medicine; Bioinformatics; DNA; Genetics","score_opus":0.12921200137641028,"score_gpt":0.5227415520295526,"score_spread":0.3935295506531423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022356865","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014562922,0.9043251,0.00056808104,0.08918481,0.0013746815,0.0035518862,0.0004918677,0.000053454212,0.00030448392],"genre_scores_gemma":[0.00003577099,0.8976822,0.0862107,0.008922114,0.0019389908,0.0034815392,0.0012313282,0.000056849938,0.00044049986],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955533,0.00027289253,0.0026198614,0.00084949913,0.00038982142,0.00031462914],"domain_scores_gemma":[0.9938895,0.0029481826,0.0019457149,0.00033277288,0.00039485135,0.0004889879],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00127933,0.00039801636,0.0028936248,0.00016800445,0.00012426681,0.000009279438,0.00023933015,0.0004178833,0.0001479319],"category_scores_gemma":[0.0006385177,0.00038012737,0.0008755585,0.0006836647,0.00072031515,0.00007568981,0.00010250305,0.00096023415,0.000015999796],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000064278676,0.002083225,0.0024654418,0.0025493477,0.00055310514,8.2036877e-7,0.0006413961,5.84931e-7,0.0000012790999,0.0015630878,0.14012884,0.8499486],"study_design_scores_gemma":[0.0018895721,0.00048254404,0.01288295,0.0025840504,0.0003713091,0.00001272838,0.0002474823,0.000008048888,0.0000015582092,0.00010183749,0.98110163,0.0003162837],"about_ca_topic_score_codex":0.000027097463,"about_ca_topic_score_gemma":0.000010702821,"teacher_disagreement_score":0.8496323,"about_ca_system_score_codex":0.0013317493,"about_ca_system_score_gemma":0.020423522,"threshold_uncertainty_score":0.99986506},"labels":[],"label_agreement":null},{"id":"W311451838","doi":"10.14694/edbook_am.2015.35.e106","title":"Biology and Clinical Management Challenges in Meningioma","year":2015,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Meningioma; Neurofibromatosis type 2; Bevacizumab; Medicine; CDKN2A; Radiosurgery; Sunitinib; Cancer research; Vascular endothelial growth factor; Neurofibromatosis; Internal medicine; Oncology; Radiation therapy; Pathology; Bioinformatics; Biology; Cancer; VEGF receptors; Chemotherapy","score_opus":0.2635993231218677,"score_gpt":0.5205361371898595,"score_spread":0.2569368140679918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W311451838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7707086,0.0030847217,0.00005940847,0.12991758,0.0005097175,0.000496576,0.0000021606843,0.000024136221,0.095197104],"genre_scores_gemma":[0.9142536,0.005109505,0.06779106,0.005972725,0.0006547386,0.000075249845,0.000029943794,0.00001711955,0.006096066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99739116,0.00036067588,0.0013233563,0.00048630673,0.00019796501,0.0002405548],"domain_scores_gemma":[0.99704534,0.0016626815,0.0005095033,0.0002795917,0.00014826884,0.00035463172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030064578,0.0001403911,0.0009597321,0.000072579285,0.000025472018,0.000003050607,0.00013337971,0.0001717962,0.000090919726],"category_scores_gemma":[0.00044571052,0.00012428372,0.00030222494,0.00015672439,0.0014954585,0.000051069623,0.00015431925,0.00032102157,0.000025685695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047357735,0.0023394886,0.51353115,0.00007017029,0.00068425765,0.000036668287,0.00080247194,0.00000131044,0.0000056420395,0.030494304,0.04299454,0.4085664],"study_design_scores_gemma":[0.0027883158,0.0028600786,0.6608794,0.000033948716,0.0001421547,0.000036974234,0.0033688992,0.00010543574,0.0000012888717,0.0022887443,0.32738063,0.00011415414],"about_ca_topic_score_codex":0.00004351522,"about_ca_topic_score_gemma":0.0000045965194,"teacher_disagreement_score":0.40845224,"about_ca_system_score_codex":0.00010910945,"about_ca_system_score_gemma":0.0006317262,"threshold_uncertainty_score":0.5510079},"labels":[],"label_agreement":null},{"id":"W3136970932","doi":"10.1200/edbk_320463","title":"Disparities in Cancer Care: The Example of Sarcoma—In Search of Solutions for a Global Issue","year":2021,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Disadvantage; Disadvantaged; Ethnic group; Multidisciplinary approach; Medicine; Health care; Cancer; Family medicine; Healthcare system; Health equity; Economic growth; Political science; Economics","score_opus":0.14920915894832548,"score_gpt":0.5007616059534191,"score_spread":0.35155244700509364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136970932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83607525,0.01108588,0.00002942111,0.15061744,0.0001689171,0.00052180554,0.00013606556,0.0000027443216,0.0013624609],"genre_scores_gemma":[0.9857376,0.0027425578,0.006206507,0.0042715706,0.0001571301,0.00028910147,0.000054564145,0.000005908799,0.0005350402],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856687,0.00015984796,0.0007170207,0.00019457951,0.00017349925,0.0001881569],"domain_scores_gemma":[0.99458647,0.0045380234,0.0002506501,0.00018964593,0.0003774276,0.000057803565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004666401,0.00007197146,0.0006466312,0.000014212938,0.000032006403,0.0000011612678,0.00008523739,0.00007398573,0.0001796985],"category_scores_gemma":[0.0003572381,0.000055861696,0.00036406112,0.00024206268,0.0012432807,0.000020129664,0.000051539402,0.00013853992,8.58389e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011586369,0.0034280166,0.9295406,0.00008735929,0.00017955652,7.8226816e-7,0.0010117423,0.000034456934,0.000025901434,0.0067073423,0.011974441,0.046893965],"study_design_scores_gemma":[0.0016524128,0.0005364317,0.94892687,0.000069253234,0.00009752663,0.0000027990118,0.0043849354,0.000043454074,0.00011210796,0.0005594371,0.04357362,0.000041138763],"about_ca_topic_score_codex":0.015213888,"about_ca_topic_score_gemma":0.001746229,"teacher_disagreement_score":0.14966235,"about_ca_system_score_codex":0.00029707144,"about_ca_system_score_gemma":0.004406683,"threshold_uncertainty_score":0.9913439},"labels":[],"label_agreement":null},{"id":"W3157218996","doi":"10.1200/edbk_100028","title":"An Arm and a Leg: The Rising Cost of Cancer Drugs and Impact on Access","year":2021,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":171,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cancer; Harm; Reimbursement; Cancer drugs; Health care; Psychological intervention; Intensive care medicine; Internal medicine; Economic growth; Nursing; Economics","score_opus":0.09505555398241844,"score_gpt":0.4685514832670566,"score_spread":0.37349592928463815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157218996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95429814,0.0040433584,0.000072044975,0.03162121,0.00025838867,0.0001386299,0.00013929023,0.0000036787592,0.009425264],"genre_scores_gemma":[0.9783898,0.00823818,0.0007366818,0.011488913,0.0003529393,0.00002384608,0.000008801608,0.0000114063605,0.0007494152],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861115,0.000050819828,0.0008246651,0.00031659298,0.000034188037,0.00016261076],"domain_scores_gemma":[0.9969165,0.0015301523,0.0010892784,0.00021816787,0.00011250085,0.00013343683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007729878,0.000109601024,0.0007179334,0.000024640683,0.00008358278,0.000025130794,0.0001737852,0.00009834012,0.0005109912],"category_scores_gemma":[0.00026143654,0.00009396846,0.00022206822,0.00011487228,0.0013542075,0.00022885684,0.0000578836,0.00023254176,0.0000045178144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001456039,0.0007927887,0.74327326,0.000023329338,0.00031380236,2.406885e-7,0.0018849149,0.00014585888,0.000011778454,0.035810724,0.01443272,0.20316501],"study_design_scores_gemma":[0.00052626466,0.00049036706,0.90023893,0.000016109256,0.000022085515,0.0000015966112,0.00077457086,0.00034101962,0.000030500998,0.008866009,0.0885763,0.00011623283],"about_ca_topic_score_codex":0.0016576373,"about_ca_topic_score_gemma":0.000062516956,"teacher_disagreement_score":0.20304878,"about_ca_system_score_codex":0.00012275575,"about_ca_system_score_gemma":0.0009761551,"threshold_uncertainty_score":0.5594995},"labels":[],"label_agreement":null},{"id":"W3160903165","doi":"10.1200/edbk_320519","title":"Locoregional Therapies for Colorectal Cancer Liver Metastases: Options Beyond Resection","year":2021,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Colorectal cancer; Malignancy; Radiofrequency ablation; Rectum; Radiology; Ablative case; Radiation therapy; Oncology; Cancer; Surgery; Internal medicine; Ablation","score_opus":0.16974227371499778,"score_gpt":0.4455270674119487,"score_spread":0.2757847936969509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160903165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8647498,0.0089929085,0.0004892121,0.12222814,0.00052026805,0.0008354849,0.00016223185,0.000026508167,0.0019954569],"genre_scores_gemma":[0.8792286,0.0088648265,0.08021386,0.016231231,0.0016609957,0.0011060126,0.00081938086,0.000032145523,0.011842957],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99845576,0.00020792661,0.00059468317,0.0003407707,0.00021306376,0.00018779117],"domain_scores_gemma":[0.9955497,0.00301974,0.00037235118,0.00014298336,0.0007475029,0.00016771909],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004918598,0.00013006249,0.0006350233,0.000027491455,0.0001264074,0.000005965413,0.00006368097,0.00013837861,0.0016510087],"category_scores_gemma":[0.00030783954,0.000115078765,0.00088768883,0.0002087405,0.0010443231,0.000070393886,0.000027204764,0.00020420596,0.000013329787],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010466614,0.0038985212,0.6829165,0.000089978086,0.0024923487,0.000007115234,0.0009383043,0.00000405814,0.0013667066,0.0037627602,0.19232228,0.11115471],"study_design_scores_gemma":[0.0028348085,0.0033241045,0.41389808,0.000041162308,0.0010273769,0.000046111014,0.0016777308,0.0005469777,0.0020760933,0.0010501614,0.5732878,0.0001896116],"about_ca_topic_score_codex":0.00013146068,"about_ca_topic_score_gemma":0.00004481853,"teacher_disagreement_score":0.3809655,"about_ca_system_score_codex":0.00018918693,"about_ca_system_score_gemma":0.0042289663,"threshold_uncertainty_score":0.9992616},"labels":[],"label_agreement":null},{"id":"W3161230492","doi":"10.1200/edbk_320939","title":"Assessment Criteria and Clinical Implications of Extranodal Extension in Head and Neck Cancer","year":2021,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Head and neck cancer; Radiation therapy; Metastasis; Disease; Malignancy; Oncology; Pathology; Adjuvant therapy; Cancer; Internal medicine","score_opus":0.1297942608610546,"score_gpt":0.5630697782638227,"score_spread":0.43327551740276804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161230492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8432259,0.0026448455,0.000025547704,0.15157534,0.00018430427,0.00016249868,0.000017547838,0.0000046282694,0.0021594136],"genre_scores_gemma":[0.9278263,0.0250705,0.03055581,0.01526158,0.00030523477,0.00005307169,0.000018954954,0.000010035619,0.0008985163],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979927,0.00020172694,0.0011482324,0.0003749629,0.00013462844,0.00014772786],"domain_scores_gemma":[0.9962641,0.0025979818,0.00038018022,0.00019046964,0.00039423714,0.00017302061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007336843,0.00010008864,0.0010555715,0.000020360189,0.000046037203,0.0000023616726,0.000043689975,0.00012439031,0.0002130642],"category_scores_gemma":[0.00046439611,0.000090911155,0.00021903114,0.00015607657,0.001684758,0.00004366019,0.00007265638,0.00032479267,6.618134e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010045618,0.0014296087,0.87128365,0.000058543108,0.00014827427,0.0000010981346,0.00024686594,2.64883e-7,0.00085556717,0.0006740174,0.011359468,0.1138422],"study_design_scores_gemma":[0.001780622,0.0011156797,0.9594953,0.00012403107,0.00011111285,0.000013486402,0.0006192516,0.00005472219,0.000019597017,0.00039896855,0.036195833,0.00007136995],"about_ca_topic_score_codex":0.0002651138,"about_ca_topic_score_gemma":0.0001496483,"teacher_disagreement_score":0.13631377,"about_ca_system_score_codex":0.00008403461,"about_ca_system_score_gemma":0.0034310247,"threshold_uncertainty_score":0.62075615},"labels":[],"label_agreement":null},{"id":"W3162944371","doi":"10.1200/edbk_320113","title":"Navigating Myelodysplastic and Myelodysplastic/Myeloproliferative Overlap Syndromes","year":2021,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Myelodysplastic syndromes; Decitabine; Medicine; Disease; Myeloid leukemia; Oncology; Lenalidomide; Bioinformatics; Internal medicine; DNA methylation; Bone marrow; Multiple myeloma; Gene; Biology; Genetics","score_opus":0.06676709730006641,"score_gpt":0.46753414615332745,"score_spread":0.40076704885326103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3162944371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8994073,0.0009016537,0.0003010924,0.09500133,0.00032091912,0.0003393286,0.000025038662,0.00003396966,0.0036693497],"genre_scores_gemma":[0.86765367,0.0032594274,0.088909745,0.025753835,0.0013241556,0.00010713121,0.00015477695,0.00005567767,0.012781566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99681485,0.00037904724,0.0012058482,0.00065356784,0.0005275763,0.00041909554],"domain_scores_gemma":[0.98631436,0.01125547,0.0006220054,0.00033133556,0.00096380594,0.0005130226],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0009160225,0.000236469,0.0012913254,0.000023628243,0.00016634472,0.000015551632,0.00014426491,0.00025145325,0.0008542522],"category_scores_gemma":[0.0047521335,0.00021855616,0.0004193879,0.00041865386,0.003237399,0.000131958,0.00020667068,0.0014241753,0.00006540863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013054943,0.0031504564,0.5246684,0.0005493503,0.002570513,0.00014075954,0.004152211,0.000032356114,0.0030668755,0.00410741,0.081279166,0.374977],"study_design_scores_gemma":[0.0046695834,0.003452133,0.868932,0.00039261242,0.00048498402,0.0009963475,0.011140436,0.0019857106,0.0008270613,0.0009964223,0.10566553,0.0004571905],"about_ca_topic_score_codex":0.000065211716,"about_ca_topic_score_gemma":0.00000713311,"teacher_disagreement_score":0.3745198,"about_ca_system_score_codex":0.0003776444,"about_ca_system_score_gemma":0.009425227,"threshold_uncertainty_score":0.99947524},"labels":[],"label_agreement":null},{"id":"W3212495299","doi":"10.14694/edbk_158927","title":"Update on Intraperitoneal Chemotherapy for the Treatment of Epithelial Ovarian Cancer","year":2016,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Debulking; Chemotherapy; Ovarian cancer; Randomized controlled trial; Oncology; Clinical endpoint; Clinical trial; Stage (stratigraphy); Cancer; Surgery; Internal medicine","score_opus":0.06646668058171958,"score_gpt":0.4597392419738262,"score_spread":0.39327256139210665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212495299","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22028343,0.0009460986,0.0002656694,0.77584827,0.00073078775,0.0010451647,0.00021281796,0.000010833697,0.00065690954],"genre_scores_gemma":[0.84922814,0.067802034,0.017343758,0.0525022,0.003999307,0.0016439371,0.000034299377,0.000045209956,0.0074011055],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987063,0.000059614737,0.00062846456,0.0002757312,0.0001619175,0.00016796599],"domain_scores_gemma":[0.9939545,0.004936937,0.0005248354,0.0002758189,0.00019538176,0.00011257529],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025117426,0.0001349884,0.00070162246,0.000014261947,0.00005681872,0.0000017668483,0.00009186822,0.00009104725,0.0010803925],"category_scores_gemma":[0.00006892784,0.000066663546,0.0006840784,0.00007267096,0.0012197401,0.00002209286,0.00000629293,0.000060251816,0.000009539622],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001600593,0.0054080468,0.03581801,0.00001103911,0.0015203216,2.4549226e-7,0.0004584306,0.000002257819,0.0002882536,0.002317376,0.034124058,0.91845137],"study_design_scores_gemma":[0.0058890074,0.007649361,0.29669395,0.00003720835,0.00029547283,0.0000013642459,0.000117742864,0.000013209808,0.0016027977,0.0002570362,0.68737954,0.000063337415],"about_ca_topic_score_codex":0.0002398755,"about_ca_topic_score_gemma":0.000014456732,"teacher_disagreement_score":0.918388,"about_ca_system_score_codex":0.00034742418,"about_ca_system_score_gemma":0.0019769082,"threshold_uncertainty_score":0.99983275},"labels":[],"label_agreement":null},{"id":"W4223965493","doi":"10.1200/edbk_351021","title":"Barriers to Access: Global Variability in Implementing Treatment Advances in Lung Cancer","year":2022,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Lung cancer; Cancer; Cancer survival; Radiation therapy; Global health; Quality (philosophy); Cause of death","score_opus":0.04305648339931472,"score_gpt":0.5496120036424352,"score_spread":0.5065555202431206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223965493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86148226,0.0015321763,0.00007135129,0.123936504,0.00049908075,0.0012962781,0.00020823469,0.0000148129775,0.0109593],"genre_scores_gemma":[0.9716597,0.0010740594,0.0054440037,0.018770551,0.00019234986,0.0017178756,0.00006407376,0.000009435381,0.0010679158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998051,0.00029201113,0.0008064694,0.00037926104,0.00020997503,0.0002612737],"domain_scores_gemma":[0.9979294,0.001236558,0.00033851774,0.00016742846,0.00008521611,0.00024285783],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00087687577,0.00011277263,0.00059180375,0.00003483392,0.00010909761,0.000003795372,0.00012781576,0.000036228044,0.0027054287],"category_scores_gemma":[0.00038330685,0.00010409529,0.00022828371,0.00050605496,0.0002596515,0.00011113452,0.000106577325,0.00017373619,0.000001183528],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00018068937,0.001072492,0.8758059,0.000016234604,0.0001510782,0.0000013920077,0.0011564224,0.00051115593,0.000003444998,0.00033868125,0.004965103,0.115797386],"study_design_scores_gemma":[0.0020014218,0.00090280705,0.6877199,0.00001495532,0.00012412158,0.000001879487,0.0030532323,0.00017757645,0.0000030228846,0.00032008166,0.30560124,0.00007979351],"about_ca_topic_score_codex":0.003594369,"about_ca_topic_score_gemma":0.0008556665,"teacher_disagreement_score":0.30063614,"about_ca_system_score_codex":0.003942543,"about_ca_system_score_gemma":0.008676644,"threshold_uncertainty_score":0.99988115},"labels":[],"label_agreement":null},{"id":"W4224250655","doi":"10.1200/edbk_350292","title":"Genetic Testing for All: Overcoming Disparities in Ovarian Cancer Genetic Testing","year":2022,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; Women's College Hospital","funders":"","keywords":"Genetic testing; Ovarian cancer; Genetic counseling; Lynch syndrome; Population; Genetic genealogy; Health equity; Ethnic group","score_opus":0.0850492284370712,"score_gpt":0.43511869451177454,"score_spread":0.35006946607470335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224250655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9792591,0.0022400268,0.0012690085,0.01502081,0.00070380355,0.0005706896,0.00011458243,0.00001052485,0.0008114955],"genre_scores_gemma":[0.7129094,0.00019605369,0.26962364,0.013869129,0.0009831871,0.0012547172,0.00006560416,0.000038225127,0.0010600585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997904,0.000223428,0.0008826543,0.00049841404,0.00018379427,0.00030772592],"domain_scores_gemma":[0.99656695,0.0021988924,0.00064599613,0.00025202328,0.00024773186,0.000088389956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000683489,0.00014787528,0.00040505204,0.000031883308,0.00018479896,0.000007517646,0.00031329144,0.000102236154,0.00012505226],"category_scores_gemma":[0.0013210522,0.00017566762,0.00023170025,0.00024849473,0.0006642878,0.0000056489216,0.00021213801,0.00028048002,9.293019e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013053074,0.0006231674,0.8022008,0.000046189107,0.00024310428,7.2998546e-7,0.00036737564,0.014525305,0.016629647,0.00009385829,0.03867663,0.1264627],"study_design_scores_gemma":[0.0012367548,0.001442579,0.8197393,0.00001619404,0.00008205956,0.00001663237,0.0010467167,0.0023714292,0.0003362816,0.00097207905,0.1724411,0.0002988858],"about_ca_topic_score_codex":0.0010935022,"about_ca_topic_score_gemma":0.00010847579,"teacher_disagreement_score":0.26835462,"about_ca_system_score_codex":0.00034584934,"about_ca_system_score_gemma":0.004395345,"threshold_uncertainty_score":0.7797154},"labels":[],"label_agreement":null},{"id":"W4225105893","doi":"10.1200/edbk_350442","title":"Current Therapy for Metastatic Head and Neck Cancer: Evidence, Opportunities, and Challenges","year":2022,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Pembrolizumab; Oncology; Head and neck squamous-cell carcinoma; Internal medicine; Immunotherapy; Head and neck cancer; Targeted therapy; Chemotherapy; Cancer; Cetuximab; Colorectal cancer","score_opus":0.6511461484117984,"score_gpt":0.5962259429381032,"score_spread":0.05492020547369525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225105893","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011146274,0.93861765,0.0000014111171,0.059114654,0.00048457275,0.0012011713,0.000106246254,0.0000108935765,0.0003519465],"genre_scores_gemma":[0.00000318521,0.9882255,0.00220568,0.0052736765,0.00072593713,0.0020859765,0.00006819192,0.00003284489,0.001378967],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99737257,0.0003509068,0.0012451649,0.00054422463,0.00024718157,0.00023996008],"domain_scores_gemma":[0.98541,0.012808685,0.0011474425,0.00021221416,0.00016640194,0.00025527345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011469766,0.0002959628,0.0037826395,0.000048330858,0.00014499054,0.00000435666,0.000121126504,0.0001092253,0.00034879596],"category_scores_gemma":[0.0005102554,0.00023009218,0.000816425,0.00010441591,0.0017200229,0.000053095253,0.000097484095,0.0005351387,7.544592e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009371668,0.000552722,0.00014250008,0.00793354,0.0009927988,4.9733666e-7,0.00043890913,1.3806046e-8,1.3679678e-8,0.00038149604,0.037421573,0.9520422],"study_design_scores_gemma":[0.0008796341,0.003938972,0.0015152748,0.0036760622,0.0012703964,0.000018116556,0.0008036605,0.0000020386829,1.15562475e-8,0.00007877944,0.9876312,0.00018584795],"about_ca_topic_score_codex":0.000078601006,"about_ca_topic_score_gemma":0.0000113414335,"teacher_disagreement_score":0.9518564,"about_ca_system_score_codex":0.00023020421,"about_ca_system_score_gemma":0.010310628,"threshold_uncertainty_score":0.9953},"labels":[],"label_agreement":null},{"id":"W4229046480","doi":"10.1200/edbk_350241","title":"Early-Onset Colorectal Cancer Survival Differences and Potential Geographic Determinants Among Men and Women in Utah","year":2022,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute on Minority Health and Health Disparities; National Cancer Institute","keywords":"Demography; Medicine; Hazard ratio; Incidence (geometry); Ethnic group; Mortality rate; Cancer registry; Population; Gerontology; Colorectal cancer; Epidemiology; Cancer; Internal medicine; Confidence interval; Environmental health","score_opus":0.0381026354791209,"score_gpt":0.38831330692817373,"score_spread":0.3502106714490528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229046480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99538094,0.0003174585,0.0000028357144,0.0033141696,0.00027227474,0.0002437853,0.000024465022,0.000012889179,0.0004311652],"genre_scores_gemma":[0.9966093,0.00079797854,0.00023462901,0.00088178145,0.00017723811,0.0003301268,0.0000060409834,0.000009813709,0.00095313124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983027,0.00029604154,0.0005324598,0.00035128515,0.0002635822,0.00025392053],"domain_scores_gemma":[0.99815315,0.0011063135,0.00037646605,0.00008179794,0.00007272842,0.00020951824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093754893,0.000115988885,0.00068044063,0.00006466407,0.000148542,0.0000064475685,0.00007397312,0.000083737825,0.00028277523],"category_scores_gemma":[0.00014973222,0.00011189478,0.00014285148,0.00022867152,0.0015875237,0.000057054378,0.00012604332,0.00047271687,3.7791966e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018262464,0.0003158191,0.9511938,0.000013873883,0.000097245604,0.0000023158373,0.0016626411,0.0000031928296,0.000033635406,0.0000034048676,0.00033956958,0.044508256],"study_design_scores_gemma":[0.0013585939,0.0058338926,0.9861755,0.000013362439,0.000054084165,0.000024832172,0.0048166397,0.0005053308,0.000005951362,0.00015664428,0.0009478539,0.000107315886],"about_ca_topic_score_codex":0.003434747,"about_ca_topic_score_gemma":0.00016432983,"teacher_disagreement_score":0.04440094,"about_ca_system_score_codex":0.0002109203,"about_ca_system_score_gemma":0.0009825531,"threshold_uncertainty_score":0.5849297},"labels":[],"label_agreement":null},{"id":"W4230568286","doi":"10.1200/edbk_175630","title":"Optimal Management of Early and Advanced HER2 Breast Cancer","year":2017,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Disease; Breast cancer; Oncology; Internal medicine; Intensive care medicine; Adjuvant chemotherapy; Cancer; Chemotherapy; Adjuvant","score_opus":0.26462721998985017,"score_gpt":0.6238183746282034,"score_spread":0.35919115463835327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230568286","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00055141374,0.9786962,0.0000070946153,0.012122745,0.00039268078,0.0012205591,0.00018396153,0.000011147354,0.0068141436],"genre_scores_gemma":[0.00007129628,0.96261686,0.016740318,0.0009265213,0.0006729717,0.00041552164,0.000047711277,0.000047936846,0.01846087],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99648994,0.00026210284,0.0017230108,0.00063569995,0.0005475399,0.00034172874],"domain_scores_gemma":[0.99414814,0.0019811506,0.0023635803,0.0006911393,0.0004547691,0.0003612279],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0011823529,0.0003030952,0.0037196698,0.00005503106,0.00008173744,0.000007687547,0.00045382575,0.00036116006,0.0008891188],"category_scores_gemma":[0.00014885372,0.00025382568,0.0012175336,0.00016850213,0.00426197,0.00006566266,0.0002587967,0.0009435349,0.000022545946],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013089723,0.0006147062,0.0017726388,0.008707713,0.0015106625,0.0000037173866,0.00008133465,5.155921e-7,1.7768335e-7,0.00015902251,0.01673999,0.9702786],"study_design_scores_gemma":[0.0007663246,0.0010389558,0.036622554,0.006840464,0.0012027335,0.000034764606,0.00015174135,0.000002407344,1.3652837e-7,0.000018284158,0.9531448,0.00017685759],"about_ca_topic_score_codex":0.00035181388,"about_ca_topic_score_gemma":0.0000037874295,"teacher_disagreement_score":0.9701018,"about_ca_system_score_codex":0.0004333583,"about_ca_system_score_gemma":0.008990312,"threshold_uncertainty_score":0.9999914},"labels":[],"label_agreement":null},{"id":"W4236787481","doi":"10.14694/edbook_am.2013.33.e295","title":"Aberrant Epigenetic Regulation: A Central Contributor to Lung Carcinogenesis and a New Therapeutic Target","year":2013,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Epigenetic therapy; Epigenetics; Vorinostat; Histone deacetylase; Epigenome; Lung cancer; Demethylating agent; Cancer epigenetics; Carcinogenesis; Cancer research; Biology; Cancer; DNA methylation; Trichostatin A; Medicine; Bioinformatics; Histone; Oncology; Genetics; Histone methyltransferase; Gene; Gene expression","score_opus":0.09407210223003434,"score_gpt":0.4478427080122863,"score_spread":0.35377060578225195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236787481","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009759643,0.9915725,0.002454693,0.0031945698,0.0003979595,0.0010858908,0.000055574015,0.0000066330185,0.0002562307],"genre_scores_gemma":[0.00047510356,0.97123456,0.01813411,0.00203945,0.0016539657,0.0001740027,0.0004156641,0.000050143826,0.005823],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99672717,0.0004860081,0.0014584187,0.0007243672,0.00022392289,0.00038014282],"domain_scores_gemma":[0.9966984,0.00089830684,0.0011665124,0.0004435122,0.0002815784,0.0005117061],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000581989,0.00036726613,0.0017765891,0.00004332584,0.00008589309,0.000017646484,0.00028549135,0.0005475705,0.00028295163],"category_scores_gemma":[0.00034793196,0.00032568368,0.0009166016,0.00018252988,0.00058256864,0.00000547425,0.00013578119,0.0002517573,0.000017999912],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029575085,0.00017408186,0.0012427137,0.00041452964,0.00063570496,1.4536761e-7,0.000101308884,0.000016549924,0.00027604902,0.00010540126,0.02125294,0.975751],"study_design_scores_gemma":[0.00033945942,0.00077828637,0.009187055,0.00018298112,0.00049276545,0.0000034231546,0.00003277014,0.000025165657,0.00008100541,0.00021361178,0.98833716,0.00032631503],"about_ca_topic_score_codex":0.0001511184,"about_ca_topic_score_gemma":0.00000895732,"teacher_disagreement_score":0.9754247,"about_ca_system_score_codex":0.00013964095,"about_ca_system_score_gemma":0.005356731,"threshold_uncertainty_score":0.99991953},"labels":[],"label_agreement":null},{"id":"W4238996943","doi":"10.14694/edbook_am.2013.33.e57","title":"Mammographic Density and Risk of Breast Cancer","year":2013,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Breast cancer; Medicine; Tamoxifen; Mammography; Risk factors for breast cancer; Family history; Menopause; Relative risk; Gynecology; Obstetrics; Cancer; Internal medicine; Oncology","score_opus":0.06564973028895799,"score_gpt":0.45907378160664647,"score_spread":0.3934240513176885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238996943","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004118689,0.9887419,0.000008438867,0.00427081,0.0002325243,0.00058995676,0.00020804256,0.0000139925705,0.001815686],"genre_scores_gemma":[0.0004591585,0.99241495,0.0038350152,0.0013005415,0.00051270076,0.000091356065,0.00006353647,0.000026826749,0.0012959094],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972808,0.0002631637,0.0015256751,0.00044823886,0.00026011872,0.00022202176],"domain_scores_gemma":[0.9930296,0.0034314,0.0024927699,0.00030877642,0.00042713663,0.0003103248],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0006681243,0.00028397058,0.0034392856,0.00010502152,0.000046821697,0.0000058629416,0.00016005975,0.00029432852,0.0003056126],"category_scores_gemma":[0.00020431758,0.00021648488,0.0023112244,0.00045899738,0.004375112,0.00009209916,0.00007690835,0.0007552742,0.000008267558],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002801316,0.0006986808,0.089291096,0.002247062,0.0019147216,4.447698e-7,0.0000356302,3.10754e-8,1.6301692e-7,0.00009263474,0.014130895,0.8915606],"study_design_scores_gemma":[0.00036380225,0.00040095006,0.20227253,0.0021488792,0.0036185067,0.0001641472,0.00010561591,0.0000022395704,1.2441275e-7,0.00013831184,0.79061526,0.00016962626],"about_ca_topic_score_codex":0.000584735,"about_ca_topic_score_gemma":0.000004603714,"teacher_disagreement_score":0.891391,"about_ca_system_score_codex":0.00007028241,"about_ca_system_score_gemma":0.0035527914,"threshold_uncertainty_score":0.9983344},"labels":[],"label_agreement":null},{"id":"W4242383671","doi":"10.14694/edbook_am.2013.33.e176","title":"Androgen Deprivation for Prostate Cancer: When and How, the Good and the Bad","year":2013,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Androgen deprivation therapy; Medicine; Prostate cancer; Prostatectomy; Radiation therapy; Oncology; Internal medicine; Randomized controlled trial; Disease; Adverse effect; Cancer","score_opus":0.14433784236185704,"score_gpt":0.5065755656683095,"score_spread":0.3622377233064525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242383671","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024696407,0.80922425,0.0000078649,0.18679366,0.00011438518,0.0032481498,0.00005875506,0.000005849978,0.00030011102],"genre_scores_gemma":[0.000043051623,0.97053295,0.0019181784,0.0039809104,0.00065288984,0.002916019,0.00014561128,0.000024613286,0.019785777],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981848,0.00036008388,0.00064385956,0.00037595534,0.00021316615,0.00022214359],"domain_scores_gemma":[0.989225,0.009111553,0.00095100806,0.0002551288,0.0003137366,0.00014360971],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.001302619,0.0002131172,0.0017084988,0.000021123285,0.00018231044,0.00002167533,0.00015997369,0.00020062149,0.00007259475],"category_scores_gemma":[0.00046840784,0.00009746204,0.000610901,0.00010962896,0.004415964,0.000054995806,0.000096110816,0.00048007295,0.000002916647],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014442275,0.0001278569,0.0017168241,0.0011647077,0.000990727,1.0685064e-7,0.00049360574,2.1934222e-8,1.5037588e-7,0.00047949198,0.065289445,0.9295926],"study_design_scores_gemma":[0.0022287837,0.00063803676,0.0014883301,0.00051926874,0.0014088054,0.000013901631,0.00039366938,0.000016962747,3.967827e-7,0.0006732151,0.9925221,0.00009653432],"about_ca_topic_score_codex":0.00015249776,"about_ca_topic_score_gemma":0.00000733356,"teacher_disagreement_score":0.9294961,"about_ca_system_score_codex":0.00015773272,"about_ca_system_score_gemma":0.0044291667,"threshold_uncertainty_score":0.99829346},"labels":[],"label_agreement":null},{"id":"W4244042359","doi":"10.14694/edbook_am.2013.33.e307","title":"Update on the Initial Therapy of Multiple Myeloma","year":2013,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Lenalidomide; Thalidomide; Bortezomib; Multiple myeloma; Medicine; Regimen; Oncology; Melphalan; Internal medicine; Maintenance therapy; Dexamethasone; Population; Pharmacology; Chemotherapy","score_opus":0.28856113041625625,"score_gpt":0.5530178974308779,"score_spread":0.2644567670146217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244042359","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016793545,0.9646738,0.000005955359,0.023496525,0.0003487158,0.0028328716,0.0001414998,0.000018014518,0.0068032295],"genre_scores_gemma":[0.0006385838,0.98450226,0.0033076194,0.006420902,0.0008508056,0.0005745993,0.0003297121,0.00004362798,0.0033318761],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959895,0.0008528472,0.0018039857,0.00046465368,0.00056069036,0.00032832453],"domain_scores_gemma":[0.97806114,0.01862074,0.0019340281,0.0006474762,0.00044170534,0.00029489986],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000952076,0.00034642217,0.0031805488,0.00006165235,0.00008392565,0.000005523721,0.0004024892,0.0003700707,0.0026880882],"category_scores_gemma":[0.0016389751,0.00019261555,0.0023129417,0.00026817783,0.0030674266,0.000039878298,0.00008915894,0.0009954132,0.00035477962],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018662903,0.0022503622,0.00084674254,0.00045886866,0.0018353096,0.000001598654,0.00006358878,6.673601e-8,6.8577117e-7,0.00029709097,0.06765921,0.9263998],"study_design_scores_gemma":[0.0013897205,0.002581197,0.005865179,0.0008562891,0.00027750092,0.000012006096,0.000115144765,0.000008584956,0.000005229313,0.00007614184,0.9886787,0.00013431814],"about_ca_topic_score_codex":0.00014147215,"about_ca_topic_score_gemma":0.0000020444054,"teacher_disagreement_score":0.92626554,"about_ca_system_score_codex":0.0001995519,"about_ca_system_score_gemma":0.007036849,"threshold_uncertainty_score":0.99964565},"labels":[],"label_agreement":null},{"id":"W4247326642","doi":"10.14694/edbook_am.2013.33.e205","title":"Revisiting the Role of Radiation Treatment for Non-serous Subtypes of Epithelial Ovarian Cancer","year":2013,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Serous fluid; Medicine; Ovarian cancer; Oncology; Radiation therapy; Chemotherapy; Clear cell; Internal medicine; Serous ovarian cancer; Disease; Cancer; Stage (stratigraphy); Carcinoma; Biology","score_opus":0.09268229458801586,"score_gpt":0.4807174761154469,"score_spread":0.38803518152743105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247326642","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004161904,0.9824018,0.000021532649,0.013043746,0.00035250862,0.0025273738,0.00031377282,0.000005464832,0.0009175974],"genre_scores_gemma":[0.0007880837,0.9871486,0.0057594413,0.0007482162,0.0023240354,0.0017425516,0.00021595247,0.000034628618,0.0012384868],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971004,0.0002213257,0.0018821241,0.00038332853,0.0002154368,0.00019735919],"domain_scores_gemma":[0.9885093,0.007047744,0.0035398148,0.00038527668,0.00039983448,0.000118012955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061003864,0.00027215978,0.0032010288,0.000036372523,0.00005905394,0.0000033839656,0.00016842749,0.0002636599,0.00036597913],"category_scores_gemma":[0.00025804885,0.00016688458,0.0020884157,0.00017363954,0.00083360355,0.000033329852,0.00002832422,0.0002091256,0.000007733981],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006433647,0.00090485404,0.0036508252,0.0013655598,0.0023656823,1.0091979e-7,0.0002661664,0.0000012385043,0.000002076776,0.0004070149,0.0027601412,0.988212],"study_design_scores_gemma":[0.0013001736,0.0018656551,0.009413314,0.0017881859,0.004251082,0.0000036734748,0.00024514602,0.000015059936,0.00003625675,0.00010037137,0.98086435,0.0001167372],"about_ca_topic_score_codex":0.0013097548,"about_ca_topic_score_gemma":0.000006556031,"teacher_disagreement_score":0.9880953,"about_ca_system_score_codex":0.000571821,"about_ca_system_score_gemma":0.008044954,"threshold_uncertainty_score":0.9975785},"labels":[],"label_agreement":null},{"id":"W4247607096","doi":"10.1200/edbk_158675","title":"Paradigm Shift in the Management Strategy for Epithelial Ovarian Cancer","year":2016,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ovarian cancer; Serous fluid; Clear cell; Fallopian tube; Endometriosis; Cancer research; Epithelial ovarian cancer; Serous carcinoma; Epithelium; Pathogenesis; Cancer; Ovarian carcinoma; Medicine; Biology; Oncology; Pathology; Carcinoma; Internal medicine; Gynecology","score_opus":0.16389491489976998,"score_gpt":0.5241776539659408,"score_spread":0.36028273906617087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247607096","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000006811644,0.85689,0.00007392342,0.13573858,0.0005572667,0.00272368,0.00027475468,0.000008275433,0.003726709],"genre_scores_gemma":[0.00010664888,0.97900605,0.0025281832,0.009701199,0.0019465518,0.004241624,0.0001450396,0.000034933324,0.002289777],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968496,0.0003300268,0.0016324869,0.00058590376,0.00027689664,0.0003250996],"domain_scores_gemma":[0.99188936,0.0061366884,0.0013128333,0.00046513637,0.000052192132,0.00014379367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011787916,0.00031733979,0.0025940037,0.000049428192,0.000061839004,0.000008423105,0.00032404496,0.00029328986,0.0006858178],"category_scores_gemma":[0.00005350457,0.00017842684,0.0018299735,0.00021029517,0.0009092966,0.000036297428,0.000039750783,0.000405758,0.00003771401],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007149016,0.0016962091,0.00035427973,0.0017528546,0.0017571426,0.0000032151922,0.00013040735,4.0178747e-7,3.3003071e-9,0.022079682,0.036143202,0.93601114],"study_design_scores_gemma":[0.0018660525,0.0010905782,0.013849329,0.0027943002,0.0021984777,0.000006823621,0.000093055045,7.579046e-7,2.6352508e-8,0.00290123,0.97503364,0.0001657113],"about_ca_topic_score_codex":0.00016859769,"about_ca_topic_score_gemma":0.000024159837,"teacher_disagreement_score":0.93889046,"about_ca_system_score_codex":0.0006121129,"about_ca_system_score_gemma":0.006161565,"threshold_uncertainty_score":0.99947256},"labels":[],"label_agreement":null},{"id":"W4247991125","doi":"10.1200/edbk_159161","title":"A Value-Based Approach to Treatment of HER2-Positive Breast Cancer: Examining the Evidence","year":2016,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Breast cancer; Medicine; Value (mathematics); Oncology; Cancer; Family medicine; Intensive care medicine; Internal medicine; Computer science","score_opus":0.3712633474379659,"score_gpt":0.5953295001663849,"score_spread":0.22406615272841895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247991125","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006947626,0.93999094,0.00017776812,0.05178701,0.0003252413,0.0028038768,0.00035594104,0.00001605448,0.004473699],"genre_scores_gemma":[0.00015940401,0.97723806,0.008381178,0.0053917384,0.001623997,0.0019420175,0.0000525107,0.000059283277,0.0051518143],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.994536,0.001400081,0.0019845918,0.0008354736,0.0008008744,0.0004429873],"domain_scores_gemma":[0.9724144,0.023756938,0.0018297767,0.00081278733,0.00074445043,0.00044165642],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0020361966,0.00041069504,0.0039322344,0.000078342244,0.000091979025,0.0000066342313,0.00055755035,0.00036748243,0.00050738343],"category_scores_gemma":[0.0009608869,0.00023134472,0.001775487,0.0005747618,0.0036335364,0.000041359133,0.00010299886,0.00059420336,0.000050750466],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019589771,0.00206148,0.0011980516,0.0019027075,0.0010789003,8.762913e-7,0.00042169946,0.0000036310794,0.0000012778497,0.00010081698,0.019927692,0.973107],"study_design_scores_gemma":[0.00063472916,0.004454077,0.007801735,0.012926275,0.0012852937,0.000033746375,0.0002831909,0.000012818677,0.0000022137488,0.000010357498,0.9723501,0.00020543428],"about_ca_topic_score_codex":0.001011276,"about_ca_topic_score_gemma":0.000004789953,"teacher_disagreement_score":0.9729015,"about_ca_system_score_codex":0.0023716358,"about_ca_system_score_gemma":0.03812396,"threshold_uncertainty_score":0.999078},"labels":[],"label_agreement":null},{"id":"W4251572647","doi":"10.14694/edbook_am.2013.33.265","title":"Difficult to Swallow: Issues Affecting Optimal Adherence to Oral Anticancer Agents","year":2013,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Intensive care medicine; Cancer; Internal medicine","score_opus":0.31309898932867997,"score_gpt":0.588655633500381,"score_spread":0.275556644171701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251572647","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0037363635,0.92447525,0.00050578633,0.055681065,0.0018149974,0.0053288043,0.000046364785,0.00009721682,0.00831415],"genre_scores_gemma":[0.00006694741,0.82198405,0.06812213,0.02679602,0.0014222336,0.0008933467,0.000107954234,0.000045537683,0.0805618],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955299,0.00037163525,0.0021128326,0.000899214,0.00062140444,0.0004650041],"domain_scores_gemma":[0.9931895,0.0029098948,0.0015691645,0.00063279056,0.0007518676,0.0009467789],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0009414865,0.00043328776,0.0038066094,0.00007378228,0.00009220697,0.000015586082,0.0005749196,0.00038505995,0.0073420224],"category_scores_gemma":[0.0023672618,0.00034732142,0.00117791,0.000746866,0.00091403734,0.000073997595,0.00019182092,0.00089843513,0.005538683],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018616203,0.0005519608,0.0004013025,0.0007415906,0.00026682278,7.854622e-7,0.00020040618,0.0000010123241,0.0000015226329,0.000035437475,0.39099663,0.6067839],"study_design_scores_gemma":[0.00035055107,0.0024484156,0.0045498293,0.0036623606,0.0005607634,0.000014858451,0.0005424997,0.000011989593,0.0000010689203,0.000009785068,0.98753464,0.00031325966],"about_ca_topic_score_codex":0.00022161937,"about_ca_topic_score_gemma":0.0000027847275,"teacher_disagreement_score":0.60647064,"about_ca_system_score_codex":0.0003613997,"about_ca_system_score_gemma":0.0063131335,"threshold_uncertainty_score":0.9998979},"labels":[],"label_agreement":null},{"id":"W4253690459","doi":"10.1200/edbk_158713","title":"Treatment of Lung Cancer in Medically Compromised Patients","year":2016,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Lung cancer; Clinical trial; Intensive care medicine; Cancer; Population; Performance status; Disease; Radiation therapy; Internal medicine","score_opus":0.0453200208877816,"score_gpt":0.46002147750916433,"score_spread":0.41470145662138275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253690459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9139674,0.00071433315,0.000019839432,0.082646936,0.0003038637,0.00040691593,0.0000352281,0.000006006598,0.001899532],"genre_scores_gemma":[0.9783722,0.007889807,0.0024216645,0.00610687,0.0002841525,0.000114703675,0.000018575896,0.000012006606,0.0047800313],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840456,0.000100834324,0.00093276147,0.0002070416,0.00021347872,0.00014129802],"domain_scores_gemma":[0.997095,0.0018506992,0.00059282774,0.00015615758,0.00019345172,0.00011190445],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024613467,0.00009528598,0.00071610266,0.000025703337,0.000015368472,5.377464e-7,0.00007628519,0.00010455641,0.0015655344],"category_scores_gemma":[0.00014914937,0.00005919289,0.00040244908,0.00012294234,0.0015661031,0.000029386596,0.00001192818,0.00006970498,0.0000026252294],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014480299,0.002702973,0.6165694,0.000015769103,0.0002979943,2.2914948e-7,0.0003126328,1.4496322e-7,0.00067090464,0.000026135,0.009055749,0.36890006],"study_design_scores_gemma":[0.009110061,0.0030174884,0.88771147,0.000088459055,0.000075622454,7.3797196e-7,0.000091517395,0.00001820428,0.00014949431,0.000026979957,0.09964941,0.00006056716],"about_ca_topic_score_codex":0.00045601875,"about_ca_topic_score_gemma":0.00002512869,"teacher_disagreement_score":0.3688395,"about_ca_system_score_codex":0.00048535375,"about_ca_system_score_gemma":0.002970772,"threshold_uncertainty_score":0.99934715},"labels":[],"label_agreement":null},{"id":"W4254088013","doi":"10.1200/edbk_175617","title":"Standard and Genomic Tools for Decision Support in Breast Cancer Treatment","year":2017,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Breast cancer; Medicine; Disease; Precision medicine; Adjuvant chemotherapy; Cancer; Clinical decision making; Intensive care medicine; Oncology; Bioinformatics; Internal medicine; Pathology; Biology","score_opus":0.13324770513893966,"score_gpt":0.5197193168087934,"score_spread":0.38647161166985367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254088013","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011373361,0.99205804,0.000071176764,0.002926238,0.00048338764,0.00087404164,0.0021479954,0.0000018473754,0.0002999595],"genre_scores_gemma":[0.00007154857,0.989478,0.0059830644,0.001234689,0.0011045145,0.00047404657,0.0004699582,0.000031114138,0.0011530631],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980817,0.00007149371,0.0010212588,0.00053440046,0.00008234109,0.00020882956],"domain_scores_gemma":[0.9955988,0.0025454946,0.0011956976,0.00037017465,0.00015000274,0.00013983183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004948831,0.00024414115,0.0017436775,0.000024783447,0.00007072494,0.000020803562,0.00024127532,0.00036384608,0.00007488466],"category_scores_gemma":[0.00044629865,0.000210689,0.00085366244,0.000029941055,0.00080146035,0.000005433667,0.000112465095,0.00014121039,0.0000024687217],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015288226,0.00021956419,0.00095686776,0.00021919736,0.00026387116,2.5899357e-7,0.000022053113,0.0000018420609,0.0000030515528,0.000037071557,0.033316102,0.9648072],"study_design_scores_gemma":[0.00076138094,0.0013320082,0.0038068914,0.00029795108,0.00031474992,0.000010899874,0.0000341723,0.0000018633646,0.0000010844262,0.00006653587,0.99317384,0.00019864258],"about_ca_topic_score_codex":0.00015411558,"about_ca_topic_score_gemma":0.00012170958,"teacher_disagreement_score":0.9646086,"about_ca_system_score_codex":0.0003261221,"about_ca_system_score_gemma":0.009608578,"threshold_uncertainty_score":0.996006},"labels":[],"label_agreement":null},{"id":"W4254463786","doi":"10.1200/edbk_156039","title":"The Cancer Survivorship Journey: Models of Care, Disparities, Barriers, and Future Directions","year":2016,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Cancer survivorship and care","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Partenariat Canadien Contre Le Cancer","keywords":"Survivorship curve; Cancer survivorship; Reimbursement; Health care; Medicine; Population; Nursing; Gerontology; Family medicine; Environmental health; Economic growth","score_opus":0.04739885183654113,"score_gpt":0.41100134539059846,"score_spread":0.3636024935540573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254463786","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3363887,0.0444754,0.00015723391,0.60238653,0.0032397772,0.00049636984,0.0002228389,0.000031654017,0.012601474],"genre_scores_gemma":[0.8607903,0.11675519,0.00095081027,0.008908058,0.0023996579,0.00013878634,0.0000128518905,0.000023836825,0.010020523],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984474,0.00020905392,0.0006540603,0.0002547471,0.00024230278,0.0001924347],"domain_scores_gemma":[0.9947489,0.0037080592,0.00049227406,0.00026272208,0.00051789335,0.00027014065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006197154,0.00011621221,0.000601484,0.000017577335,0.00015847058,0.000004312229,0.00013477083,0.000139786,0.00024951258],"category_scores_gemma":[0.0002723476,0.000068625486,0.00038338228,0.0001501911,0.0026346114,0.00007556396,0.00004646628,0.00025927878,0.0000010042439],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005640037,0.00021448752,0.34910497,0.00010169911,0.00056498125,2.86951e-7,0.004684527,0.0000013566878,0.000041254407,0.013508185,0.0693566,0.56185764],"study_design_scores_gemma":[0.00069570896,0.00056203775,0.1939206,0.00006852576,0.00016673609,0.0000046127398,0.010213034,0.000010362275,0.000026692447,0.0013793125,0.7928573,0.000095089454],"about_ca_topic_score_codex":0.00412818,"about_ca_topic_score_gemma":0.0023020762,"teacher_disagreement_score":0.72350067,"about_ca_system_score_codex":0.0001713313,"about_ca_system_score_gemma":0.003235876,"threshold_uncertainty_score":0.9707335},"labels":[],"label_agreement":null},{"id":"W4254478771","doi":"10.14694/edbook_am.2013.33.420","title":"Emerging Molecular-Targeted Therapies in Early-Phase Clinical Trials and Preclinical Models","year":2013,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Crizotinib; Medicine; Anaplastic lymphoma kinase; Sorafenib; Clinical trial; Targeted therapy; Context (archaeology); Oncology; Internal medicine; Bioinformatics; Cancer; Biology; Lung cancer","score_opus":0.3633105090765392,"score_gpt":0.6074786253619576,"score_spread":0.2441681162854184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254478771","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008252668,0.97446316,0.000039454713,0.013609887,0.0004543091,0.0025489144,0.000047346122,0.000024789151,0.0005594886],"genre_scores_gemma":[0.00096683943,0.97441465,0.016349778,0.0054653957,0.00083183363,0.0009797356,0.0001975724,0.00007035086,0.0007238665],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9860403,0.004397389,0.0076202033,0.0010804913,0.00043419487,0.00042743984],"domain_scores_gemma":[0.94915605,0.04501845,0.0042955624,0.000637103,0.0003143259,0.0005785172],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008614489,0.0005655816,0.010622158,0.00012453555,0.0000566149,0.00001719298,0.00027607655,0.001022354,0.0005106206],"category_scores_gemma":[0.0053035226,0.00041204412,0.0044663604,0.0003300572,0.0023920152,0.00011513633,0.00015280634,0.0015993305,0.000047539525],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001383592,0.0077760695,0.008462596,0.0006383384,0.0026885548,0.000010241392,0.00020848542,5.243092e-7,1.9551658e-7,0.00038620995,0.009574584,0.97011584],"study_design_scores_gemma":[0.0055143544,0.0031783076,0.0097709885,0.002215018,0.0035953023,0.000026733296,0.00024526642,0.00009788983,2.9598706e-7,0.001020716,0.9739517,0.00038341313],"about_ca_topic_score_codex":0.00017519247,"about_ca_topic_score_gemma":0.0000034868274,"teacher_disagreement_score":0.9697324,"about_ca_system_score_codex":0.00021859679,"about_ca_system_score_gemma":0.005338085,"threshold_uncertainty_score":0.99983317},"labels":[],"label_agreement":null},{"id":"W4255520119","doi":"10.14694/edbook_am.2013.33.81","title":"Connecting Molecular Pathways to Hereditary Cancer Risk Syndromes","year":2013,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"SDHB; SDHD; BAP1; Cancer research; SDHA; Cancer; Paraganglioma; Fumarase; Germline mutation; Biology; Cowden syndrome; Cancer syndrome; Medicine; Melanoma; Pathology; Mutation; Genetics; Succinate dehydrogenase; Gene; Mitochondrion","score_opus":0.05212541167803813,"score_gpt":0.41366342842708154,"score_spread":0.3615380167490434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255520119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9267911,0.0014609288,0.0007655199,0.06590055,0.0008055185,0.0007934337,0.000040953404,0.000055916436,0.003386091],"genre_scores_gemma":[0.90073556,0.0012674452,0.050954323,0.044248205,0.0009809268,0.00040249262,0.000053239935,0.00006295532,0.0012948512],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99738276,0.00023622975,0.0010858553,0.0005428706,0.0003843779,0.00036788278],"domain_scores_gemma":[0.9957085,0.001962469,0.00078996964,0.00041956952,0.00057866663,0.0005408256],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006030866,0.00021391166,0.0010083031,0.00005087304,0.00009786272,0.0000073059796,0.00019824202,0.00024011837,0.0026959018],"category_scores_gemma":[0.0014391607,0.00020611729,0.0007316627,0.00033274153,0.0006764096,0.00008147842,0.00010236795,0.00074062665,0.0002502728],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024595967,0.0022378874,0.04937658,0.00011551753,0.002029294,0.00002274009,0.00264069,0.0006409715,0.0125039825,0.0006003462,0.35571027,0.5738758],"study_design_scores_gemma":[0.0042604953,0.0067583527,0.48828197,0.00033977383,0.0010154345,0.0002144365,0.008419377,0.0010982224,0.0028259577,0.001943634,0.4840141,0.0008282344],"about_ca_topic_score_codex":0.002035047,"about_ca_topic_score_gemma":0.000027050206,"teacher_disagreement_score":0.5730475,"about_ca_system_score_codex":0.00037539192,"about_ca_system_score_gemma":0.0034189129,"threshold_uncertainty_score":0.9982158},"labels":[],"label_agreement":null},{"id":"W4256065302","doi":"10.14694/edbook_am.2013.33.e20","title":"Treatment Algorithms for Hormone Receptor-Positive Advanced Breast Cancer: Applying the Results from Recent Clinical Trials into Daily Practice—Insights, Limitations, and Moving Forward","year":2013,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Exemestane; Fulvestrant; Breast cancer; Medicine; Tamoxifen; Oncology; Everolimus; Aromatase inhibitor; Estrogen receptor; Internal medicine; Clinical trial; Metastatic breast cancer; Aromatase; Letrozole; Cancer","score_opus":0.14692105894424096,"score_gpt":0.505966747079464,"score_spread":0.35904568813522303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256065302","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003212377,0.9750465,0.0002378996,0.018211754,0.0008114945,0.0043159365,0.0008374498,0.000011026501,0.00020665687],"genre_scores_gemma":[0.000019699974,0.94336724,0.04428013,0.0018836805,0.0025470937,0.0039643357,0.003006018,0.00005477283,0.0008770472],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99192137,0.0031911593,0.003315518,0.0010417422,0.00022430014,0.0003059089],"domain_scores_gemma":[0.9563918,0.03736102,0.004811964,0.00048776495,0.0006578417,0.0002896193],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0032620588,0.00048620923,0.0030393358,0.000029117524,0.00028134868,0.00002964814,0.00033100013,0.00094848516,0.000012628735],"category_scores_gemma":[0.007046954,0.00030942415,0.0018644565,0.0001550372,0.0015038784,0.000025001957,0.0001428953,0.0006647363,0.0000109527255],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008030591,0.0007213061,0.000009253166,0.00007946978,0.0035698137,2.7272466e-7,0.00022260634,0.0000032129562,0.000071886534,0.000033421085,0.032999374,0.96148634],"study_design_scores_gemma":[0.0024525449,0.0030215965,0.00010238996,0.00034794438,0.0025327418,0.000011385764,0.0011681573,0.00003605617,0.0000165762,0.00006428569,0.9899197,0.0003266066],"about_ca_topic_score_codex":0.00028272503,"about_ca_topic_score_gemma":0.0000075122684,"teacher_disagreement_score":0.9611597,"about_ca_system_score_codex":0.0002725983,"about_ca_system_score_gemma":0.0047241272,"threshold_uncertainty_score":0.9999358},"labels":[],"label_agreement":null},{"id":"W4280495159","doi":"10.1200/edbk_359521","title":"Cancer Groundshot: Building a Robust Cancer Control Platform in Addition To Launching the Cancer Moonshot","year":2022,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Psychological intervention; Cancer; Work (physics); Business; Medicine; Economic growth; Economics; Nursing; Engineering","score_opus":0.11609885501829365,"score_gpt":0.40718396440485616,"score_spread":0.2910851093865625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280495159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75340486,0.0077573047,0.001182017,0.22397098,0.0027664402,0.0008825718,0.0018068776,0.000023563889,0.008205385],"genre_scores_gemma":[0.92797124,0.0028464033,0.0014489526,0.060810685,0.0012767335,0.0021606013,0.000023060626,0.000034753655,0.003427541],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99724233,0.000079054655,0.0015656837,0.00057461904,0.00010101312,0.00043731317],"domain_scores_gemma":[0.9963118,0.0016365142,0.0015105886,0.00027850375,0.00009380295,0.00016881319],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019551571,0.00019191595,0.0010038276,0.00009654243,0.00035877174,0.000023078826,0.00054744503,0.000106569794,0.008356059],"category_scores_gemma":[0.00032539797,0.0001970319,0.0004288833,0.0004216152,0.0005457445,0.00027561563,0.00014509758,0.000757167,0.000027379005],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038212215,0.0007770738,0.5230129,0.000021630438,0.0004476853,7.539031e-7,0.0035961878,0.059489578,0.000024787272,0.05374876,0.26700273,0.091495804],"study_design_scores_gemma":[0.0011687193,0.0003128659,0.28693035,0.000024612495,0.000028555725,0.0000013721466,0.0012484106,0.002186012,0.0000028652885,0.0061537754,0.70166534,0.00027713898],"about_ca_topic_score_codex":0.017533446,"about_ca_topic_score_gemma":0.0017415812,"teacher_disagreement_score":0.43466258,"about_ca_system_score_codex":0.0019768085,"about_ca_system_score_gemma":0.0019554242,"threshold_uncertainty_score":0.99255043},"labels":[],"label_agreement":null},{"id":"W4280509666","doi":"10.1200/edbk_358995","title":"Treatment Sequencing in Resectable Lung Cancer: The Good and the Bad of Adjuvant Versus Neoadjuvant Therapy","year":2022,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Immunotherapy; Oncology; Lung cancer; Adjuvant; Internal medicine; Clinical trial; Adjuvant therapy; Neoadjuvant therapy; Precision medicine; Cancer; Breast cancer; Pathology","score_opus":0.16877204165223453,"score_gpt":0.5254166203150492,"score_spread":0.3566445786628147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280509666","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011884379,0.97248954,3.091825e-7,0.021696549,0.0005017221,0.0019075243,0.00006446381,0.000005630402,0.0021458454],"genre_scores_gemma":[0.0006810063,0.9927478,0.0002895738,0.0018548602,0.00043050965,0.0024814745,0.00007523757,0.000029173085,0.0014103834],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99657434,0.00087684195,0.0014824697,0.00046808086,0.00034756633,0.0002507175],"domain_scores_gemma":[0.97914344,0.018528584,0.0016428194,0.00048589794,0.00009470718,0.00010452498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00120906,0.00030230585,0.0032266553,0.00003767329,0.00012780131,0.000005027869,0.00023869165,0.00015549404,0.0006616643],"category_scores_gemma":[0.00023146655,0.00014671203,0.0013432095,0.0003204019,0.0020209567,0.000028969675,0.00009285777,0.0006107621,0.0000012569055],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00073800306,0.0007723566,0.0033253129,0.0005749881,0.0028325836,0.0000026490407,0.0014714178,0.000008528885,7.633838e-8,0.00053620525,0.005939541,0.9837983],"study_design_scores_gemma":[0.007091526,0.0028336241,0.0020128023,0.0009317724,0.002216356,0.000014403391,0.0012009337,0.00004385721,5.4223966e-7,0.00003023921,0.9835049,0.00011906941],"about_ca_topic_score_codex":0.005873795,"about_ca_topic_score_gemma":0.00017791148,"teacher_disagreement_score":0.9836793,"about_ca_system_score_codex":0.004138856,"about_ca_system_score_gemma":0.018029692,"threshold_uncertainty_score":0.9996841},"labels":[],"label_agreement":null},{"id":"W4280529326","doi":"10.1200/edbk_349799","title":"Checkpoint Immunotherapy in Pediatrics: Here, Gone, and Back Again","year":2022,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Immunogenicity; Cancer; Immunotherapy; Pediatric oncology; Clinical trial; Lymphoma; Pediatric cancer; Oncology; Immune system; Internal medicine; Immunology; Pediatrics","score_opus":0.046503994747724646,"score_gpt":0.41669958455230804,"score_spread":0.3701955898045834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280529326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88546395,0.006252916,0.000019194267,0.0966621,0.000426961,0.00048689375,0.000021866646,0.000013314026,0.010652784],"genre_scores_gemma":[0.7796221,0.026492633,0.023653021,0.13392985,0.0011562521,0.000316798,0.00012546235,0.000060976465,0.03464291],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980153,0.0002570258,0.0009752893,0.00031215328,0.0002444644,0.00019579547],"domain_scores_gemma":[0.9974617,0.0015928089,0.0005591052,0.00020775158,0.00007752524,0.000101115555],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014475138,0.00012060667,0.0006613457,0.00005005841,0.00007954939,0.0000032327569,0.00012535411,0.00008394387,0.0033883036],"category_scores_gemma":[0.00011027258,0.000117631454,0.000400393,0.0003372999,0.0010993864,0.00004329121,0.000069413916,0.0005211023,0.000012211519],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004310872,0.0036244055,0.52405864,0.00006618595,0.0004022322,0.0000033646836,0.0022427219,0.000010077314,0.0013812901,0.00022268979,0.10929683,0.3543807],"study_design_scores_gemma":[0.003228693,0.001951013,0.48439422,0.000008104203,0.000027088168,0.000021300284,0.0028970037,0.000030390642,0.000014233605,0.00018498348,0.5071371,0.00010585953],"about_ca_topic_score_codex":0.00048119726,"about_ca_topic_score_gemma":0.000009251618,"teacher_disagreement_score":0.39784026,"about_ca_system_score_codex":0.0003357133,"about_ca_system_score_gemma":0.0023346688,"threshold_uncertainty_score":0.9975227},"labels":[],"label_agreement":null},{"id":"W4281250923","doi":"10.1200/edbk_349307","title":"Revising the Treatment Pathways in Lymphoma: New Standards of Care—How Do We Choose?","year":2022,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"Cancer Research UK; European Hematology Association","keywords":"Rituximab; Medicine; Follicular lymphoma; Prednisone; Lymphoma; Vincristine; Oncology; CHOP; Internal medicine; Cyclophosphamide; Diffuse large B-cell lymphoma; Refractory (planetary science); Chemotherapy; Biology","score_opus":0.14322419516008214,"score_gpt":0.487645114634505,"score_spread":0.3444209194744229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281250923","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024898088,0.9761122,0.0000017502088,0.018879307,0.0003913398,0.0014051831,0.00022795788,0.000010382846,0.0027229288],"genre_scores_gemma":[0.0002692001,0.9931386,0.0018867467,0.0013599951,0.00073448214,0.0005004857,0.00025524234,0.000042165673,0.0018130518],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957678,0.0006895438,0.0019329523,0.00062015,0.0006883217,0.0003012435],"domain_scores_gemma":[0.98724914,0.009261582,0.0023414083,0.00067486597,0.00022547819,0.00024754196],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000970406,0.00042794965,0.0045059123,0.00007326632,0.000100294754,0.000009571075,0.00029443967,0.0002828481,0.0009853131],"category_scores_gemma":[0.00056761154,0.00026651198,0.0030357079,0.00046648047,0.0011323442,0.000037776474,0.00009751235,0.00033750955,0.000007176213],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00007682472,0.0035179951,0.0013745875,0.0011829707,0.0011109895,0.000006742718,0.0016534507,5.89536e-7,3.0363182e-8,0.00026724325,0.034499884,0.9563087],"study_design_scores_gemma":[0.002608652,0.0041256826,0.0034308452,0.0024687052,0.0019212717,0.000029932275,0.0025391066,6.699417e-7,5.85858e-7,0.00006683057,0.98262876,0.00017897332],"about_ca_topic_score_codex":0.00038621822,"about_ca_topic_score_gemma":0.000014803229,"teacher_disagreement_score":0.9561297,"about_ca_system_score_codex":0.005297261,"about_ca_system_score_gemma":0.038755633,"threshold_uncertainty_score":0.9999787},"labels":[],"label_agreement":null},{"id":"W4281552585","doi":"10.1200/edbk_350829","title":"Evolving Role of Adjuvant Systemic Therapy for Kidney and Urothelial Cancers","year":2022,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kidney Foundation of Canada","funders":"","keywords":"Medicine; Renal cell carcinoma; Sunitinib; Oncology; Adjuvant; Nivolumab; Food and drug administration; Adjuvant therapy; Kidney cancer; Internal medicine; Carcinoma; Metastatic Urothelial Carcinoma; Cancer; Urothelial carcinoma; Immunotherapy; Bladder cancer; Pharmacology","score_opus":0.04383669729226688,"score_gpt":0.41812400890761536,"score_spread":0.3742873116153485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281552585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9038249,0.014762151,0.00012990586,0.06931034,0.0011665407,0.0026990308,0.0006914751,0.00003534831,0.0073802737],"genre_scores_gemma":[0.9676404,0.0018827001,0.005108307,0.021731373,0.0004757568,0.0005018647,0.00005405462,0.000021773334,0.0025837666],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99861264,0.00012206166,0.0006383357,0.00025819597,0.000218764,0.00014997342],"domain_scores_gemma":[0.9977081,0.0012106006,0.0005535422,0.00015472953,0.00019816273,0.0001748981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046781523,0.00010371902,0.0007188862,0.000023006181,0.00010204666,0.0000015476915,0.00009450932,0.00005339951,0.0006346551],"category_scores_gemma":[0.00019272843,0.00009279634,0.00036537944,0.000094605246,0.00070312875,0.00003132975,0.000038927912,0.00018683997,9.0207067e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004473693,0.0031219705,0.4259453,0.00022429414,0.0020670288,8.1895354e-7,0.0059874305,0.00003807367,0.0070497673,0.001019003,0.18018304,0.3698896],"study_design_scores_gemma":[0.011352053,0.015175925,0.21477376,0.00008703911,0.00047176014,0.000057604448,0.010662776,0.0004991379,0.00056286535,0.0011838102,0.7449312,0.00024205961],"about_ca_topic_score_codex":0.0005821849,"about_ca_topic_score_gemma":0.0000021109886,"teacher_disagreement_score":0.56474817,"about_ca_system_score_codex":0.0003092471,"about_ca_system_score_gemma":0.0067372606,"threshold_uncertainty_score":0.9988936},"labels":[],"label_agreement":null},{"id":"W4281675779","doi":"10.1200/edbk_350358","title":"Personalizing Adjuvant Endocrine Therapy for Early-Stage Hormone Receptor–Positive Breast Cancer","year":2022,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Endocrine system; Breast cancer; Oncology; Medicine; Adjuvant; Internal medicine; Hormone receptor; Adjuvant therapy; Stage (stratigraphy); Medical prescription; Hormone; Cancer; Gynecology; Pharmacology; Biology","score_opus":0.0643257032058528,"score_gpt":0.455452952006897,"score_spread":0.3911272488010442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281675779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73914486,0.007985223,0.00054257043,0.24717085,0.00084720604,0.0016190002,0.0014992851,0.00006535246,0.0011256417],"genre_scores_gemma":[0.8313375,0.0064030774,0.04141217,0.081337854,0.0030540691,0.0027937684,0.00039291562,0.00011576233,0.033152893],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976862,0.00020899475,0.00081616844,0.00050306227,0.00041950564,0.00036605346],"domain_scores_gemma":[0.9958552,0.0023058224,0.000899176,0.0002450208,0.00047144463,0.00022334972],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000593927,0.00021057126,0.0009923996,0.000037474954,0.00026733833,0.0000040347527,0.00020334983,0.00006383384,0.0034870969],"category_scores_gemma":[0.00008988672,0.00020049466,0.0007596176,0.0002410704,0.001419528,0.000102032,0.00008556365,0.0005665125,0.000006131352],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013645458,0.00436691,0.13119511,0.000050401475,0.0022108795,0.0000029159146,0.0056721778,0.00011391884,0.0064873635,0.0012572884,0.06928519,0.7657124],"study_design_scores_gemma":[0.0041435165,0.003213997,0.41647825,0.000017364799,0.00008674155,0.00003688252,0.0040494557,0.000054905748,0.000107504435,0.0001491924,0.571485,0.0001771691],"about_ca_topic_score_codex":0.0006314559,"about_ca_topic_score_gemma":0.0000036891129,"teacher_disagreement_score":0.76553524,"about_ca_system_score_codex":0.000758532,"about_ca_system_score_gemma":0.0032650037,"threshold_uncertainty_score":0.9974238},"labels":[],"label_agreement":null},{"id":"W4281690523","doi":"10.1200/edbk_100032","title":"Sexuality After Cancer as an Unmet Need: Addressing Disparities, Achieving Equality","year":2022,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Cancer survivorship and care","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Human sexuality; Reproductive health; Cancer; Health care; Medicine; Psychology; Gerontology; Gender studies; Political science; Sociology; Population; Environmental health","score_opus":0.13212671191610895,"score_gpt":0.5111819653307264,"score_spread":0.37905525341461743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281690523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9026741,0.0014647514,0.000061371305,0.08963368,0.0011545649,0.00027351212,0.0001489106,0.00003620768,0.0045529203],"genre_scores_gemma":[0.8930001,0.0003368188,0.0017644602,0.093597375,0.0012052977,0.00059722015,0.0001664445,0.000025420617,0.009306857],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99673074,0.00088724564,0.0009957037,0.00049898087,0.00058264245,0.00030467444],"domain_scores_gemma":[0.996416,0.0018907896,0.000693321,0.00041496023,0.00024025307,0.00034470728],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001917701,0.00016894458,0.0009038942,0.000029400982,0.00023814966,0.000010107678,0.00021209744,0.000113362934,0.0076964316],"category_scores_gemma":[0.0002931709,0.00017173174,0.0005173066,0.0002787915,0.0014420216,0.00013115445,0.00019428827,0.00088496436,0.000006511006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013024672,0.0027102816,0.8236458,0.00012207065,0.00036279965,0.0000029003397,0.005196755,0.000018229168,0.000057761634,0.0014346417,0.046309665,0.118836634],"study_design_scores_gemma":[0.0006693826,0.0012300553,0.5306531,0.000023406872,0.0001662122,0.000010557756,0.009494976,0.000042529336,0.000007674182,0.00040268607,0.45712683,0.00017254688],"about_ca_topic_score_codex":0.012614099,"about_ca_topic_score_gemma":0.0005115728,"teacher_disagreement_score":0.41081718,"about_ca_system_score_codex":0.00064227957,"about_ca_system_score_gemma":0.0056098974,"threshold_uncertainty_score":0.9951717},"labels":[],"label_agreement":null},{"id":"W4281791850","doi":"10.1200/edbk_351153","title":"Current State of Adjuvant Therapy for Melanoma: Less Is More, or More Is Better?","year":2022,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Dabrafenib; Adjuvant; Adjuvant therapy; Disease; Trametinib; Oncology; Clinical trial; Internal medicine; Melanoma; Placebo; Surgery; Cancer; Metastatic melanoma; Vemurafenib; Pathology; Alternative medicine","score_opus":0.09061740385038856,"score_gpt":0.4565235831820147,"score_spread":0.3659061793316261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281791850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82881606,0.0010731299,0.0003637931,0.1667785,0.0009453106,0.0011855076,0.00023706381,0.00002399278,0.0005766284],"genre_scores_gemma":[0.66653615,0.006983882,0.019553693,0.25451618,0.0012903818,0.0012946749,0.0002746499,0.00008671786,0.049463686],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99789846,0.00011139925,0.0010154672,0.00037081158,0.00039545115,0.00020839764],"domain_scores_gemma":[0.99697024,0.001407191,0.00091629324,0.00029484922,0.0002663924,0.00014502533],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00057577295,0.0001483136,0.0008622462,0.00004979235,0.000115064955,0.0000025689194,0.00018170422,0.000040686635,0.0019003479],"category_scores_gemma":[0.00009610633,0.00012433964,0.0006833778,0.00019960849,0.0008735247,0.000027130502,0.00009862834,0.00033775685,0.0000050442013],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015050671,0.002410037,0.011062607,0.000069655944,0.00046647183,0.0000014699845,0.0023007863,0.00000837941,0.00009348241,0.00004349356,0.31175342,0.67028517],"study_design_scores_gemma":[0.002404706,0.0048264917,0.088368356,0.000014901394,0.0001316145,0.000023741544,0.0029378603,0.00028974027,0.0001759039,0.0002632672,0.9004381,0.00012533134],"about_ca_topic_score_codex":0.00007060028,"about_ca_topic_score_gemma":0.000002910613,"teacher_disagreement_score":0.6701598,"about_ca_system_score_codex":0.00019811855,"about_ca_system_score_gemma":0.0017845011,"threshold_uncertainty_score":0.99901205},"labels":[],"label_agreement":null},{"id":"W4283277318","doi":"10.1200/edbk_349861","title":"Breast Cancer Priorities in Limited-Resource Environments: The Price-Efficacy Dilemma in Cancer Care","year":2022,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Breast cancer; Psychological intervention; Medicine; Cancer; Dilemma; Productivity; Work (physics); Economic growth; Business; Intensive care medicine; Economics; Nursing","score_opus":0.06037602506699173,"score_gpt":0.36786773483663143,"score_spread":0.3074917097696397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283277318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8893068,0.012054701,0.0000136832095,0.086162075,0.0007071482,0.0004989481,0.0006856637,0.000008453024,0.010562561],"genre_scores_gemma":[0.9715495,0.006254523,0.00023869268,0.016669692,0.0005659357,0.00060441985,0.000026648377,0.0000267878,0.0040637944],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975596,0.00011690403,0.0014235056,0.0004644606,0.0000812234,0.00035429312],"domain_scores_gemma":[0.9971101,0.001258881,0.0012247642,0.00028328126,0.00002859963,0.00009436147],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00091862655,0.00016212149,0.00081862084,0.00007655758,0.00015314786,0.000011303642,0.00047513866,0.000101094585,0.0024182836],"category_scores_gemma":[0.00012659776,0.00016909167,0.000334806,0.00030313907,0.001014095,0.00016600477,0.0001855644,0.000699834,0.000022801529],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014931009,0.0008846634,0.89531636,0.0000130062135,0.00009790862,5.83117e-7,0.0059031798,0.003448763,0.0000018981392,0.010697586,0.025148371,0.05833838],"study_design_scores_gemma":[0.0006006414,0.000110167195,0.5226613,0.0000063561247,0.000005399844,0.00000117011,0.0025623566,0.00006493427,5.209137e-7,0.00045114756,0.47342557,0.00011042216],"about_ca_topic_score_codex":0.0063620578,"about_ca_topic_score_gemma":0.00028823788,"teacher_disagreement_score":0.4482772,"about_ca_system_score_codex":0.0016119152,"about_ca_system_score_gemma":0.001200577,"threshold_uncertainty_score":0.9984936},"labels":[],"label_agreement":null},{"id":"W4375853203","doi":"10.1200/edbk_390980","title":"Developing Sustainable Cancer and Aging Programs","year":2023,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Frailty in Older Adults","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Geriatric oncology; Context (archaeology); Cancer; Medicine; Health care; Gerontology; Population ageing; Developing country; Population; Oncology; Intensive care medicine; Internal medicine; Environmental health; Political science; Economic growth; Geography","score_opus":0.10709444676463448,"score_gpt":0.49455019920521676,"score_spread":0.3874557524405823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4375853203","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4173751,0.0005284085,0.00007350015,0.5781305,0.00023921047,0.0004329334,0.00000252228,0.00007711819,0.0031407503],"genre_scores_gemma":[0.45458946,0.0076563815,0.07366715,0.056010757,0.0017366378,0.00047713658,0.00013938817,0.00005839551,0.40566468],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984983,0.000064413136,0.00060665724,0.00030150704,0.00021073074,0.00031835953],"domain_scores_gemma":[0.9970909,0.0018532313,0.0003393409,0.00015128734,0.00038502875,0.00018025986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076951,0.00010609624,0.00056297495,0.00003653308,0.00008984386,0.000006113195,0.00008780184,0.00010295027,0.00012179471],"category_scores_gemma":[0.0006829137,0.0000985321,0.00019219026,0.00042312514,0.0014639952,0.00007568786,0.00009662266,0.0002926872,0.000023496807],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004619225,0.00028263647,0.30027846,0.00019333985,0.00024441865,0.0000045148854,0.0015353442,0.0000035469895,0.000026877935,0.0030168758,0.092196465,0.60217136],"study_design_scores_gemma":[0.00077928836,0.0004454226,0.38282803,0.00008347689,0.00006463453,0.000010204081,0.005851262,0.00011332181,0.000017800156,0.0008741921,0.60883486,0.00009748367],"about_ca_topic_score_codex":0.0004888141,"about_ca_topic_score_gemma":0.000012806292,"teacher_disagreement_score":0.60207385,"about_ca_system_score_codex":0.00024153385,"about_ca_system_score_gemma":0.0041189515,"threshold_uncertainty_score":0.73068434},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"other","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W4376107823","doi":"10.1200/edbk_390778","title":"COVID-19 and Other Viral Infections in Patients With Hematologic Malignancies","year":2023,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Tocilizumab; Chimeric antigen receptor; Immunology; Population; Disease; Immune system; Internal medicine; Immunotherapy","score_opus":0.08741768583104755,"score_gpt":0.4779941578406663,"score_spread":0.39057647200961876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376107823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95500934,0.00005259086,0.000014763898,0.04174773,0.00006648867,0.00039978448,0.0000112595335,0.000030429615,0.0026675991],"genre_scores_gemma":[0.91865665,0.00052510865,0.0030956347,0.057168495,0.00022305512,0.0001857697,0.0000667054,0.00003054025,0.02004807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985994,0.00017284325,0.0004942458,0.00026979038,0.00024980895,0.0002139049],"domain_scores_gemma":[0.99591756,0.0032601545,0.00023506983,0.00016726043,0.00014066124,0.00027930128],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00074036507,0.000096477794,0.00055110006,0.0000735252,0.000060187576,0.000003360988,0.00006937818,0.000109980836,0.0017866301],"category_scores_gemma":[0.0011484672,0.00007634053,0.00015023566,0.00041886084,0.0021458578,0.000040161878,0.000049473736,0.0003109409,0.00003104582],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033056713,0.001099657,0.9648543,0.000041219726,0.000105007864,0.0000011893735,0.00058312755,0.0000070202664,0.000055964745,0.0004499628,0.025310602,0.007161355],"study_design_scores_gemma":[0.0023347635,0.0021493766,0.7567448,0.000014202288,0.000022968266,0.0000071208974,0.0006738693,0.000023525448,0.0000052040455,0.00040386987,0.23755182,0.000068453264],"about_ca_topic_score_codex":0.0002906861,"about_ca_topic_score_gemma":0.00003107518,"teacher_disagreement_score":0.21224122,"about_ca_system_score_codex":0.00021641064,"about_ca_system_score_gemma":0.0029887112,"threshold_uncertainty_score":0.9991259},"labels":[],"label_agreement":null},{"id":"W4376128378","doi":"10.1200/edbk_100035","title":"Patient Advocates and Researchers as Partners in Cancer Research: A Winning Combination","year":2023,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Mental Health and Patient Involvement","field":"Health Professions","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"National Cancer Institute; NRG Oncology; ECOG-ACRIN Cancer Research Group; American College of Radiology Imaging Network; Patient-Centered Outcomes Research Institute","keywords":"Inclusion (mineral); Translational research; Public relations; Work (physics); Political science; Engineering ethics; Patient advocacy; Medicine; Psychology; MEDLINE; Engineering; Social psychology","score_opus":0.7295360724744826,"score_gpt":0.7098320963651151,"score_spread":0.01970397610936747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376128378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9080224,0.00038158728,8.198515e-7,0.08147768,0.00040140175,0.000895074,0.000011177883,0.00001842307,0.008791409],"genre_scores_gemma":[0.95947564,0.0060330355,0.0008007704,0.023405159,0.000253878,0.0012394569,0.00016920849,0.000018386098,0.00860449],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951019,0.0022182942,0.0012022947,0.0003429663,0.0005442666,0.0005902312],"domain_scores_gemma":[0.98371553,0.014850496,0.0005165519,0.00015469972,0.0004265444,0.0003361612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067499913,0.000092207476,0.00042170828,0.00012781667,0.0004159071,0.0000025034674,0.0001244304,0.00016548496,0.0005836762],"category_scores_gemma":[0.00115319,0.000086040316,0.0000883824,0.00074183685,0.00143999,0.00008518035,0.00017165221,0.0011066669,0.00015851621],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034413693,0.00078042847,0.7069172,0.00030701616,0.000039935574,8.3320043e-7,0.023592724,0.000011752813,0.000026448633,0.0023072204,0.1532124,0.11245988],"study_design_scores_gemma":[0.0014945524,0.0027004469,0.5176837,0.00044814014,0.000007883338,1.7749716e-7,0.083110996,0.00036846419,0.0000129840855,0.0048337085,0.3892205,0.00011848469],"about_ca_topic_score_codex":0.004361907,"about_ca_topic_score_gemma":0.0002167839,"teacher_disagreement_score":0.23600811,"about_ca_system_score_codex":0.0005974771,"about_ca_system_score_gemma":0.0055128606,"threshold_uncertainty_score":0.9779578},"labels":[],"label_agreement":null},{"id":"W4376270062","doi":"10.1200/edbk_390272","title":"Patient-Reported Outcomes in Pediatric Patients With Cancer","year":2023,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute","keywords":"Medicine; Quality of life (healthcare); Pediatric cancer; Clinical trial; Pediatric oncology; MEDLINE; Clinical Practice; Adaptation (eye); Quality (philosophy); Intensive care medicine; Cancer; Family medicine; Psychology; Nursing","score_opus":0.062521808625965,"score_gpt":0.4574969696229202,"score_spread":0.3949751609969552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376270062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91850215,0.00010109121,0.0000034102443,0.07924114,0.00046432271,0.0004832131,0.000024267043,0.000045922592,0.0011344746],"genre_scores_gemma":[0.953491,0.00085659267,0.0034394148,0.037704468,0.0005904247,0.00020887224,0.00016584684,0.000039266837,0.0035041592],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968538,0.00019766385,0.0015527849,0.00044939911,0.00063533714,0.00031101317],"domain_scores_gemma":[0.9942834,0.0035114272,0.0012155906,0.00032203758,0.0004181661,0.00024937594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007513392,0.00017811375,0.0011495361,0.00009514222,0.000046065008,0.0000030876097,0.0001192603,0.00013940381,0.00038705062],"category_scores_gemma":[0.001114905,0.0001467121,0.0003854927,0.00079750957,0.00077087706,0.000083607796,0.00006330983,0.00044751447,0.00003994751],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024314325,0.0020431,0.9263005,0.00004655828,0.00024401219,0.0000016314838,0.0013604813,0.0000135703995,7.3441095e-7,0.000023696333,0.05352519,0.016197376],"study_design_scores_gemma":[0.0029730508,0.0014306799,0.96797496,0.00003538205,0.00015289887,7.442952e-7,0.00090469304,0.000012048952,0.0000018242854,0.000071649265,0.026294086,0.00014800197],"about_ca_topic_score_codex":0.00086978055,"about_ca_topic_score_gemma":0.00013960707,"teacher_disagreement_score":0.041674435,"about_ca_system_score_codex":0.00022741366,"about_ca_system_score_gemma":0.0040958473,"threshold_uncertainty_score":0.72658575},"labels":[],"label_agreement":null},{"id":"W4377014547","doi":"10.1200/edbk_389810","title":"Current Treatment Strategies and Risk Stratification for Oral Carcinoma","year":2023,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Risk stratification; Stage (stratigraphy); Disease; Adjuvant therapy; Radiation therapy; Basal cell; Adjuvant; Systemic therapy; Oncology; Surgery; Intensive care medicine; Internal medicine; Cancer; Chemotherapy","score_opus":0.1735293901787698,"score_gpt":0.519910241948531,"score_spread":0.3463808517697612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377014547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9610354,0.0015719106,0.000090343194,0.035373304,0.00029951415,0.0005028448,0.00004453169,0.000028798355,0.0010533904],"genre_scores_gemma":[0.97006714,0.018771693,0.006953938,0.0009803935,0.00062139716,0.00033529638,0.00013449683,0.000012568299,0.0021230965],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99885684,0.00007777238,0.0005304895,0.00026561803,0.000110983216,0.00015829757],"domain_scores_gemma":[0.9969653,0.0022452788,0.00034287805,0.00012916297,0.00019425567,0.00012315343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043213475,0.000103192804,0.0006166518,0.000022646293,0.00010519639,0.0000055767755,0.00003889369,0.00006119379,0.000038351398],"category_scores_gemma":[0.00021734495,0.00008188827,0.00026898598,0.00013108329,0.00092362775,0.000059358,0.000015358302,0.00012284149,0.000009118457],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022455711,0.0007994759,0.29271677,0.000061534476,0.00030242105,1.8848483e-7,0.0016036315,0.0000032996838,0.00006512008,0.0019437526,0.052830428,0.6494488],"study_design_scores_gemma":[0.0012133742,0.0032688763,0.7414266,0.000012731148,0.00018995868,0.0000012456211,0.0044665984,0.00026620654,0.000021428259,0.0008495254,0.24822108,0.00006238835],"about_ca_topic_score_codex":0.00019491141,"about_ca_topic_score_gemma":0.00003601096,"teacher_disagreement_score":0.6493864,"about_ca_system_score_codex":0.00011546038,"about_ca_system_score_gemma":0.0026774197,"threshold_uncertainty_score":0.47496277},"labels":[],"label_agreement":null},{"id":"W4377014607","doi":"10.1200/edbk_389830","title":"How to Make Evidence-Based Integrative Medicine a Part of Everyday Oncology Practice","year":2023,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Clinical Oncology; Oncology; Medicine; Internal medicine; Integrative medicine; Alternative medicine; Health professionals; Clinical Practice; Health care; Cancer; Nursing; Pathology","score_opus":0.28350750376950007,"score_gpt":0.5636061549660836,"score_spread":0.2800986511965835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377014607","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10316463,0.0006768527,0.0005860056,0.88686603,0.0009777636,0.00072066457,0.00002420436,0.000031494084,0.006952364],"genre_scores_gemma":[0.7069101,0.0076100826,0.04964279,0.18694447,0.0058332295,0.00046200404,0.00019245324,0.000044212746,0.04236066],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99681735,0.0006226833,0.0012560294,0.0004499417,0.00057540927,0.00027856036],"domain_scores_gemma":[0.9589867,0.037862655,0.0012527179,0.00029694592,0.0013144757,0.0002865277],"candidate_categories":["metaresearch","sts"],"consensus_categories":[],"category_scores_codex":[0.0026794714,0.00020967452,0.0016260266,0.00011293707,0.00007837931,0.0000019281986,0.00021767801,0.00005515211,0.00069145137],"category_scores_gemma":[0.023386864,0.00014656161,0.0004370322,0.00077578437,0.003521029,0.000107445056,0.00012090079,0.0004771521,0.000027521184],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001674424,0.0016667009,0.06134365,0.00010362404,0.001177854,0.000011697217,0.0051839966,0.000009297164,0.0005537718,0.0012105836,0.6272489,0.2998155],"study_design_scores_gemma":[0.0018400952,0.017503174,0.12175271,0.000486029,0.00040324955,0.000008787878,0.03241585,0.000052238513,0.0001241453,0.00018401642,0.8251252,0.00010448112],"about_ca_topic_score_codex":0.00026100114,"about_ca_topic_score_gemma":0.000032865977,"teacher_disagreement_score":0.69992155,"about_ca_system_score_codex":0.0002706207,"about_ca_system_score_gemma":0.003349188,"threshold_uncertainty_score":0.9991908},"labels":[],"label_agreement":null},{"id":"W4377087661","doi":"10.1200/edbk_390384","title":"Genetic and Genomic Testing for Prostate Cancer: Beyond DNA Repair","year":2023,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"","keywords":"Prostate cancer; Medicine; DNA repair; Genetic testing; Precision medicine; Disease; Personalized medicine; Clinical trial; Cancer; MSH2; Germline; Microsatellite instability; Oncology; DNA mismatch repair; Bioinformatics; Internal medicine; Biology; Gene; Genetics; Pathology; Colorectal cancer; Microsatellite","score_opus":0.10653805387541397,"score_gpt":0.486012156683782,"score_spread":0.379474102808368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377087661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.929271,0.0018370392,0.0000055245596,0.06659575,0.00017835124,0.00081446796,0.000050480907,0.000055544977,0.0011918736],"genre_scores_gemma":[0.67311746,0.029835766,0.15451439,0.03156569,0.0037502435,0.002687334,0.0003473182,0.00012723323,0.104054555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986123,0.00005988033,0.00056055235,0.0003404215,0.000155173,0.00027166435],"domain_scores_gemma":[0.99551564,0.0035309053,0.00029787736,0.00014512253,0.00030837976,0.00020208072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059414346,0.00010373494,0.0005247271,0.00003471566,0.0001064037,0.0000037585874,0.00006339288,0.00008150438,0.000072051145],"category_scores_gemma":[0.0005178218,0.00008675917,0.00027330767,0.0002532279,0.0013361878,0.000030675303,0.000055581306,0.00018184254,0.000012068627],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035113184,0.0003131195,0.6560584,0.00014547413,0.00037335165,0.0000019698393,0.0005897998,0.000007501948,0.0012806202,0.000064449574,0.11103691,0.22977729],"study_design_scores_gemma":[0.0018251927,0.0023274051,0.866362,0.00003720917,0.00014165565,0.0000064247347,0.000657088,0.0007540736,0.00004488178,0.0006229202,0.12713471,0.00008646166],"about_ca_topic_score_codex":0.00014202343,"about_ca_topic_score_gemma":0.0000058152004,"teacher_disagreement_score":0.2561535,"about_ca_system_score_codex":0.0001772777,"about_ca_system_score_gemma":0.0038921759,"threshold_uncertainty_score":0.69045526},"labels":[],"label_agreement":null},{"id":"W4377234119","doi":"10.1200/edbk_389880","title":"Implementing Innovation: Informatics-Based Technologies to Improve Care Delivery and Clinical Research","year":2023,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Cancer survivorship and care","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Interoperability; Medicine; Clinical trial; Informatics; Leverage (statistics); Health care; Health informatics; Best practice; Nursing; Computer science; Political science; World Wide Web; Internal medicine","score_opus":0.15055212613434485,"score_gpt":0.5463792284950127,"score_spread":0.39582710236066787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377234119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.887999,0.00019859975,0.00008526957,0.10709841,0.00045536956,0.0005667684,0.000030368332,0.000112115566,0.0034541206],"genre_scores_gemma":[0.9653257,0.00069553516,0.014038021,0.017205713,0.00058219413,0.0001699054,0.00015293703,0.000019413439,0.0018105445],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99711215,0.00017184926,0.0015522925,0.0003100392,0.0004512003,0.00040246753],"domain_scores_gemma":[0.9919253,0.005484409,0.00047864616,0.00033985695,0.0016323186,0.00013948248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004122058,0.00011669169,0.0006491252,0.00019342091,0.00017504716,0.00001150192,0.00018020495,0.00022217502,0.00008657586],"category_scores_gemma":[0.0026297497,0.00010820652,0.00026299083,0.0015555291,0.0018642889,0.000070971495,0.00029411312,0.0006049653,0.00004519305],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018725298,0.00020229869,0.25182694,0.00014293399,0.00013657112,8.935768e-7,0.0021917871,0.0000018968036,0.000064897235,0.0008880722,0.08117483,0.6631816],"study_design_scores_gemma":[0.001273042,0.0032883913,0.24042991,0.000072248884,0.00007018911,0.0000019349238,0.09491661,0.00022585943,0.000127285,0.00034690477,0.6590997,0.0001479428],"about_ca_topic_score_codex":0.00023729417,"about_ca_topic_score_gemma":0.000093245275,"teacher_disagreement_score":0.66303366,"about_ca_system_score_codex":0.00019076437,"about_ca_system_score_gemma":0.0040473295,"threshold_uncertainty_score":0.71797884},"labels":[],"label_agreement":null},{"id":"W4378980099","doi":"10.1200/edbk_390334","title":"Frontline Management of Nodal Peripheral T-Cell Lymphomas","year":2023,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Anaplastic large-cell lymphoma; Brentuximab vedotin; Vincristine; Medicine; Lymphoma; Oncology; BCL6; Internal medicine; CD30; Anthracycline; Peripheral T-cell lymphoma; CHOP; Cyclophosphamide; Cancer research; Chemotherapy; Immunology; T cell; B cell; Cancer; Breast cancer; Immune system","score_opus":0.061678216736186245,"score_gpt":0.43936448155116903,"score_spread":0.3776862648149828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378980099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9002753,0.00058349624,0.00002601838,0.053772297,0.00043139947,0.00044259147,0.000027660282,0.00004258422,0.04439866],"genre_scores_gemma":[0.92140317,0.0037516428,0.03015912,0.0074229892,0.00041622625,0.00012824521,0.0001638646,0.000021861237,0.03653288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981244,0.00007943507,0.0009438576,0.00031470085,0.0003192484,0.00021831354],"domain_scores_gemma":[0.99763924,0.001146619,0.00056314294,0.0002812548,0.00018525534,0.00018447985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045455282,0.0001387332,0.00083053875,0.000031314547,0.00004430314,0.00000206487,0.00012059347,0.00010483052,0.00091253244],"category_scores_gemma":[0.000052141306,0.0001174094,0.0006935151,0.0002692673,0.000980488,0.000034947352,0.0000767739,0.00010366713,0.000106032094],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045046123,0.009361713,0.4902997,0.0002120725,0.00144593,0.000018196593,0.00075095036,0.000027642318,0.00013924128,0.0021554567,0.3080083,0.18713032],"study_design_scores_gemma":[0.0039629783,0.0016370325,0.7755665,0.000045811947,0.0003013442,0.0000058060155,0.001685936,0.00014215862,0.00015841323,0.00019621653,0.2162048,0.00009300047],"about_ca_topic_score_codex":0.00013097005,"about_ca_topic_score_gemma":0.000001932356,"teacher_disagreement_score":0.2852668,"about_ca_system_score_codex":0.00025993408,"about_ca_system_score_gemma":0.0012973787,"threshold_uncertainty_score":0.99915904},"labels":[],"label_agreement":null},{"id":"W4379779875","doi":"10.1200/edbk_389942","title":"Current Therapeutic Targets in Cancer Cachexia: A Pathophysiologic Approach","year":2023,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"Cachexia; Medicine; Cancer cachexia; Cancer; Cancer therapy; Bioinformatics; Food and drug administration; Intensive care medicine; Pharmacology; Internal medicine; Biology","score_opus":0.4707800957487996,"score_gpt":0.6228491491615229,"score_spread":0.1520690534127233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379779875","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000020377116,0.9869992,0.000019564544,0.010107625,0.0007779859,0.0011938211,0.000045748493,0.000036549234,0.00079909735],"genre_scores_gemma":[0.0000133473895,0.98089284,0.0043094936,0.009825567,0.0015407989,0.0011872558,0.00038029233,0.000046794685,0.0018036143],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957699,0.00064608245,0.002261752,0.00064397434,0.0002879474,0.0003903044],"domain_scores_gemma":[0.9937906,0.0037597269,0.0016783408,0.0003085797,0.00019614544,0.00026660852],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013217245,0.000314358,0.0040433276,0.00011376318,0.000059674934,0.000003078069,0.00022557129,0.00044107187,0.00033592133],"category_scores_gemma":[0.0002992447,0.00024674865,0.0015290825,0.0006283283,0.0012009556,0.000028811513,0.000074962634,0.0018181647,0.00007756973],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031691652,0.0022631146,0.0009294627,0.011736741,0.00025690204,0.0000010582136,0.00018249732,6.7613865e-7,1.6486601e-7,0.00024266848,0.033893555,0.95046145],"study_design_scores_gemma":[0.0006389481,0.00044626178,0.0073243785,0.003814128,0.0004904199,0.0000071084264,0.00023439611,0.000031373573,1.9392612e-8,0.0004568745,0.9863642,0.00019188006],"about_ca_topic_score_codex":0.0001001917,"about_ca_topic_score_gemma":0.0000036637693,"teacher_disagreement_score":0.95247066,"about_ca_system_score_codex":0.0006883066,"about_ca_system_score_gemma":0.011043757,"threshold_uncertainty_score":0.99999845},"labels":[],"label_agreement":null},{"id":"W4381331225","doi":"10.1200/edbk_389516","title":"Shared Decision Making in the Care of Patients With Cancer","year":2023,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Conversation; Trustworthiness; Plan (archaeology); Health care; Psychology; Medicine; Social psychology; Political science","score_opus":0.03877888360976148,"score_gpt":0.44805177852339784,"score_spread":0.4092728949136364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381331225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99348557,0.00039452326,0.00009207795,0.0048122206,0.00017486219,0.00020845102,0.000069825655,0.0000028219113,0.0007596646],"genre_scores_gemma":[0.98792684,0.00032971418,0.0073710303,0.0037337197,0.00017962338,0.00010669593,0.0001677566,0.000009992863,0.00017461779],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891835,0.00010854302,0.00044292494,0.00022459209,0.00019384408,0.00011176325],"domain_scores_gemma":[0.9982641,0.0007941597,0.00038454382,0.0002198672,0.00031367832,0.00002365136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000335542,0.00007227482,0.00022776621,0.00002070898,0.00003578242,0.000002335838,0.00023666103,0.000088678105,0.000080679114],"category_scores_gemma":[0.00024014301,0.000053132964,0.0001422229,0.00027901423,0.00064064935,0.000004049108,0.0000571434,0.000116695075,0.000003016721],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026686775,0.0003187453,0.77827775,0.000018568164,0.00010597266,1.2995011e-7,0.0020580443,0.0007214612,0.0001285209,0.00005925071,0.07607917,0.14196554],"study_design_scores_gemma":[0.0005630069,0.00049351685,0.925464,0.000024361561,0.000020327298,1.8812067e-7,0.00243623,0.000018917732,0.00006115896,0.00009900288,0.07075506,0.0000642633],"about_ca_topic_score_codex":0.000043442607,"about_ca_topic_score_gemma":0.000082529456,"teacher_disagreement_score":0.14718623,"about_ca_system_score_codex":0.00007401251,"about_ca_system_score_gemma":0.0016790845,"threshold_uncertainty_score":0.29786238},"labels":[],"label_agreement":null},{"id":"W4390599409","doi":"10.1200/edbk_430336","title":"Emerging Insights in Small-Cell Carcinoma of the Genitourinary Tract: From Diagnosis to Novel Therapeutic Horizons","year":2024,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute","keywords":"Medicine; Genitourinary system; Prostate cancer; Oncology; Radiation therapy; Prostate; Bladder cancer; Internal medicine; Cancer; Urology","score_opus":0.1391443420681022,"score_gpt":0.4639796543301897,"score_spread":0.3248353122620875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390599409","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011297997,0.97361046,0.000007897641,0.010843443,0.0009723675,0.0012905356,0.0001775785,0.000009570975,0.0017901757],"genre_scores_gemma":[0.012744478,0.9754228,0.0022050305,0.0049937107,0.001127372,0.0006571305,0.00007916147,0.00006288839,0.002707424],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969846,0.00026930732,0.0016701578,0.0005782284,0.00026404017,0.0002336373],"domain_scores_gemma":[0.9945307,0.0037405146,0.00090966304,0.0004935929,0.00013081187,0.00019472757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027537276,0.00034959204,0.0027062704,0.00008496559,0.00004493142,0.0000042135944,0.00037241593,0.00034990447,0.0002762768],"category_scores_gemma":[0.000118389,0.0002274337,0.0019865006,0.00055416103,0.00067567674,0.000026145754,0.00014067945,0.00094075757,0.000044279033],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005813019,0.0063811056,0.0140662845,0.0018148471,0.0009766166,0.0000050433173,0.001591898,5.976475e-7,0.000004487826,0.00007479796,0.008849043,0.96617717],"study_design_scores_gemma":[0.00082960783,0.0013970294,0.03939048,0.0019345,0.0038547344,0.000008678777,0.00042362843,0.00000198808,0.0000066625553,0.00014027327,0.95182806,0.00018433538],"about_ca_topic_score_codex":0.0010725539,"about_ca_topic_score_gemma":0.000047705515,"teacher_disagreement_score":0.9659928,"about_ca_system_score_codex":0.00043075538,"about_ca_system_score_gemma":0.008864841,"threshold_uncertainty_score":0.996754},"labels":[],"label_agreement":null},{"id":"W4390692472","doi":"10.1200/edbk_430428","title":"Immuno-Oncology Advances in Genitourinary Cancers","year":2024,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Genitourinary system; Oncology; Standard of care; Prostate cancer; Renal cell carcinoma; Germ cell tumors; Prostate carcinoma; Internal medicine; Cancer; Chemotherapy","score_opus":0.05426018189409378,"score_gpt":0.48883817498398463,"score_spread":0.43457799308989087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390692472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4149361,0.11437759,0.00014519262,0.25546268,0.005142358,0.0013837758,0.00008141234,0.00013750026,0.2083334],"genre_scores_gemma":[0.88494045,0.049602013,0.015284362,0.027822854,0.0024291363,0.000331117,0.00007452871,0.000046188725,0.019469356],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981621,0.00015084137,0.00085347466,0.00038712643,0.0002022982,0.0002441533],"domain_scores_gemma":[0.9971282,0.0021777148,0.00023025558,0.00018849861,0.000113986316,0.00016136773],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004667341,0.00014631213,0.0008120342,0.000055240085,0.000037248916,0.0000037682291,0.00011659004,0.00016558688,0.0011560974],"category_scores_gemma":[0.00012695472,0.00012612867,0.0004754549,0.000295544,0.0013547185,0.00013525998,0.00003768123,0.00045223627,0.000057442332],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074239564,0.0016015819,0.076987535,0.0001299539,0.0005071949,0.000032229218,0.0014289105,0.000019067626,0.0001760789,0.00068366237,0.055977706,0.8617137],"study_design_scores_gemma":[0.0012971117,0.0034116309,0.10795596,0.00008854283,0.00014683767,0.00004702619,0.0012761392,0.000077467164,0.00003421184,0.00062232953,0.884936,0.00010677058],"about_ca_topic_score_codex":0.00050594285,"about_ca_topic_score_gemma":0.000057119283,"teacher_disagreement_score":0.8616069,"about_ca_system_score_codex":0.0010215148,"about_ca_system_score_gemma":0.010530467,"threshold_uncertainty_score":0.999757},"labels":[],"label_agreement":null},{"id":"W4395682051","doi":"10.1200/edbk_438592","title":"State-Of-The-Art Advancements on Cancer Vaccines and Biomarkers","year":2024,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Cancer; Medicine; Immunosuppression; Immune system; Disease; Cancer vaccine; Immunology; Immunotherapy; Internal medicine","score_opus":0.03374536051917354,"score_gpt":0.4170760212623856,"score_spread":0.38333066074321204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395682051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9055502,0.038793553,0.000039938237,0.050327715,0.0031619852,0.00034137632,0.00006521915,0.000023266479,0.0016967797],"genre_scores_gemma":[0.87135404,0.02253931,0.00080466503,0.01205992,0.00012422577,0.00010575303,0.000034750974,0.000028391387,0.09294891],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99857134,0.00032760145,0.0006463024,0.00024179576,0.000049038506,0.00016389594],"domain_scores_gemma":[0.9959604,0.0033923083,0.00035180623,0.0001859471,0.00009121373,0.000018314031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048235935,0.00011992235,0.00043574686,0.000030680832,0.00008621034,0.0000034252969,0.00017818008,0.00010290151,0.0008540919],"category_scores_gemma":[0.00017671312,0.00008460319,0.00031698638,0.00016237094,0.0018403245,0.00006252757,0.00005454669,0.00028650288,0.000045613662],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013115857,0.0007240222,0.01946265,0.000058965823,0.0020637661,2.0734599e-7,0.00091118057,0.000007259533,0.03639333,0.00077528035,0.20941123,0.7288805],"study_design_scores_gemma":[0.00061502657,0.00078835944,0.16662262,0.00009053361,0.000055788474,0.000004496589,0.00022966093,0.0000049515825,0.0044489466,0.0002775009,0.82677543,0.00008666322],"about_ca_topic_score_codex":0.00009536977,"about_ca_topic_score_gemma":0.0000054576335,"teacher_disagreement_score":0.72879386,"about_ca_system_score_codex":0.0000566805,"about_ca_system_score_gemma":0.0012691607,"threshold_uncertainty_score":0.9351707},"labels":[],"label_agreement":null},{"id":"W4396683966","doi":"10.1200/edbk_100044","title":"Geriatric Oncology: A 5-Year Strategic Plan","year":2024,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Frailty in Older Adults","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"National Cancer Institute","keywords":"Geriatric oncology; Oncology; Geriatrics; Medicine; Internal medicine; Medical education; Resource (disambiguation); Nursing; Cancer","score_opus":0.2225309863388641,"score_gpt":0.535923430521747,"score_spread":0.31339244418288287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396683966","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003445527,0.9158452,0.0000038076562,0.025477529,0.0019142791,0.0012667251,0.0001451599,0.000086329084,0.055226475],"genre_scores_gemma":[0.00001853136,0.92298764,0.011601827,0.006200712,0.0040914686,0.00031052154,0.0006215032,0.000104270526,0.05406353],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99388,0.0006566356,0.0033484716,0.0010600489,0.00054379855,0.0005110999],"domain_scores_gemma":[0.9877718,0.008250359,0.0023131731,0.0007218083,0.00036774014,0.0005750925],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0015203014,0.0006079757,0.0062736496,0.00016650486,0.00006803363,0.000014936574,0.00050728937,0.0012978112,0.002199338],"category_scores_gemma":[0.00075283553,0.00047757986,0.0038820992,0.00080980686,0.0029046277,0.00006031426,0.00019036079,0.002787067,0.0017724923],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047383084,0.0012422419,0.0000720942,0.0052809655,0.0015507399,0.000014594665,0.0001362909,1.2398972e-7,1.1624565e-7,0.0008509488,0.3685169,0.62228763],"study_design_scores_gemma":[0.0008070331,0.0034187648,0.00020233278,0.0028927315,0.006084491,0.00023841702,0.0006159744,0.0000062998206,4.582473e-8,0.0005757213,0.9847976,0.00036057364],"about_ca_topic_score_codex":0.00008682964,"about_ca_topic_score_gemma":0.000008645773,"teacher_disagreement_score":0.621927,"about_ca_system_score_codex":0.0011697426,"about_ca_system_score_gemma":0.03625391,"threshold_uncertainty_score":0.9999987},"labels":[],"label_agreement":null},{"id":"W4398157422","doi":"10.1200/edbk_432196","title":"Integrating Palliative Care and Hematologic Malignancies: Bridging the Gaps for Our Patients and Their Caregivers","year":2024,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Palliative care; Medicine; Specialty; Psychological intervention; Disease; Curative care; Distress; Caregiver burden; Quality of life (healthcare); Nursing; Intensive care medicine; Health care; Family medicine; Ambulatory care; Dementia; Internal medicine","score_opus":0.2431857234803085,"score_gpt":0.5522212594916391,"score_spread":0.3090355360113306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398157422","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018755279,0.9914158,0.000037116366,0.004608303,0.0003132871,0.0009781052,0.00021639833,0.000012070614,0.00054338307],"genre_scores_gemma":[0.001457675,0.98956865,0.00586515,0.0017289394,0.0004041986,0.00019591257,0.00022499589,0.000027714363,0.0005267381],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997883,0.00021216656,0.0011048303,0.00045101313,0.00015296537,0.00019602822],"domain_scores_gemma":[0.99177176,0.006056058,0.0013007715,0.00017711025,0.0005760522,0.0001182339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043979456,0.00031093872,0.0025889399,0.00003932882,0.000089820016,0.000007790196,0.00014813921,0.00025876483,0.0000061238657],"category_scores_gemma":[0.0016269828,0.00017354108,0.0010536106,0.0001629697,0.0013483122,0.00003230025,0.00010748106,0.0005379063,0.0000018639522],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032450003,0.00017218092,0.008270721,0.014517654,0.0013937065,6.4469214e-7,0.015630815,8.2812925e-8,4.5040835e-7,0.0005721266,0.04410914,0.9153],"study_design_scores_gemma":[0.00042092524,0.0011375434,0.0004995486,0.0101945875,0.0015318991,0.000004057528,0.06212453,0.00000866561,0.0000016194126,0.00010159404,0.9238194,0.00015560885],"about_ca_topic_score_codex":0.00006479976,"about_ca_topic_score_gemma":0.000005524427,"teacher_disagreement_score":0.91514444,"about_ca_system_score_codex":0.00020279975,"about_ca_system_score_gemma":0.0023136886,"threshold_uncertainty_score":0.7076799},"labels":[],"label_agreement":null},{"id":"W4398763962","doi":"10.1200/edbk_438512","title":"Integrating Patient-Reported Outcomes Into the Care of People With Advanced Cancer—A Practical Guide","year":2024,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Cancer survivorship and care","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Session (web analytics); Medicine; Health care; Patient satisfaction; Perspective (graphical); Quality of life (healthcare); Patient experience; MEDLINE; Medical education; Nursing; Computer science","score_opus":0.03891200248129527,"score_gpt":0.47973647318206203,"score_spread":0.44082447070076675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398763962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8176162,0.0036835817,0.00026392227,0.17053723,0.000998526,0.00049372617,0.000016409029,0.000037285274,0.0063530714],"genre_scores_gemma":[0.9698458,0.0008820537,0.016070742,0.010699759,0.00028764227,0.00019352463,0.00004061914,0.00002326203,0.001956597],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99792403,0.00014193398,0.0010356227,0.00033102473,0.0004021533,0.00016521977],"domain_scores_gemma":[0.9932411,0.004943376,0.0006545537,0.00029670142,0.0007356269,0.00012865775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041041282,0.00014667689,0.0007807075,0.00002408489,0.00006419995,0.0000061812707,0.00010386258,0.000099984936,0.00029711795],"category_scores_gemma":[0.00096607604,0.00008741843,0.00048343223,0.00034211532,0.0012502806,0.000080884034,0.000048800674,0.00052546884,0.0000031831896],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042416347,0.0005059738,0.44223505,0.00022094502,0.0010975322,0.000004674309,0.04629897,0.000015838248,0.00012866622,0.001391824,0.038410652,0.4692657],"study_design_scores_gemma":[0.00090847677,0.003491959,0.30959353,0.00034149154,0.00075150153,0.000037642138,0.13611494,0.000116385156,0.00017297105,0.00014608464,0.54813325,0.00019172966],"about_ca_topic_score_codex":0.004495927,"about_ca_topic_score_gemma":0.0017509913,"teacher_disagreement_score":0.50972265,"about_ca_system_score_codex":0.0002759214,"about_ca_system_score_gemma":0.007743464,"threshold_uncertainty_score":0.9978817},"labels":[],"label_agreement":null},{"id":"W4398793085","doi":"10.1200/edbk_100039","title":"Common Sense Oncology: Equity, Value, and Outcomes That Matter","year":2024,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Transformative learning; Equity (law); Clinical Oncology; Medicine; Common sense; Oncology; Internal medicine; Toxicity; Intensive care medicine; Psychology; Cancer; Political science","score_opus":0.231916039514466,"score_gpt":0.5091675060736109,"score_spread":0.27725146655914495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398793085","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013575512,0.89075327,0.000020666783,0.025193626,0.0018219396,0.00047893595,0.00054714136,0.000022416178,0.08102623],"genre_scores_gemma":[0.00015273354,0.9520138,0.0024527176,0.02078199,0.000853897,0.00011884765,0.00010653204,0.000073956464,0.023445565],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952723,0.00015396022,0.003149409,0.0009059376,0.00007328696,0.00044515354],"domain_scores_gemma":[0.9915194,0.00394383,0.0036798792,0.00049697334,0.00005787692,0.00030207445],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0021778054,0.00048489732,0.0061702067,0.0001350469,0.00009480618,0.00004634182,0.00042568715,0.0008245588,0.0011998313],"category_scores_gemma":[0.0002879412,0.0004510605,0.002159241,0.00018377011,0.0023572664,0.00019589903,0.0005175378,0.001193452,0.0018027644],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010692755,0.0003590204,0.010283412,0.0014412717,0.0009553736,0.0000020426687,0.0002111411,3.3874133e-7,3.862431e-9,0.031849988,0.30474675,0.6501399],"study_design_scores_gemma":[0.00028696578,0.0003811604,0.0076211933,0.00044033193,0.0004916471,0.000022651413,0.000092471,0.000008323305,1.5754338e-8,0.018002927,0.97223574,0.0004165534],"about_ca_topic_score_codex":0.00043646462,"about_ca_topic_score_gemma":0.000017588112,"teacher_disagreement_score":0.667489,"about_ca_system_score_codex":0.0007964084,"about_ca_system_score_gemma":0.002390768,"threshold_uncertainty_score":0.9997941},"labels":[],"label_agreement":null},{"id":"W4399166823","doi":"10.1200/edbk_432564","title":"Enhancing Early-Stage Breast Cancer Survivorship: Evidence-Based Strategies, Surveillance Testing, and Imaging Guidelines","year":2024,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Cancer survivorship and care","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Survivorship curve; Breast cancer; Cancer survivorship; Multidisciplinary approach; Stage (stratigraphy); Medicine; Cancer; Internal medicine; Political science","score_opus":0.13206842151539738,"score_gpt":0.47713497426335405,"score_spread":0.34506655274795667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399166823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7402423,0.025016364,0.0011883756,0.2287098,0.00203441,0.00044858383,0.00014492772,0.0001561118,0.0020591342],"genre_scores_gemma":[0.9681748,0.0031353775,0.0065669203,0.016474487,0.0019455067,0.00008617705,0.000019625497,0.000038048976,0.0035590155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99731433,0.00028750653,0.001115986,0.00059437385,0.00037956942,0.0003082277],"domain_scores_gemma":[0.9874667,0.010583917,0.00043237366,0.00026601195,0.0009798026,0.00027121668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023024646,0.00022065654,0.00080561533,0.000051568626,0.00008654074,0.00004380671,0.00014197428,0.00012108058,0.00061273074],"category_scores_gemma":[0.0014237188,0.00019581357,0.00036852868,0.00045717935,0.0014685133,0.0002521089,0.000053560358,0.0005166686,0.000009216412],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016791146,0.00015456391,0.86118394,0.000399157,0.00016688638,0.0000060045268,0.00060418784,0.000024167732,0.00055843283,0.00032666186,0.012902024,0.123506084],"study_design_scores_gemma":[0.0004377822,0.00041360524,0.9285783,0.0011530967,0.00014071981,0.000029598483,0.0023216566,0.0020340707,0.00005163124,0.00021949143,0.06436051,0.0002595264],"about_ca_topic_score_codex":0.027939402,"about_ca_topic_score_gemma":0.0024240073,"teacher_disagreement_score":0.22793256,"about_ca_system_score_codex":0.00023979691,"about_ca_system_score_gemma":0.009520555,"threshold_uncertainty_score":0.9960945},"labels":[],"label_agreement":null},{"id":"W4409096394","doi":"10.1200/edbk-25-473204","title":"Treatment Innovations in Pancreatic Cancer: Putting Patient Priorities First","year":2025,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Pancreatic cancer; Medicine; Incidence (geometry); Cancer; Adenocarcinoma; Mortality rate; Optimism; Oncology; Internal medicine; Colorectal cancer; Lung cancer; Intensive care medicine; Psychology","score_opus":0.1615551782959492,"score_gpt":0.5467261171897432,"score_spread":0.38517093889379395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409096394","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00092485786,0.96234393,0.000013752907,0.024116421,0.00034910633,0.0020797176,0.00009333066,0.000021397267,0.010057467],"genre_scores_gemma":[0.00007087097,0.96625024,0.00976863,0.0021429716,0.0005305322,0.0020143501,0.00021847532,0.000027405818,0.018976541],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99516964,0.0005118418,0.0029347322,0.00061473204,0.00034238672,0.0004266969],"domain_scores_gemma":[0.9797675,0.017472208,0.0016671735,0.00044801395,0.00044229915,0.000202787],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007271051,0.00038795374,0.005740036,0.00022922616,0.00012950288,0.0000064987494,0.00021367469,0.00053764274,0.00056497427],"category_scores_gemma":[0.0018913873,0.00030651534,0.0012944241,0.00095232605,0.0018222429,0.00004845467,0.000106716696,0.000863942,0.00002436746],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048713955,0.0019175645,0.06810549,0.005111054,0.0012264053,0.0000052392943,0.00046356613,8.5514114e-7,3.7868176e-8,0.00045585606,0.014229247,0.90843594],"study_design_scores_gemma":[0.0010407754,0.002158327,0.012248775,0.006876716,0.0020657224,0.000018509614,0.00046927598,0.000027990432,8.192493e-8,0.00011200131,0.97480655,0.00017527708],"about_ca_topic_score_codex":0.0013278996,"about_ca_topic_score_gemma":0.00010524536,"teacher_disagreement_score":0.9605773,"about_ca_system_score_codex":0.0022235413,"about_ca_system_score_gemma":0.03836546,"threshold_uncertainty_score":0.99993867},"labels":[],"label_agreement":null},{"id":"W4409318051","doi":"10.1200/edbk-25-472460","title":"Updates on Treatments and Management of Nasopharyngeal Carcinoma","year":2025,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Nasopharyngeal carcinoma; Medicine; Oncology; Radiation therapy; Clinical trial; Head and neck cancer; Disease; Internal medicine; Immunotherapy; Chemotherapy; Cancer; Immunology","score_opus":0.07635681292903022,"score_gpt":0.47953767734710884,"score_spread":0.4031808644180786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409318051","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00053147564,0.9677208,0.0000011049357,0.0053581283,0.00024873196,0.0008373832,0.000077927114,0.000009043765,0.025215402],"genre_scores_gemma":[0.00019280669,0.97668934,0.0018544989,0.004108422,0.00014226792,0.0001519688,0.0002824919,0.000017912065,0.01656027],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977329,0.00017138918,0.0012379017,0.0004381932,0.00023455739,0.00018510257],"domain_scores_gemma":[0.99620754,0.0019426378,0.0013216159,0.00026758848,0.00011784592,0.00014280119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032082733,0.00025993396,0.0028894867,0.00005771476,0.00004324397,0.0000021670662,0.00013460666,0.0002865298,0.00019207719],"category_scores_gemma":[0.00008725405,0.00020920196,0.001202734,0.0002367148,0.0010319815,0.000021700094,0.00006973223,0.0003464507,0.000009253947],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000102932776,0.0013684904,0.0022378166,0.006312465,0.00243945,0.0000019678826,0.00005426976,1.0870596e-7,2.7293899e-8,0.00065693504,0.07098323,0.9158423],"study_design_scores_gemma":[0.001849063,0.0022473934,0.013805748,0.0036636256,0.0042162854,0.000002645453,0.00035014955,0.0000011511814,2.2140625e-7,0.0001129593,0.9736118,0.00013900363],"about_ca_topic_score_codex":0.00007717582,"about_ca_topic_score_gemma":0.000001109039,"teacher_disagreement_score":0.9157033,"about_ca_system_score_codex":0.00032805593,"about_ca_system_score_gemma":0.003394983,"threshold_uncertainty_score":0.8531008},"labels":[],"label_agreement":null},{"id":"W4409677239","doi":"10.1200/edbk-25-472902","title":"Gut Microbiota in Immuno-Oncology: A Practical Guide for Medical Oncologists With a Focus on Antibiotics Stewardship","year":2025,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Dysbiosis; Gut flora; Medicine; Psychological intervention; Oncology; Clinical trial; Internal medicine; Intensive care medicine; Microbiome; Antibiotics; Immunology; Bioinformatics; Biology; Microbiology","score_opus":0.08206199488603057,"score_gpt":0.533359224881705,"score_spread":0.4512972299956744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409677239","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00049771,0.92016166,0.00044387524,0.06420742,0.001301703,0.004185679,0.00045211194,0.000026591906,0.008723229],"genre_scores_gemma":[0.00010925932,0.94385785,0.035592187,0.012764364,0.0009792164,0.00014003515,0.00081923767,0.00005935711,0.00567848],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99374,0.0012311215,0.0028561465,0.0012022372,0.0003061691,0.0006643294],"domain_scores_gemma":[0.9869458,0.009225084,0.0023378185,0.00071543746,0.00043381535,0.00034205394],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0031584925,0.00057214237,0.003767651,0.00011527614,0.000112794805,0.000012193881,0.0007325637,0.002185252,0.000099022094],"category_scores_gemma":[0.0042220727,0.00046099038,0.0015089356,0.00036378822,0.0027566212,0.0000068521413,0.00028168713,0.0013669011,0.000016072645],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006824497,0.004290379,0.00025574875,0.0031916548,0.0009015494,0.000008768908,0.0000577018,0.0000010110845,0.00009411474,0.0006562648,0.31859103,0.67126936],"study_design_scores_gemma":[0.0018220722,0.007641154,0.0007857039,0.0024621175,0.000509211,0.00009021541,0.00017254644,0.0000017718381,0.0000073590636,0.00004645461,0.98604494,0.0004164677],"about_ca_topic_score_codex":0.00010114689,"about_ca_topic_score_gemma":0.00027207186,"teacher_disagreement_score":0.6708529,"about_ca_system_score_codex":0.00067521987,"about_ca_system_score_gemma":0.06420788,"threshold_uncertainty_score":0.9999573},"labels":[],"label_agreement":null},{"id":"W4410025580","doi":"10.1200/edbk-25-473450","title":"Financial Toxicity and Breast Cancer: Why Does It Matter, Who Is at Risk, and How Do We Intervene?","year":2025,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Breast cancer; Medicine; Quality of life (healthcare); Survivorship curve; Cancer; Radiation therapy; Disease; Psychological intervention; Intensive care medicine; Finance; Internal medicine; Nursing; Business","score_opus":0.06326364671304849,"score_gpt":0.40018915404509475,"score_spread":0.3369255073320463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410025580","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00071725267,0.90335906,0.000052004543,0.087362185,0.0009027113,0.00043015767,0.004587582,0.000008382178,0.0025806725],"genre_scores_gemma":[0.00010389352,0.95215416,0.0007742721,0.016225848,0.0009276522,0.00015690688,0.000030625142,0.00003250552,0.029594107],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99653244,0.00014053073,0.0019166908,0.0009848876,0.000054112093,0.00037135414],"domain_scores_gemma":[0.9926907,0.0026088706,0.003977237,0.00038830572,0.00011268046,0.0002222255],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010785968,0.00044151617,0.0041993577,0.00011272867,0.00018524677,0.000050235936,0.00038932182,0.0006316006,0.0020458256],"category_scores_gemma":[0.0004535057,0.00040793556,0.001253067,0.00019436495,0.0020041473,0.00022382346,0.00034362706,0.0007632505,0.000049767088],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002435145,0.00016691288,0.024261748,0.001560547,0.0002743242,1.6293802e-7,0.00022723648,1.3979538e-7,5.028033e-9,0.0016349964,0.3910877,0.58076185],"study_design_scores_gemma":[0.00047013088,0.00018336058,0.019122252,0.0016782708,0.00023293859,0.000007063756,0.00007833589,0.0000055755263,7.7461586e-8,0.0041664043,0.9736553,0.00040033163],"about_ca_topic_score_codex":0.00091820455,"about_ca_topic_score_gemma":0.00021993261,"teacher_disagreement_score":0.5825676,"about_ca_system_score_codex":0.00057886593,"about_ca_system_score_gemma":0.0017979459,"threshold_uncertainty_score":0.9998373},"labels":[],"label_agreement":null},{"id":"W4410085635","doi":"10.1200/edbk-25-472654","title":"Key Updates in Testicular Cancer: Optimizing Survivorship and Survival","year":2025,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Survivorship curve; Germ cell tumors; Radiation therapy; Testicular cancer; Malignancy; Disease; Cancer; Intensive care medicine; Psychosocial; Quality of life (healthcare); Oncology; Chemotherapy; Internal medicine; Nursing","score_opus":0.11636713874466618,"score_gpt":0.5194502457231406,"score_spread":0.4030831069784744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410085635","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035008922,0.9916739,0.000009442324,0.005661684,0.00033136044,0.0007064013,0.000092250644,0.000016839022,0.0011580702],"genre_scores_gemma":[0.000114100236,0.9847605,0.0100604845,0.0018549517,0.00031287054,0.00025473497,0.00032299414,0.000027068425,0.0022923022],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970756,0.0004376117,0.0014037016,0.0005846183,0.0002326558,0.0002657958],"domain_scores_gemma":[0.98841834,0.0097722355,0.0010348547,0.00030142415,0.00018717474,0.00028594286],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00062646077,0.00032842287,0.0034521404,0.000077621924,0.000047456375,0.0000071832355,0.00014794047,0.00032865733,0.00019865473],"category_scores_gemma":[0.0015903439,0.00026829357,0.0010846589,0.00037906892,0.0011458155,0.000038297887,0.00010474147,0.0005716125,0.000008182318],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035978836,0.001551102,0.06558085,0.00489373,0.0010779426,0.000009789379,0.000055086562,0.0000019891452,3.9055447e-8,0.0002734731,0.0031111457,0.92340887],"study_design_scores_gemma":[0.0011127797,0.00051707943,0.05407321,0.0071571483,0.0038687564,0.000015094694,0.00016874706,0.00001764206,5.3505524e-8,0.00011547776,0.93270653,0.0002474919],"about_ca_topic_score_codex":0.0009980714,"about_ca_topic_score_gemma":0.00004392828,"teacher_disagreement_score":0.92959535,"about_ca_system_score_codex":0.0003134653,"about_ca_system_score_gemma":0.0101751955,"threshold_uncertainty_score":0.99997693},"labels":[],"label_agreement":null},{"id":"W4410805438","doi":"10.1200/edbk-25-473708","title":"Emerging Strategies for Drug-Based Cancer Risk Reduction","year":2025,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute","keywords":"Medicine; Cancer; Colorectal cancer; Adverse effect; Cancer prevention; Prostate cancer; Breast cancer; Intensive care medicine; Population; Clinical trial; Familial adenomatous polyposis; Bioinformatics; Internal medicine; Environmental health","score_opus":0.051576618647588036,"score_gpt":0.48329831807899964,"score_spread":0.4317216994314116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410805438","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000037102585,0.98383343,0.00085403526,0.0026292833,0.010600502,0.0007919464,0.00037189567,0.000010561558,0.0008712272],"genre_scores_gemma":[0.0000070456863,0.9536149,0.0067684213,0.0016372646,0.023886126,0.0010319172,0.0007029613,0.00003355542,0.012317791],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971738,0.00038965157,0.0013262524,0.000687941,0.00014745019,0.00027494328],"domain_scores_gemma":[0.995898,0.0012110284,0.0019790765,0.00039531628,0.0003951473,0.00012144007],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008539032,0.00031875755,0.0018862427,0.000048381273,0.00012889951,0.000010684572,0.00032738573,0.00044405827,0.000094771654],"category_scores_gemma":[0.0004320728,0.00029773117,0.0022043975,0.00018941848,0.0011066833,0.0000069682706,0.000061874554,0.00040780343,0.00000254628],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039297352,0.00018085206,0.000023289225,0.0012994658,0.0003994158,1.9236663e-9,0.00003203256,0.000029463232,0.000006056522,0.00012316938,0.385838,0.61202896],"study_design_scores_gemma":[0.00046481076,0.0002558175,0.00006192329,0.0006005488,0.0012007542,9.828545e-7,0.00043419152,0.000007563487,0.0000043900627,0.00014115428,0.99656254,0.0002653258],"about_ca_topic_score_codex":0.00029991052,"about_ca_topic_score_gemma":0.000048440368,"teacher_disagreement_score":0.6117636,"about_ca_system_score_codex":0.00011968474,"about_ca_system_score_gemma":0.023507033,"threshold_uncertainty_score":0.9999475},"labels":[],"label_agreement":null},{"id":"W4410805509","doi":"10.1200/edbk-25-472778","title":"Navigating B-ALL in the Era of Blinatumomab","year":2025,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Blinatumomab; Medicine; Dosing; Clinical trial; Intensive care medicine; Expanded access; Cytokine release syndrome; Oncology; Internal medicine; Chimeric antigen receptor; Immunotherapy; Cancer; Lymphoblastic Leukemia; Leukemia","score_opus":0.13792749939694088,"score_gpt":0.5668002481655495,"score_spread":0.42887274876860865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410805509","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030213004,0.9513645,0.000022501634,0.03971851,0.00029208395,0.0013523428,0.000043487238,0.000010135632,0.006894268],"genre_scores_gemma":[0.00014735037,0.9753601,0.009298769,0.01172325,0.000619939,0.00023839972,0.00020671226,0.0000255643,0.0023799154],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.994538,0.0011112634,0.0028133201,0.0005104826,0.0006761508,0.00035077755],"domain_scores_gemma":[0.95437497,0.04237827,0.0020650942,0.0006098239,0.00042910056,0.00014272529],"candidate_categories":["sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.003155189,0.00029151785,0.0038640539,0.00004408087,0.00004269512,0.000004405267,0.0007145755,0.0005453076,0.00022465886],"category_scores_gemma":[0.0050565484,0.00019514919,0.001893872,0.0008925354,0.0029914803,0.00003809793,0.00019321851,0.0034816628,0.00002433688],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003924,0.0013301397,0.0003933417,0.0057025873,0.00049680064,0.0000049570244,0.0004727971,3.7028946e-7,1.7500359e-7,0.00039137417,0.055407,0.9357612],"study_design_scores_gemma":[0.0010706974,0.00097241736,0.0017000589,0.00996204,0.0009709665,0.000052041458,0.0007975702,0.00002387885,2.4359247e-7,0.00014816757,0.9841653,0.00013662089],"about_ca_topic_score_codex":0.0002608828,"about_ca_topic_score_gemma":0.000004821984,"teacher_disagreement_score":0.9356246,"about_ca_system_score_codex":0.00091455795,"about_ca_system_score_gemma":0.03824418,"threshold_uncertainty_score":0.9997218},"labels":[],"label_agreement":null},{"id":"W4410805629","doi":"10.1200/edbk-25-481126","title":"Is Less More? Maximizing Outcomes by Tailoring Treatments to Patients: Oncofertility and Oncomenopause","year":2025,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec; University of British Columbia","funders":"","keywords":"Oncofertility; Survivorship curve; Life expectancy; Psychological intervention; Medicine; Quality of life (healthcare); Fertility preservation; Fertility; Gerontology; Menopause; Intensive care medicine; Cancer; Environmental health; Nursing; Internal medicine; Population","score_opus":0.14147386513744598,"score_gpt":0.5115697493739042,"score_spread":0.37009588423645823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410805629","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02875609,0.93366534,0.000028841334,0.031730123,0.0009147239,0.0026508954,0.00037343783,0.00003961776,0.0018409279],"genre_scores_gemma":[0.0003165004,0.96416813,0.004115561,0.016707994,0.00020580426,0.00036961833,0.000357786,0.000027708482,0.0137309],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99561924,0.00050278276,0.0020738933,0.001194019,0.00027053498,0.0003395416],"domain_scores_gemma":[0.99242604,0.0048079747,0.0012370223,0.00073464116,0.00041561952,0.00037870748],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00096230366,0.00047253782,0.004634009,0.00007353043,0.00012470341,0.000005659976,0.00025334203,0.00053041783,0.00013119077],"category_scores_gemma":[0.0020193656,0.0003578288,0.0011409364,0.000308849,0.0018959966,0.00007130429,0.0002342689,0.00076601,0.000020129632],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037608275,0.002682447,0.1698719,0.0016913248,0.0015951936,3.8237576e-7,0.00021827496,1.6227887e-8,4.359492e-7,0.000010532018,0.022496521,0.80105686],"study_design_scores_gemma":[0.00064222934,0.0009115261,0.3552162,0.00073382194,0.001168867,0.0000014598191,0.00010636234,1.7448085e-7,9.456884e-7,0.000028393568,0.64102805,0.00016200471],"about_ca_topic_score_codex":0.000176803,"about_ca_topic_score_gemma":0.0000020256873,"teacher_disagreement_score":0.80089486,"about_ca_system_score_codex":0.0006882436,"about_ca_system_score_gemma":0.0033729188,"threshold_uncertainty_score":0.99988735},"labels":[],"label_agreement":null},{"id":"W4410883721","doi":"10.1200/edbk-25-472268","title":"Implementing Evidence-Based Strategies to Improve Pediatric Oncology Infection Management","year":2025,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Intensive care medicine; Low and middle income countries; MEDLINE; Pediatric oncology; Evidence-based practice; Health care; Cancer; Developing country; Alternative medicine; Internal medicine; Pathology","score_opus":0.15351235716473138,"score_gpt":0.5565993691203138,"score_spread":0.40308701195558244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410883721","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014374609,0.93237036,0.0013405589,0.048303306,0.0023438567,0.0038952292,0.0000677974,0.00009729319,0.011437858],"genre_scores_gemma":[0.000043558626,0.9396908,0.025675805,0.025099654,0.0031164573,0.0009822999,0.00019252404,0.00004757626,0.0051513184],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9918687,0.0015488558,0.00407318,0.001158967,0.0006875827,0.0006627359],"domain_scores_gemma":[0.9740863,0.020439332,0.003662418,0.00077200617,0.00059130474,0.0004486811],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006104406,0.0005525354,0.004932577,0.00031277598,0.00017265753,0.000024047502,0.00043835086,0.00060703803,0.0005717181],"category_scores_gemma":[0.0023106455,0.0005217341,0.002815488,0.00115443,0.0007866178,0.00016103218,0.00037899235,0.0012635407,0.00009024727],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009506406,0.0013802148,0.0016301883,0.02198288,0.0010749185,0.0000021807812,0.00020090023,0.0000032656505,1.3159064e-7,0.0005942131,0.08342165,0.8896144],"study_design_scores_gemma":[0.00082337554,0.0029716997,0.0055748797,0.0056889136,0.0047978573,0.0000054941584,0.0007511407,0.0000036191143,2.81331e-7,0.000108489694,0.9789096,0.00036462228],"about_ca_topic_score_codex":0.0006615627,"about_ca_topic_score_gemma":0.000074844036,"teacher_disagreement_score":0.89548796,"about_ca_system_score_codex":0.0015612784,"about_ca_system_score_gemma":0.036362223,"threshold_uncertainty_score":0.99972343},"labels":[],"label_agreement":null},{"id":"W4411141158","doi":"10.1200/edbk-25-472464","title":"Artificial Intelligence for Head and Neck Squamous Cell Carcinoma: From Diagnosis to Treatment","year":2025,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Head and neck squamous-cell carcinoma; Medicine; Radiation therapy; Clinical trial; Malignancy; Radiation treatment planning; Oncology; Head and neck cancer; Internal medicine","score_opus":0.11480080505809327,"score_gpt":0.5053163263542124,"score_spread":0.39051552129611916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411141158","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017686764,0.95380276,0.001086717,0.039671715,0.000703396,0.0017832,0.0001515171,0.000017999515,0.0010140229],"genre_scores_gemma":[0.0005423791,0.92767096,0.056494642,0.009326101,0.0014723781,0.00086340366,0.00032133656,0.000031911,0.0032769165],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970575,0.00020510121,0.0016254493,0.0006726568,0.00017626597,0.00026300346],"domain_scores_gemma":[0.9778502,0.020500943,0.0007868753,0.00030373113,0.00015621318,0.000402065],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005199322,0.0003114366,0.0030253553,0.00006686028,0.00008837468,0.0000098498485,0.00018172772,0.00029948037,0.00015805183],"category_scores_gemma":[0.002170371,0.00025015412,0.0013007435,0.00020214044,0.00086100295,0.000019758943,0.00007798682,0.00053984433,0.000014915836],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006066706,0.0014000352,0.0020637957,0.0014979412,0.00017690117,0.000001296369,0.00022610878,0.0000014420407,1.6758258e-7,0.0001625244,0.015129256,0.9792799],"study_design_scores_gemma":[0.00031706804,0.0028741101,0.0013898166,0.0009804198,0.0017930439,0.0000038900107,0.00014497526,0.00008700921,0.0000018473847,0.00034299967,0.9918825,0.00018231668],"about_ca_topic_score_codex":0.00053516834,"about_ca_topic_score_gemma":0.000009318604,"teacher_disagreement_score":0.97909755,"about_ca_system_score_codex":0.00037091234,"about_ca_system_score_gemma":0.005534389,"threshold_uncertainty_score":0.99999505},"labels":[],"label_agreement":null},{"id":"W4411369061","doi":"10.1200/edbk-25-473822","title":"Proposed Policy Changes to Cancer Care and Oncologic Drug Reimbursement: Exploring the Rationale and Anticipating the Consequences","year":2025,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Telehealth; Health care; Business; Payment; Medicine; Public economics; Actuarial science; Finance; Economics; Telemedicine; Economic growth","score_opus":0.15354776935788725,"score_gpt":0.4359996405009555,"score_spread":0.28245187114306824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411369061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56590784,0.005954427,0.00004375504,0.41888255,0.00038410028,0.00043392472,0.000050901388,0.000006414322,0.008336053],"genre_scores_gemma":[0.919647,0.011684404,0.0023964022,0.061010424,0.00065654254,0.00038848486,0.0000051699244,0.000008220603,0.0042033712],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987815,0.000060931274,0.00064261426,0.00029638968,0.0000342831,0.00018429903],"domain_scores_gemma":[0.99718016,0.0018862657,0.00059933146,0.00015248457,0.0001100548,0.00007168056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089021196,0.00010436888,0.00047175272,0.000043592863,0.00028579315,0.000026133277,0.0001938783,0.000049417962,0.000069309965],"category_scores_gemma":[0.0007896742,0.00007734706,0.00009902312,0.0001904789,0.001832481,0.000103915685,0.00009943173,0.00019508511,0.0000051160423],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008205169,0.0001558245,0.22285785,0.0000811233,0.00029268733,1.6714326e-7,0.021768944,0.00009111038,0.000025123001,0.38263777,0.04575923,0.3262481],"study_design_scores_gemma":[0.00037096802,0.00031261254,0.3253036,0.000039097813,0.000025881372,6.26573e-7,0.010719135,0.00005799051,0.000027631577,0.015573853,0.6474427,0.00012587971],"about_ca_topic_score_codex":0.002768199,"about_ca_topic_score_gemma":0.0005124465,"teacher_disagreement_score":0.6016835,"about_ca_system_score_codex":0.00019845192,"about_ca_system_score_gemma":0.0011774292,"threshold_uncertainty_score":0.67518526},"labels":[],"label_agreement":null},{"id":"W51594977","doi":"10.14694/edbook_am.2012.32.197","title":"Establishing the Standard of Care for Patients with Newly Diagnosed and Recurrent Glioblastoma","year":2012,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Temozolomide; Medicine; Bevacizumab; Oncology; Clinical trial; Randomized controlled trial; Internal medicine; Adjuvant; Dacarbazine; Standard of care; Dosing; Cancer; Chemotherapy","score_opus":0.028420493555544175,"score_gpt":0.3951774383224095,"score_spread":0.3667569447668653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W51594977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97821474,0.0011603725,0.000024937008,0.019337878,0.00020383693,0.00071643566,0.000070566704,0.000005031632,0.0002661782],"genre_scores_gemma":[0.9813496,0.00038674075,0.015406872,0.0022842716,0.00029235953,0.00015511524,0.00005359678,0.00001163824,0.00005980779],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988854,0.000073521296,0.00048076312,0.00016362706,0.00022620431,0.00017049526],"domain_scores_gemma":[0.99248946,0.006131715,0.0005484672,0.00015813604,0.00051041576,0.0001617803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034011021,0.00010099163,0.00059021055,0.000016196222,0.00007236169,0.000003642843,0.000062788786,0.000062066756,0.000042864565],"category_scores_gemma":[0.0006994839,0.000055331075,0.00022890653,0.00009741357,0.0009258564,0.00007670021,0.000029080242,0.00012598406,7.461117e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013778207,0.0021031518,0.80726904,0.000058028505,0.00024482285,9.594008e-8,0.0022798358,0.0000011409912,0.0000019276417,0.00037893813,0.018683488,0.16760169],"study_design_scores_gemma":[0.003927284,0.013167405,0.8118146,0.00006673617,0.00032006556,0.0000012949977,0.003702192,0.00000418127,0.000043510136,0.000034331602,0.16685602,0.00006238628],"about_ca_topic_score_codex":0.000038482398,"about_ca_topic_score_gemma":0.000018743813,"teacher_disagreement_score":0.1675393,"about_ca_system_score_codex":0.00010595731,"about_ca_system_score_gemma":0.00073024136,"threshold_uncertainty_score":0.34113565},"labels":[],"label_agreement":null}]}